





Molecular mechanisms of mitochondrial redox-coupled 













A thesis presented to the  
Graduate School 
of the  
Institute of Science and Technology Austria, Klosterneuburg, Austria  
in partial fulfillment of the requirements  
for the degree of  





The dissertation of Domen Kampjut, titled “Molecular mechanisms of mitochondrial redox-






 Supervisor: Leonid Sazanov, IST Austria, Klosterneuburg, Austria 
 
 
 Signature:                                                             
 
 
Committee Member: Martin Loose, IST Austria, Klosterneuburg, Austria 
 
 
  Signature:                                                             
 
 
Committee Member: David Haselbach, Institute of Molecular Pathology, Vienna, Austria 
 
 
  Signature:                                                             
                                 
 
 Exam Chair: Florian Schur, IST Austria, Klosterneuburg, Austria 
 
 


































© by Domen Kampjut, September, 2020 
 
All Rights Reserved 
 




I hereby declare that this dissertation is my own work and that it does not contain other 
people’s work without this being so stated; this thesis does not contain my previous work 
without this being stated, and the bibliography contains all the literature that I used in writing 
the dissertation. 
 
I declare that this is a true copy of my thesis, including any final revisions, as approved by my 
thesis committee, and that this thesis has not been submitted for a higher degree to any other 
university or institution. 
 
I certify that any republication of materials presented in this thesis has been approved by the 









September 8, 2020 
 
 










Mitochondria are sites of oxidative phosphorylation in eukaryotic cells. Oxidative 
phosphorylation operates by a chemiosmotic mechanism made possible by redox-driven proton 
pumping machines which establish a proton motive force across the inner mitochondrial 
membrane. This electrochemical proton gradient is used to drive ATP synthesis, which powers 
the majority of cellular processes such as protein synthesis, locomotion and signalling. In this 
thesis I investigate the structures and molecular mechanisms of two inner mitochondrial proton 
pumping enzymes, respiratory complex I and transhydrogenase. I present the first high-
resolution structure of the full transhydrogenase from any species, and a significantly improved 
structure of complex I. Improving the resolution from 3.3 Å available previously to up to 2.3 
Å in this thesis allowed us to model bound water molecules, crucial in the proton pumping 
mechanism. For both enzymes, up to five cryo-EM datasets with different substrates and 
inhibitors bound were solved to delineate the catalytic cycle and understand the proton 
pumping mechanism. In transhydrogenase, the proton channel is gated by reversible 
detachment of the NADP(H)-binding domain which opens the proton channel to the opposite 
sites of the membrane. In complex I, the proton channels are gated by reversible protonation 
of key glutamate and lysine residues and breaking of the water wire connecting the proton 
pumps with the quinone reduction site. The tight coupling between the redox and the proton 
pumping reactions in transhydrogenase is achieved by controlling the NADP(H) exchange 
which can only happen when the NADP(H)-binding domain interacts with the membrane 
domain. In complex I, coupling is achieved by cycling of the whole complex between the 
closed state, in which quinone can get reduced, and the open state, in which NADH can induce 
quinol ejection from the binding pocket. On the basis of these results I propose detailed 
mechanisms for catalytic cycles of transhydrogenase and complex I that are consistent with a 
large amount of previous work. In both enzymes, conformational and electrostatic mechanisms 
contribute to the overall catalytic process. Results presented here could be used for better 
understanding of the human pathologies arising from deficiencies of complex I or 
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1.1.  The chemiosmotic theory 
All cellular life requires a source of energy to drive energetically unfavourable 
reactions, such as synthesis of peptides, maintenance of ion gradients and trafficking of 
subcellular components. The majority of these processes are coupled to the hydrolysis of ATP, 
which is highly favourable under the cellular conditions. Standard free energy change of the 
reaction ATP -> ADP + Pi is -30.5 kJ/mol at 1 M concentrations of substrates and pH = 7. In 
cells, concentrations of ATP, ADP and Pi are tightly regulated and because of the 
disequilibrium between them, the free energy of the above reaction is closer to -52 kJ/mol. ATP 
was first isolated in 1929 from muscle cells. In 1940 it was proposed to be the universal energy 
currency of life and in 1948 mitochondria were established as the sites of oxidative 
phosphorylation in the cell. It was not until 1961 that Peter Mitchell proposed how oxidative 
phosphorylation replenishes ATP in cells, and only by about 1975 did his hypothesis become 
widely appreciated. Unravelling the mechanism of oxidative phosphorylation can be placed 
alongside genetic code determination as one of the grand challenges of biology in the second 
half of the 20th century. 
Initially, a substrate-level phosphorylation was proposed to drive ATP formation, 
whereby a high-energy phosphorylated intermediate is produced in catabolism that can donate 
a phosphate group to ADP. This process does exist in glycolysis and provides a small amount 
of cellular ATP. The reaction is catalysed by phosphoglycerate kinase, 1,3-
bisphosphoglycerate + ADP ⇌ glycerate 3-phosphate + ATP in glycolysis. However, no 
similar intermediate could be found in mitochondria. Secondly, ATP synthesis from ADP to Pi 
could be driven by a specialized enzyme via a conformational change mechanism. However, 
such an enzyme could not be isolated and it was not clear where the free energy to drive the 
ATP synthesis could come from. Finally, in 1961, Peter Mitchell proposed that ADP 
phosphorylation in mitochondria occurs by coupling this process to a proton gradient which 
exists across the mitochondrial inner membrane, as well as across thylakoid and bacterial cell 
membranes (Mitchell, 1961). This hypothesis requires the existence of an ion-impermeable 
membrane with two types of proton pumps embedded in it. It was widely debated in the 1960s 
and 1970s and eventually proven. In 1978, Peter Mitchell received a Nobel Prize for developing 
the theory. 
One of the first conclusive proofs came from the Jagendorf experiments. Thylakoids 




resulted in fast ATP production, even in the absence of light as normally required by thylakoid 
membranes (Uribe and Jagendorf, 1968).  
The theory envisaged the existence of two types of membrane-embedded proton pumps. 
Redox-reaction driven proton pumps (NADH oxidase in Figure 1.1) use the free energy from 
oxidation reactions to pump protons across the membrane. In photosynthetic organisms, light 
is used to drive proton pumping. In both autotrophic and heterotrophic organisms, however, 
the ATP synthase couples the energetically favourable flow of protons down their 
electrochemical gradient to ATP synthesis by a unique rotary catalytic mechanism (Walker, 
2012). ATP synthase is one of the most conserved and ancient proteins and it has been 
suggested that it was one of the first enzymes to have evolved, potentially even before the 
evolution of cellularity. In primordial life, an ancestral ATP synthase could have been involved 
in harvesting environmental proton gradients, such as those that exist in deep-sea hydrothermal 
vents (Martin, Sousa and Lane, 2014). This would evolutionary explain why all life uses proton 
(or sometimes ion) gradients in the energy metabolism and the conservation of the ATP 
synthase. 
 
Figure 1.1 Mitchell's chemiosmotic hypothesis.  
Energy-transducing membranes are impermeable to protons and contain two types of proton pumps. Redox-
coupled proton pumps (NADH oxidase in the scheme) pump protons to the P-side (+) using the free energy from 
substrate oxidation reactions. ATP synthase (ATPase in the scheme) uses the resulting proton motive force for 
ATP synthesis.  
Figure adapted from Mitchell, 1978 
Figure 1.1. Mitchell’s chemiosmotic hypothesis. 
Energy transducing membranes are impermeable to protons and contain two types of proton pumps. 
Redox-coupled proton pumps (NADH oxidase in the scheme) pump protons to the P-side (+) using the 
free energy from substrate oxidation reactions. ATP synthase (ATPase in the scheme) uses the resulting 
proton motive force for ATP synthesis. 
Figure adapted from Mitchell, 1978
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Proton motive force in bioenergetics refers to the difference in the proton 
electrochemical potential on each side of the membrane. Pmf has two thermodynamically 
interchangeable components, one due to the concentration difference of protons on either side 
of the membrane (pH) and one due to the difference in the electric potential (): Pmf =  
- 59pH. In most cases of bioenergetic membranes (with the exception of thylakoid), the 
majority of pmf comes from electric components.  
Evolutionary, mitochondria and chloroplasts are direct successors of bacteria, as they 
were acquired ~ 2 billion years ago by the eukaryotic cell in the process of endosymbiosis. 
During the evolution, the symbiotic relationship tightened and modern-day mitochondria have 
relinquished most of their genes to the nucleus, but retained a handful of genes coding for 
components of the electron transport chain and gene expression machinery. The reasons for 
this are not entirely clear, however. Mitochondria are also important in cells for signalling, 
production of certain metabolites and have a crucial role in apoptosis.  
 
1.2.  The mitochondrial electron transport chain 
If the primordial life may have depended on the external proton gradient to sustain ATP 
production, modern life generates these gradients using its own specialised machinery. In the 
case of mitochondria, the redox reactions result in proton pumping by respiratory complexes I, 
III and IV. Complex I catalyses the transfer of electrons from NADH to ubiquinone, complex 
III from ubiquinone to cytochrome c and complex IV from cytochrome c to oxygen. This 
creates a stepping gradient from the most reducing substrate with midpoint-electric potentials 
and a sequential release of energy and its storing in proton gradient. The main consumer of the 
proton gradient is the ATP synthase. Other consumers of the proton gradient include 
transhydrogenase, which maintains a high NADPH/NADP+ ratio, metabolite carriers 
(phosphate carrier, Na+ and Ca2+ cycling) and the uncoupling proteins. In mitochondria, some 
other metabolic reactions contribute to ubiquinone reduction as well, but they are not coupled 
to proton translocation across the membrane. They include complex II (succinate 
dehydrogenase), electron transfer flavoprotein-ubiquinone oxidoreductase (ETF-QO), GPDH 
and dihydroorotate dehydrogenase. In other organisms, especially in bacteria, this basic 
electron transfer chain framework can be expanded with several other possible entry points and 
branching pathways, depending on the substrates and environmental conditions.  
The ETC complexes are large multi-subunit assemblies with many redox cofactors 




eukaryotic enzymes typically containing several supernumerary subunits which are not 
catalytically active but are important for additional layers of regulation or stability. 
Mitochondrial DNA has retained genes for several of the core subunits of ETC complexes, 
while all of the other genes, apart from a handful of genes connected with the mitochondrial 
protein synthesis have been relocated to the nucleus. The reason why genes for ETC complexes 
remained in mitochondria is not clear but could include high hydrophobicity of the proteins 
they encode or the need for faster in situ gene expression regulation in response to redox signals 
that cannot be achieved by retrograde signalling to the nucleus (Allen, 2015). Recently it was 
also discovered that complexes also exist in the form of supercomplexes (Schagger and 
Pfeiffer, 2000). Supercomplexes exist in varying compositions, depending on the organism and 
the tissue from which they come. The physiological function of them is currently the subject 
of intense investigation. The main hypothesis being debated is that they help to organise 
respiratory complexes in a tightly packed membrane, whereas the substrate channelling 
hypothesis has largely been disproven (Lobo-Jarne and Ugalde, 2018).  
 
 
Figure 1.2. Mammalian mitochondrial proton pumping enzymes.  
The structures of the mitochondrial proton pumping enzymes have recently become available. Proteins are 
coloured by subunits: red colours represent subunits encoded in the mitochondrial genome, blue colours are 
the core subunits conserved across all organisms but not encoded by the mtDNA and yellow colours are 
supernumerary subunits. Electric potentials of substrate-product pairs are indicated in the scheme for the 
typical ratios present in mitochondria (hence NADH and NADPH have different potentials). 
 
Biochemically, all of the above complexes I, III and IV (as well as transhydrogenase) 
catalyse redox-coupled proton pumping but achieve it by radically different means, which 
reflect their distinct evolutionary ancestry. ATPase is not considered a redox-coupled proton 
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pump, because proton pumping in ATPase is linked to a phosphorylation reaction by a unique 
rotary coupling mechanism and will not be discussed further here. Complex I and 
transhydrogenase will be described in more detail in sections 1.5 and 1.3 respectively. Their 
structures became available only recently and the mechanism for their reactions is not firmly 
established yet. Complexes III and IV, however, have been structurally characterised over 20 
years ago and their mechanisms are well understood. They are briefly introduced below to 
enable comparison with complex I and transhydrogenase in the Discussion. 
Complex III catalyses electron transfer from ubiquinol to cytochrome c (Figure 1.3). It 
is the only one of the respiratory complexes which operates by a redox loop, originally 
envisaged by Mitchell. Mitchell’s proposal stated that protons are taken up by a mobile carrier 
from the N-side of the membrane and then released to the P-side during oxidation of the mobile 
carrier. The stoichiometry of a redox loop is always 1 proton per 1 electron. Complex III is an 
obligate dimer with 11 subunits per monomer in mammals (Iwata et al., 1998). The catalytic 
core subunits are conserved from bacteria and are necessary for the reaction (Smith, Fox and 
Winge, 2012). They include cytochrome b, which contains haemes bH and bL, cytochrome c, 
which contains haem c1 and binds cytochrome c, and Rieske protein which contains an Fe2S2 
cluster that transfers electrons between the two cytochromes. Complex III oxidises two 
molecules of quinol and reduces one molecule of quinone per catalytic cycle. In the first half 
of the cycle, one molecule of quinol is oxidised at the Qo site near the IMS. The resulting two 
protons are released into the IMS, while the two electrons bifurcate: one goes towards the Qi 
site via the two haems, while the other one goes via the FeS cluster of a mobile Rieske protein 
towards the cytochrome c. In the second half of the cycle, another molecule of quinol is 
oxidised at the Qo site and the resulting protons and electrons follow the same pathways as in 
the first half. At the Qi site, the two electrons are then used to reduce a molecule of quinone, 
with the two required protons originating from the matrix. Overall, this results in consumption 
of two protons from the matrix side, release of four protons to the IMS and reduction of two 
molecules of cytochrome c. The majority of the charge transfer comes from the movement of 
an electron from P-side to N-side, hence complex III pumps net one proton per each electron 
transferred, consistent also with the energy available from the midpoint electric potential 






Figure 1.3. Complex III - bc1 complex.  
Complex III transfers electrons from quinol to cytochrome c and pumps protons by a redox loop mechanism. One 
of the monomers is shown in grey and the other one in red (with the exception of the Rieske protein in blue). Redox 
centres are shown as sticks and the movements of electrons and substrates are shown in full arrows for the first 
half of the catalytic cycle and in dotted arrows for the second half of the catalytic cycle.  
Figure based on PDB 1PPJ 
 
Complex IV was the first redox-coupled proton pump for which the crystal structure 
was solved (Iwata et al., 1995). Mammalian complex IV contains 13-14 subunits, while its 
bacterial counterparts contain three core subunits. All three are encoded by the mtDNA in 
mammals. COX1 contains a haem a group and a binuclear haem a3-CuB centre (binuclear 
cluster, BNC), COX2 contains the CuA centre, while COX3 does not have any prosthetic 
groups. Complex IV catalyses the final electron transfer reaction between cytochrome c and 
dioxygen via the haems and the metal centres (Figure 1.4). Oxygen is bound by the BNC and 
its reduction occurs in four steps, during which tyrosine donates an electron and a proton for 
O-O cleavage, forming a tyrosyl radical. During each step, one “chemical” proton is taken up 
from the N-side for water formation, and one “pumped” proton is taken up to be pumped to the 
P-side of the membrane (Blomberg, 2016). Complex IV is thus both a redox loop and a direct 
proton pump. For the chemical protons, there is charge transfer against the PMF and their 
release as a part of a neutral water molecule to the same side of the membrane. Translocation 
Figure 1.3. Complex III - bc1 complex
Complex III transfers electrons from quinol to cytochrome c. It is an obligate dimer, one monomer is 
shown in grey here. It is the nly respirat ry c mplex to operate a redox cycle for pumping protons. In the 
first half of the cycle, shown i  full arrows, 1 molecule of quinol is oxidised at the Qo site near the IMS. 
This realeases 2 protons into the IMS. Electrons from qui ol bifurc , on  goes towards the Qi site via 
two haems, while the other one goes via the FeS cluster on a mobile Rieske protein towards cytochrome c. 
In the second half of the cycle, shown in dotter arrows, another molecule of quinol is oxidised at the Qo 
site and the two electron follow the same bifurcated path as in the first half. At Qi site, the two electrons 
and two protons from the matrix are used to reduce a molecule of quinone. Overall, this results in 
consumption of two protons from the matrix side, release of four protons to the IMS and reduction of two 
molecules of cytochrome c. Most of the charge transfer in this mechanism comes from the inward 
mo ement of two lectrons.


























of the pumped protons occurs by vectorial proton transfer from the N-side to the P-side. The 
process of coupling between electron transfer and proton pumping is linked by almost purely 
Coulombic principles and does not depend on the protein conformational changes. Preventing 
slipping (re-release of the proton into the N-side of the membrane) is prevented by kinetic 
restriction (Wikström and Sharma, 2018).  
 
Figure 1.4. Complex IV - cytochrome c oxidase. 
Complex IV is the final oxidase which transfers electrons from cytochrome c to oxygen. Details of the mechanism 
are described above. Complex IV pumps four protons by a direct mechanism and consumes further four protons 
from the matrix side for the formation of water.  











Figure 1.4. Complex IV - cytochr me c oxidase
The structures of the mitochondrial proton pumping enzymes have recently become available. Proteins are 
coloured by subunits: red colours represent subunits encoded in the mitochondrial genome, blue colours 
are the core subunits conserved across all organisms but not encoded by the mtDNA and yellow colours 
are supernumerary subunits. Electric potentials of substrate-product pairs are indicated in the scheme for 
the typical ratios present in mitochondria (hence NADH and NADPH have different potentials). 



















1.3. Transhydrogenase  
Proton-translocating nicotinamide nucleotide transhydrogenase (NNT) is another 
redox-driven proton pump, which is found in many bacterial species and mitochondria. It 
catalyses a fully reversible transfer of hydride between NAD(H) and NADP(H) and pumps one 
proton for each hydride transferred: 
NADH + NADP+ + H+P <-> NAD+ + NADPH + H+N 
It has a unique feature of operating on the substrates with the same mid-point electric 
potential, although due to the different relative oxidized/reduced ratios of the two substrate 
pools, the electric potentials of NADPH and NADH differ in vivo (Figure 1.2) (Jackson et al., 
2015). The direction of the reaction depends on the relative ratios between the substrate and 
product concentrations and the proton motive force (PMF) across the membrane. The reaction 
from the left-hand side to the right-hand side is referred to as the “forward transhydrogenation” 
and the opposite reaction is referred to as “reverse transhydrogenation”. The fact that forward 
transhydrogenation is coupled to proton pumping was established by experiments in which 
transhydrogenase was reconstituted into mixed liposomes with ATP synthase or 
bacteriorhodopsin. When either of these secondary proton pumps established proton motive 
force, forward transhydrogenation was increased up to 30 fold (Eytan, Eytan and Rydström, 
1987; Eytans et al., 1987). Transhydrogenase can enrich products over substrate by ~500 fold 
under the PMF typically present across the inner mitochondrial membrane (Jackson, 2012). In 
vitro, transhydrogenase can also catalyse “cyclic transhydrogenation”, in which a reducing 
equivalent is transferred from NADH (or its analogue APADH) to a tightly bound NADP+ and 
then to another molecule of NAD+ (or APAD+). In this process, no protons are pumped across 
the membrane. The reaction has a low pH optimum and is very unlikely to be of any 
physiological importance but it was used to investigate the mechanism and proton pumping of 
transhydrogenase (Jackson, 2012).  
All of the known transhydrogenases have a similar obligate homodimeric structure.  
Each monomer is composed of three domains, NAD(H)-binding dI, transmembrane dII and 
NADP(H)-binding dIII, split between one, two or three polypeptides. The spatial arrangement 
of these domains has been revealed for the first time by the architecture of T. thermophilus 




Figure 1.5. Architecture of T. thermophilus transhydrogenase.  
Isolated domains of T. thermophilus NNT were crystallised and docked into a 7Å crystal structure of full 
transhydrogenase. This revealed the asymmetry of the dimer where dIII-a is attached to dI (face-up), while dIII-
b is attached to dII (face-down). Hydride transfer is only possible in the face-up orientation. 
Figure based on PDB 4O9U. 
 
1.3.1. Evolutionary origin of transhydrogenase 
Transhydrogenase can be found in all three domains of life. In Bacteria and Archaea it 
is localised in the plasma membrane and in Eukarya it is found in the inner mitochondrial 
membrane. It is present in 57% and 46% of eukaryotic and bacterial phyla, respectively, but 
only in 3% of archaeal phyla (Marreiros et al., 2016). Within the eukaryotes there is a sharp 
distinction between animals, fungi and protists, which almost always contain transhydrogenase 
and higher plants, from which transhydrogenase is entirely absent. This is because in plants 
other NADPH-producing enzymes are more dominant and because light reactions of 
photosynthesis produce a lot of NADPH (Corpas and Barroso, 2014). Bacterial species also 
encode another transhydrogenase enzyme, UdhA, which is soluble and not linked to PMF. 
These two transhydrogenases do not share structural features or their origin and appear to have 
opposing metabolic roles (Heinemann et al., 2016). UdhA and NNT are differentially regulated 
by ArcA, which activates NNT transcription and represses UdhA transcription in a redox-
dependent fashion, thus reducing NADH production, while increasing NADPH production 













Figure 1.6. Architecture of T. thermophilus transh drogenase
Isolated domains of T. thermophilus NNT were crystallised and docked into a 7Å crystal structure of full 
transhydrogenase. This revealed the asymmetry of the dimer where dIII-a is attached to dI (face-up), while 
dIII-b is attached to dII (face-down). Hydride transfer is only possible in the face-up orientation.




NADPH is produced, indicating that UdhA is typically a NADPH consumer, while NNT is a 
NADPH producer (Sauer et al., 2004). 
The exact evolutionary origin of transhydrogenase is unclear. The strong sequence 
similarity of the known transhydrogenases suggests a single origin. Because it is nearly absent 
from Archaea, it probably evolved in bacteria after the Archaea split from the bacterial lineage. 
It was then transferred to Eukarya via endosymbiosis of α-proteobacteria which became 
modern mitochondria. Evolutionary analysis suggests that transhydrogenase evolved in tandem 
with an ion-translocating NADH dehydrogenase (complex I), their functions probably being 
complementary (Studley et al., 1999; Albracht, Meijer and Rydström, 2011). Only the 
NAD(H)-binding domain, dI, shows any sequence similarity to other proteins, specifically to 
bacterial alanine dehydrogenase and eukaryotic saccharopine dehydrogenase (Studley et al., 
1999). dIII and dII do not share significant sequence similarity to other protein families. 
Sequence of the dIII domain is, however, the most conserved between species followed by dI 
and dII respectively.  
Interdomain fusion and splicing occurred several times during the evolution and some 
species have all the three domains encoded on a single polypeptide, while others have them 
distributed over two or three polypeptides or encoded in a different sequence (Figure 1.6). The 
number of transmembrane helices also varies between 12 and 14 in different species. High-
resolution structure of transhydrogenase would provide an explanation of how these modular 
domains with distinct evolutionary origins work together.  
 
 
Figure 1.6. Domain split of model transhydrogenases.  
NNT is split into one, two or three polypeptide chains. dII-dIII linker is conserved in all transhydrogenases, while 
the dI-dII linker and TM1 are limited to NNTs with - polypeptide split (e.g. E. coli) and single polypeptide NNTs 
(metazoans, including mammals). TM5 is only present in metazoans. 





1.3.2. Physiological role of transhydrogenase 
Transhydrogenase operates at the interface between catabolism and anabolism by 
interconverting NADP(H) and NAD(H) pools. Furthermore, it interacts also with the proton 
motive force, which makes it unique among the metabolic enzymes. Physiologically, 
mitochondrial transhydrogenase runs in the forward direction and provides NADPH at the 
expense of NADH and the pmf (Figure 1.7). NADPH is a substrate for anabolic reactions and 
the reactive oxygen species detoxification system. Finely tuned NADPH/NADP+ ratio is also 
an important signifier of the oxidative status within the cell (Rydström, 2006; Jackson, 2012). 
NADPH regulates the redox state of the mitochondrial matrix by maintaining a highly reduced 
glutathione pool via NADPH-linked glutathione reductase. NADPH level is also important for 
hydrogen peroxide detoxification in mitochondria. Peroxidases depend on electrons from 
thioredoxins that are in turn reduced by electrons ultimately originating from NADPH. This 
system is particularly crucial for mitochondria, as they generate a lot of hydrogen peroxide as 
a by-product of mitochondrial metabolism in particular by complexes I and III as well as other 
NADH-linked dehydrogenase enzymes. Indeed, when NNT is knocked out from a superoxide 
dismutase-deficient mouse strain, the effect is lethal, despite neither of the individual knock-
outs being lethal by themselves (Kim et al., 2010). The role of NNT in ROS detoxification is 
further made clear by a finding that the loss of NNT increases the expression of mitochondrial 
catalase, which is an alternative hydrogen peroxide detoxifier (Dogar et al., 2020). Overall, 
respiratory state of the mitochondria and presence of other sources of NADPH in liver 






Figure 1.7. Physiological roles of transhydrogenase.  
Transhydrogenase operates in the forward mode physiologically. NADPH which it produces is used for anabolic 
reactions directly. NADPH is also a substrate for glutathione reductase (GR), which is an essential part of the 
ROS detoxification system. It could also be involved in regulation of the Krebs cycle.  
Adapted from Nickel et al., 2015. 
 
Another possible role of NNT was suggested to be fine-tuning of the Krebs cycle and 
linking its regulation to NAD(P)H/NAD(P)+ levels and pmf. If NADP-linked isocitrate 
dehydrogenase (IDH2) operates in the reverse direction and NAD-linked isocitrate 
dehydrogenase in the forward direction they establish a futile cycle of -ketoglutarate and 
isocitrate. This makes the metabolic flow at this stage of the Krebs cycle much more sensitive 
to allosteric regulation (Sazanov and Jackson, 1994). Since transhydrogenase is pmf-linked, 
this would also allow coupling of Krebs cycle regulation to the pmf. At lower pmf NADPH 
levels would diminish and reverse flow via IDH2 would dimish as well. This would stimulate 
the Krebs cycle to regenerate NADH and consequently pmf. This hypothesis also elegantly 
explains why transhydrogenase is linked to the pmf and the seemingly superfluous presence of 
two mitochondrial isocitrate dehydrogenases. So far, the experimental evidence in favour of 
the proposal has demonstration the reverse operation of IDH2 (Rosiersl et al., 1994) but not 
the full futile cycle yet. 
In bacteria NNT is also believed to provide NADPH for anabolic reactions. This has 
been exploited extensively for the biotechnological purposes because overexpression of either 
of the bacterial transhydrogenases often significantly increases yields of valuable secondary 
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metabolites (Jan et al., 2013; Shi et al., 2013). In E. coli without either of the transhydrogenase 
enzymes, concentrations of the Krebs cycle intermediates drastically increase, citrate up to 60 
fold, while glutamate levels decrease (Timischl et al., 2008). This can be explained by NADH-
mediated inhibition of Krebs cycle and increased glutamate catabolism to supply necessary 
NADPH. The only exception to NADPH-producing role of NNT are specialized anaerobic 
parasites, such as a cestode H. diminuta. They operate NNT in the reverse direction which 
generates proton motive force and thus supports anaerobic ATP production (Mercer-Haines 
and Fioravanti, 2008).  
Despite the fact that NNT is a core bioenergetic enzyme, its loss is not lethal in humans 
or mice because mitochondria have other sources of NADPH that are able to partly compensate 
for NNT loss (Francisco et al., 2018). These sources include the NADP-linked isocitrate 
dehydrogenase (IDH2), malic enzyme and glutamate dehydrogenase. NNT expression also 
varies widely between tissues. In mice it is the highest in heart, kidney, liver and testicles. The 
lowest expression (more than 10 times lower than in heart) was found in skin, skeletal muscle 
and brain (Arkblad et al., 2002). Nevertheless, recent proteomic data suggest that differences 
between tissues are lower and that brain tissue in fact highly expresses NNT (Uhlén et al., 
2015). The previously observed differences could also reflect intra-tissue heterogeneity, 
different densities of mitochondria in different tissues or different rates of proteolytic turnover 
of NNT in different tissues.  
 
1.3.3. Relevance of transhydrogenase in disease 
Despite not being lethal, loss of transhydrogenase nevertheless results in pathological 
conditions in humans. In 2012, a link between NNT deficiency and a rare form familial 
glucocorticoid deficiency (FGD) was described (Meimaridou et al., 2012; Flück, 2017). NNT 
deficiency accounts for ~10% of all FGD cases. Patients of FGD suffer primarily of isolated 
glucocorticoid deficiency often accompanied by hypoglycaemia, seizures, failure to thrive, 
muscle weakness and frequent infections. Disease is currently treatable well with hormone 
supplementation but needs to be diagnosed promptly before a fatal hypoglycaemic attack could 
occur. The pathophysiological cascade between transhydrogenase deficiency and 
glucocorticoid deficiency has been proposed to involve either diminished NADPH levels, ROS 
dysregulation or both. Adrenal tissue might be particularly sensitive to ROS stress which would 
increase in the absence of NNT (R Prasad et al., 2014). The ROS hypothesis is supported by 
the fact that mutations in thioredoxin reductase 2 (TXNRD2), another ROS homeostasis 




other hand directly affect steroid hormone synthesis as the mitochondrial cytochrome enzymes 
responsible for corticoid synthesis depend on NADPH. This hypothesis is partly supported by 
the fact that some FGD patients also exhibit gonadal symptoms and hypothyroidism (Roucher-
Boulez et al., 2016). It is not clear why relatively few FGD patients also have decreased 
mineralocorticoid levels. Overall, the phenotypic heterogeneity of FGD is large and even 
patients from the same families can be affected very differently, which suggests that there is a 
large effect of the environment and genetic background on the outcome of the disease. 
Phenotypes of heterozygotes are also not clear in humans nor in mice and more research also 
needs to be done to uncover potential non-symptomatic patients with NNT deficiency. 
In mice, a widely used strain C57BL/6J (6J) has been shown to have dysfunctional 
transhydrogenase due to a missense mutation and several exon deletions in its NNT gene which 
predisposes it to metabolic abnormalities similar to the type II diabetes (Toye et al., 2005). The 
glucose intolerance is caused by insulin response to glucose stress in 6J mice compared to 6N 
(sister strain with intact NNT gene) mice (Fergusson et al., 2014). Absence of NNT interferes 
with release of insulin from pancreatic -islet cells because lack of NNT prevents glucose from 
closing the K+ATP channels and opening the Ca2+ channels in pancreatic beta cells (Attané et 
al., 2016). It has been rather controversially proposed that reverse NNT operation could be 
responsible for the release of insulin in -cells (Santos et al., 2017). Pancreatic -cells lacking 
NNT also show a profound increase in ROS (Ronchi et al., 2013). In humans, there also appears 
to be a link between NNT deficiency and diabetes as described recently for a patient with 
adrenal insufficiency and diabetes as a cause of NNT loss (Scott, Van Vliet and Deladoëy, 
2017). NNT expression was also found to be higher in visceral fat of obese patients compared 
to normal weight people (Heiker et al., 2013).  
Under non-physiological circumstances, i.e. heart failure, transhydrogenase can 
strikingly operate in the reverse direction to compensate for the decreased proton motive force 
(Nickel et al., 2015). Oxidation of NADPH to re-establish pmf, however, comes at a cost of 
increased oxidative stress and ROS production (Nickel et al., 2015). This is consistent with a 
finding that brain damage resulting from postnatal hypoxic ischemia brain injury was reduced 
in 6J mice compared to 6N (Wolf et al., 2016). Inhibition of transhydrogenase could thus have 
a potentially therapeutic effect in ischemia-reperfusion injury and in situations involving 
increased ROS in general. 
NNT could also be a target for inhibitors in several cancers. The occurrence of 
spontaneous as well as some types of chemically induced cancers is much lower in C57BL/6J 
15 
 
mice than in other mouse strains, possibly due to increased susceptibility to ROS (Albracht, 
Meijer and Rydström, 2011). NNT knockdowns were also found to lead to reduced 
tumorigenicity and proliferation of SK-Hep1 cells (Ho et al., 2017). Furthermore, NNT was 
found to be over-expressed in several tumours: in non-small lung cancer (He, Zhang and Xia, 
2020), bladder cancer (Wu et al., 2019), gastric cancer (Li et al., 2018) and cholangiocarcinoma 
(Gu et al., 2019; Huang et al., 2019). NNT is downregulated in gastric tumour tissue but 
upregulated in invasive tumours (Esfandi et al., 2019). In breast cancer, NNT expression does 
not differ but NNT-AS1 (antisense long non-coding RNA against NNT) was found to be 
downregulated (Gargari et al., 2019). Inhibition of transhydrogenase thus deserves more 
research in the coming years and new NNT inhibitors need to be developed as no specific nano-
molar affinity inhibitors are currently known.  
Finally, NNT inhibition could be used to treat infections. 6J mice were more resistant 
to pulmonary infection with Streptococcus pneumoniae due to the reduced macrophage 
inflammatory response (Ripoll et al., 2012). The malaria parasite has also been recently shown 
to be dependent on NNT to provide NADPH to apicoplast and crystalloid organelles (Saeed et 
al., 2020). Overall, transhydrogenase is an important emerging drug target in cancer and 
metabolic diseases. NNT inhibitors could be particularly useful because NNT inhibition is not 
lethal in humans.  
 
1.4.Recent structural and mechanistic understanding of transhydrogenase 
Kaplan and co-workers first described transhydrogenation activity in Pseudomonas 
fluorescens and in animal tissues (Colowick et al., 1952; Kaplan, Colowick and Neufeld, 1952, 
1953). Later transhydrogenases were described in many organisms but most biochemical and 
structural work has been done on the four model transhydrogenases: from Escherischia coli, 
Rhodospirillum rubrum, Thermus thermophilus and Bos taurus.  
Since 1999 structures of isolated domains and dI2dIII complexes from several of these 
species were solved by x-ray crystallography in native, reduced or oxidised states (Prasad et 
al., 1999; Cotton et al., 2001; Singh et al., 2003; Sundaresan et al., 2003; Mather et al., 2004; 
Johansson et al., 2005). While these structures showed the atomic details of protein folds and 
interaction with substrates, they failed to explain the unique mechanism of NNT which depends 
on the arrangement and coordination of all the domains in the dimer. Below I briefly describe 
the structures of isolated domains of NNT and then discuss the architecture of intact 




dI always purifies and crystallises as a dimer. Dimer of two ~40 kDa monomers is 
stabilised by a large buried surface extended by an elongated hairpin (ovine residues 172-184) 
reaching out from each monomer into the neighbour. NAD(H) occupies a classical nucleotide 
binding site in one of the two Rossmann folds that comprise the dI monomer (Prasad et al., 
2002; Johansson et al., 2005; Sundaresan et al., 2005).  
dIII domain on the other hand crystallises as a monomer. The ~20 kDa domain 
comprises a single classical Rossmann fold with six-stranded -sheet but NADP(H) binds in a 
non-classical manner with a reverse nucleotide orientation which is important for bringing the 
NADP nucleotide into close contact with NAD nucleotide on the dI domain for direct hydride 
transfer (Prasad et al., 1999; Jeeves et al., 2000; White et al., 2000). All the solved structures 
of dIII domain to date have essentially the same conformation. Loops D and E are 
transhydrogenase-specific and highly conserved structural elements that have been proposed 
to be involved in the mechanism. Loop E closes over the nucleotide binding pocket, whereas 
loop D could provide contact surface for interactions with other domains. Loop D  has been 
observed in two different conformations in R. rubrum dIII in the two molecules in one 
asymmetric unit and since loop D is also not close to the nucleotide binding pocket this 
transition probably is not catalytically important (Sundaresan et al., 2003). The alternative, 
non-dI binding conformation of dIII is therefore still not resolved and only a structure of an 
intact enzyme can reveal different redox-dependent conformations of dIII.  
Structures of dI2dIII heterotrimers from T. thermophilus and R. rubrum showed the 
nicotinamide rings closely poised for hydride transfer between NAD(H) and NADP(H) across 
the dI/dIII interface and established that hydride transfer between the two nucleotide must be 
direct as they approach each other to within 3-4 Å. Surprisingly, they also demonstrated that 
only one copy of dIII can bind to dI2 at a time (Cotton et al., 2001; Singh et al., 2003; Mather 
et al., 2004; Sundaresan et al., 2005). Binding of two molecules of dIII to the dI dimer in the 
same orientation is sterically prohibited and binding of the second dIII monomer would either 
require reorganization of its structure or the first dIII to detach.  
Structure of the transmembrane dII was elucidated only recently. Isolated T. 
thermophilus dII was solved in meso and revealed a unique fold and a putative proton 
translocation pathway (Leung et al., 2015). An improved 2.2 Å resolution structure of T. 
thermophilus dII structure delineated the proton transfer pathway in more detail and observed 
the presence of relatively large solvent-accessible cavities on either side of the membrane 
(Padayatti et al., 2017). These cavities are separated by a couple of highly conserved residues, 
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α2H42 and T214, which are involved in proton transport. E. coli transhydrogenase which is 
the most biochemically characterized bacterial enzyme also contains a histidine residue near 
the centre of the membrane but it appears to be H91 based on mutagenesis studies (Hu et al., 
1999).  
To date, the only intact architecture of NNT was determined at 6.9 Å resolution in the 
presence of NADP+ from T. thermophilus+ (Leung et al., 2015). It showed that NNT is an 
asymmetric dimer, with dIII adopting a face-up position (suitable for hydride transfer) in one 
monomer and a face-down conformation in the other monomer, compatible with the finding 
that only one dIII can bind to dI2 at a time (Leung et al., 2015).  
The existence of the asymmetric conformation of NNT led to a proposal of a “division 
of labour” mechanism (Figure 1.8) in which dIII rotates 180º and alternatively functions in 
proton translocation (face-down) and hydride transfer (face-up) (Jackson et al., 2015). The key 
feature of the mechanism which prevents slipping (i.e. decoupling proton transfer from hydride 
transfer) is the occlusion (kinetic restriction) of the nucleotide bound to dIII. Kinetic studies of 
the cyclic NAD(H) reaction (where NADP(H) remains bound to dIII) revealed that the 
occluded NADP(H) state is elevated at a low pH, when the key protonatable residue in dII is 
protonated (Hutton et al., 1994; Sazanov and Jackson, 1995). It was also shown that the binding 
affinities of NAD(H) to dI are not altered during the catalytic cycle; this domain usually 
remains open (Hutton et al., 1994; Hu et al., 1995; Venning et al., 1998, 2000). The proposed 
mechanism involved six tightly regulated consecutive steps which required strict out-of-phase 





Figure 1.8. Division of labour mechanism of NNT.  
Reactions on the two monomers (blue and red) proceed in an anti-phase fashion. dIII can exist in occluded (full 
outline) and open (dashed outline) conformation, while dI is always open. dIII cycles between face-up and face-
down conformations. dII can exist in occluded, open-to-N-side or open-to-P-side conformations. Coupling is 
achieved by interaction between dII and dIII. 
Reproduced from Jackson et al., 2015 
 
However, the details of this mechanism were largely speculative in the absence of high-
resolution structure of NNT in several of the proposed intermediate steps. While being 
consistent with the T. thermophilus architecture and most of the previous biochemical work 
they also failed to account for the key finding that NADP+/NADPH have different effects on 
the conformation of NNT (Yamaguchi and Hatefi, 1989; Yamaguchi, Wakabayashi and Hatefi, 
1990). NADPH has been shown to increase the susceptibility of several bonds outside of the 
dIII domain (in particular within the dI-dII linker) to tryptic hydrolysis which suggests that 
NADPH can bring about long-range conformational changes (Yamaguchi, Wakabayashi and 
Hatefi, 1990). Similarly, NADPH and NADP+ lead to different susceptibility of Cys893 to 
chemical modification in mitochondrial and bacterial enzyme (Yamaguchi and Hatefi, 1989; 
Bragg and Hou, 1999). Clearly, NADPH and NADP+ promote radically different 
conformations of transhydrogenase, whereas according to the proposed mechanism, their 
effects on the NNT should not differ. This indicates a clear need to understand the mechanism 




Figure 1.8. Previously proposed mechanism of transhydrogenase. 
 a, Schematic representation of the domains, linkers, binding sites and conformation of the mammalian 
transhydrogenase in the “double face-down” (both dIII attached to dII) conformation (apo and NADP+ 
datasets). Other possible conformations of NNT include one or both dIII detached, the asymmetric 
conformation in T. thermophilus (N.B. the absence of dI-dII linker) and the sterically prohibited double-
face-up conformation.
Adapted from Jackson et al., 2015
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1.5.  Complex I 
Complex I is the largest of the mitochondrial respiratory complexes with a total mass 
of ~ 1 MDa. It can be divided into the membrane domain (MD) and the peripheral arm (PA), 
in total composed of 45 polypeptide subunits. Fourteen of them are the “minimal catalytically 
active” core subunits conserved throughout bacterial and eukaryotic complex I (Figure 1.9) 
(Baradaran et al., 2013). The rest of the subunits are species-specific and are believed to be 
important for the regulation and stability of the complex (Stroud et al., 2016). Mammalian 
complex I is not catalytically active until fully assembled with all of its supernumerary 
subunits. Supernumerary subunits are mostly small (10-20 kDa with the exception of the 39 
kDa and 42 kDa subunits) and form a “cage” around the evolutionary conserved core subunits 
(Figure 1.10) (Fiedorczuk et al., 2016). It has been described that supernumerary subunits are 
necessary for the stability and activity of complex I but the exact function of many of the 
supernumerary subunits have not yet been established. Particularly interesting are the 
supernumerary subunits with bound cofactors. 13 kDa binds a Zn2+ ion, which could mean that 
it has a redox signaling role. Because of the vicinity of the Zn2+ ion to the FeS chain (13 Å 
away from N6a and 15 Å away from N5 clusters), it could directly influence the electron 
transfer reactions and electric potentials of FeS clusters. Similarly, 39 kDa has a NADPH 
molecule bound and could have a role in sensing the NADP+/NADPH ratio. It could also have 
a role in anchoring the PA to the membrane via the amphipathic helix. Complex I also contains 
two SDAP subunits which bind an acyl-phosphopantetheine molecule. This could link complex 
I assembly to the fatty acid metabolism. Finally, subunit B14.7 could be important for 
supercomplex I-III formation and B12 and AGGG subunits could be important for complex I-





Figure 1.9. Core subunits of complex I.  
Subunits conserved in all organisms and necessary for the reaction of complex I are labelled with 
corresponding colours and mammalian supernumerary subunits are shown in grey.  
Adapted from Kampjut & Sazanov, 2020. 
 
 
Figure 1.10. Supernumerary subunits of complex I.  
Supernumerary subunits in ovine complex I are coloured and labelled and core subunits are shown in grey. 













Figure 1.11. Core subunits of complex I. 
Subunits conserved in all organisms and necessary for the reaction of complex I are labelled with 
corresponding colors and m mmalian supernumerary subunits are shown in grey. 
Adapted from Kampjut & Sazanov, 2020.
NADH
quinone
Fig 1.12. Supernumerary subunits of complex I. 
Su ern merary subunits in ovine complex I are coloured and labelled and core subunits are shown in grey.




1.5.1. Evolution of complex I 
Complex I has a modular structure and each of the several modules has a unique 
function and evolutionary history (Figure 1.11). At some point during the evolution of complex 
I, several pre-existing modules combined together to form a modern complex I. This event 
probably preceded the evolution of mitochondria because complex I is present in modern 
bacteria and archaea (Gabaldón, Rainey and Huynen, 2005). 
N-module of complex I is the dehydrogenase module consisting of 75 kDa, 51 kDa and 
24 kDa subunits, containing the FMN cofactor and several FeS clusters. It catalyses NADH 
dehydrogenation. It is the latest evolutionary addition to complex I and it evolved as an 
electron-receiver from the Krebs cycle in aerobic respiratory chains. Some organisms lack 51 
kDa and 24 kDa subunits and probably get electrons from flavodoxins (Finel, 1998).  
Q-module is the connecting module between the peripheral and membrane arms and is 
homologous to soluble [NiFe] hydrogenases. It consists of the 49 kDa, PSST, TYKY and 30 
kDa subunits. 49 kDa and PSST are ancient electron transferring enzymes and the quinone 
binding site in complex I directly corresponds to the NiFe active site in hydrogenase (Brandt, 
2006). TYKY is a ferredoxin-like protein that was added later to the assembly and the 30 kDa 
was added last and has no catalytic role but provides stability to the assembly.  
   
Figure 1.11. Modular architecture of complex I.  
a. Complex I is composed of N, Q and P modules. Nqo8 (homologue of ND1) was added later and does not have 
a clear evolutionary history. b. Mrp antiporter and [NiFe] hydrogenase are the evolutionary precursors of the 
N/Q-module and P-modules respectively. 
Adapted from Sazanov, 2015. 
 
Fig 1.13. Modular architecture of complex I and evolutionary precursors. 
a. o plex I is composed of modules. b. Mrp antiporter and [NiFe] hydrogenase are the evolutionary 
precursors of the N/Q-module and P-modules respectively.
Adapted from Sazanov, 2015.
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P-module is the proton pumping module which can be further divided into the distal Pd 
and proximal Pp modules. It evolved from the H+/Na+ antiporter (Mrp). Subunits ND5 (MrpA), 
ND4 and ND2 (MrpD) and ND4L (MrpC) have direct homologues with the Mrp subunits 
(Mathiesen and Hägerhäll, 2002, 2003). Subunit ND6 is also homologous to the C-terminal 
part of MrpA (Dzioba-Winogrodzki et al., 2009). 
Acquisition of the rest of membrane arm, which is critical for the connection between 
the redox and proton pumping arms of complex is not clear evolutionary as subunits ND3 and 
ND1 do not have any known homologues. ND1 is the most conserved of the membrane 
subunits and is crucial for the coupling mechanism in complex I, hence it is probably that it 
emerged only once during the evolution (Efremov and Sazanov, 2012). Unexpectedly, the core 
fold of ND1 is similar to a half-channel of the antiporter-like subunit, the similarity that only 
became apparent once the structure of complete complex I was solved as the sequence identity 
is below 20% (Baradaran et al., 2013). Nevertheless, helices in ND1 are much more tilted 
relative to the membrane than in antiporters and some of them are very short (e.g. TMH5) and 
others are very long (e.g. TMH1).  
Supernumerary subunits were incrementally acquired during the evolution (Elurbe and 
Huynen, 2016). It is likely that the complex I in the -proteobacterial endosymbiont which 
gave rise to the modern mitochondria already contained some supernumerary subunits. 
Paracoccus denitrificans for example contains three supernumerary subunits (B17.2, 18kDa, 
13kDa homologues) which were likely present already in the mitochondrial ancestor (Yip et 
al., 2011). In total six supernumerary subunits were acquired from the proto-mitochondrial 
ancestor’s genome: SDAP, 39kDa (homologous to short chain dehydrogenase), 13kDa, B17.2, 
18kDa, 42kDa. The rest of the supernumerary subunits originated in the host genome. Fourteen 
of them are shared between all eukaryotes: B14.7, ESSS, B8, PDSW, B13, PGIV, 15kDa, B22, 
B16.6, B18, B14, B12, MWFE, NUXM. After the plants split from the fungal and animal 
lineage, three additional subunits were acquired which are not present in plants: B15, ASHI, 
B9. Finally, after the animal lineage has diverged, eight more subunits were added (AGGG, 
SGDH, B14.5a, B14.5b, B17, 10kDa, MNLL, KFYI) and NUXM subunit was lost. This leads 
to the modern 45-subunit mammalian complex I.  
Apart from these different versions of complex I in different organisms, there exists a 
larger superfamily of complex I-like enzymes. The closest to the canonical complex I is its 
chloroplast analogue, NDH. It is also found in cyanobacteria and some archaea and bacteria. It 
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contains only 11 subunits and lacks the entire N-module, hence the electron donor to NDH is 
likely ferredoxin. Several structures of NDH recently became available which show a high 
degree of conservation with complex I (Laughlin et al., 2019; Schuller et al., 2019; Zhang et 
al., 2020). The folds of the conserved subunits are the same, and the quinone binding site is 
largely superimposable, although it is disordered to varying degrees in all of the NDH 
structures. Because sequences of NDH have been shown to display variability greater than the 
sequences of the full 14-subunit complex I, it was concluded that the 11-subunit NDH-like 
complex is likely an ancestor to all present-day complex I enzymes (Moparthi and Hägerhäll, 
2011). 
Structure of the hydrogen gas evolving membrane bound hydrogenase (Mbh) also 
recently became available (Yu et al., 2018). This protein contains 14 subunits, 10 of which are 
homologous to the minimal complex I without the N-module and one of the antiporter-like 
subunits and 4 of which are homologous to the sodium-translocating module of Mrp. 
Strikingly, the P-module-like part of the Mbh is rotated 180º around the membrane plane 
normal. How exactly such an arrangement still results in a coupled reaction that drives proton 
and sodium pumping is not yet understood but will be crucial for any generalization of complex 
I mechanism to other similar redox-coupled pumps.  
Other complex I-related proteins which have not been structurally characterised yet 
include the 11-subunit Fpo complex from M. mazei (also without the N-module), formate 
hydrogenlyases FHL-2 (10-subunit, lacking the flavoprotein part of the N-module and ND3 
and ND6) and FHL-1 (7-subunit, lacking additional two antiporter-like subunits ND4 and ND2 
compared to FHL-2), as well as the energy-converting oxidoreductase (Ech), the simplest of 
the complex I homologues (6-subunit, containing only the Q-module and ND1 and ND5 
homologues).  
The structures of these proteins will be crucial for our understanding of the adaptations 
of complex I-like proteins for different substrates and could provide important insights into the 
shared elements of the mechanism. The high modularity of the complex I not only in with 
respect to the electron input module but also in terms of the proton-pumping modules is striking 
and will need to be understood in terms of the coupling mechanism. The structure of the 









1.5.2. Assembly of complex I 
Assembly of complex I is also modular as it involves formation of independent 
assemblies which are later combined together (Vartak et al., 2015; Stroud et al., 2016; 
Guerrero-Castillo et al., 2017). Interestingly, many supernumerary subunits assemble with the 
separate modules before the assembly of the full core of complex I. Assembly also involves 
several assembly factors which later dissociate.  
The main five modules of complex I which are assembled first include: 
- N module consisting of 51kDa,24kDa,75kDa, B8 subunits, 
- Q/Pp-a module consisting of Q module (49 kDa, PSST, TYKY and 30 kDa 
subunits) with added ND1, PGIV, B9, B16.6 subunits and TIMMDC1 assembly 
factor, 
- Pp-b module consisting of ND2, ND3, ND4L, ND6, KFYI and B14.5b subunits and 
assembly factors ACAD9, ECSIT, NDUFAF1, TMEM126B and putatively also 
COA1 TMEM186 
- Pd-a module consisting of the Pd’ module (SGDH, PDSW, ESSS, B17 subunits ) 
with added MNLL and ND4 subunits and assembly factors TMEM70 and 
FOXRED1 and putatively also ATP5SL assembly factor 
- Pd-b module consisting of the Pd’ module with added ND5, B18, B12, ASHI, 
AGGG, SDAP and B22 subunits. 
During the maturation process, Pd-a and Pd-b subunits join together with the 42 kDa 
and B15 subunits to form a Pd-680kDa subcomplex. Similarly, Q/Pp-a and Q/Pp-b modules 
combine together with the B9 and MWFE subunits as well as the NDUFAF2 assembly factor 
to form the Q/Pp-736kDa subcomplex. In the final maturation step, the main assemblies are 
combined into the Q/P subassembly, and in the final step, N-module as well as B14.7 and 
SDAP subunits are added and all the assembly factors dissociate.  
 
1.5.3. Diseases of complex I 
Complex I deficiency is also implicated in a number of inborn human diseases and is 
the most frequently diagnosed single enzyme deficiency of a mitochondrial enzyme. The two 
conditions with which complex I deficiency is most often correlated are LHON (Leber’s 
Hereditary Optic Neuropathy) and MELAS (Mitochondrial Encephalomyopathy, Lactic 
Acidosis, and Stroke-like episodes) (Rodenburg, 2016). However, clinical manifestations of 
complex I deficiency are varied and can sometimes be hard to diagnose, firstly because of the 
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heteroplasmy effects and secondly because of secondary effects of complex I mutations which 
can include increased ROS production, altered mitochondrial morphology and membrane 
potential. At the moment, the only available treatment for complex I deficiency is symptomatic. 
Detailed review of human patient mutations in relation to complex I structure and mechanism 
has identified several mechanistically important hot-spots of mutations that will be discussed 
in Chapter 4 (Fiedorczuk and Sazanov, 2018). Furthermore, several known drugs, such as 
metformin, bind to it and inhibit it but the mechanisms of inhibition and physiological 
consequences are not well understood (Fontaine, 2018).  
 
1.6.  Recent structural and mechanistic understanding of complex I 
1.6.1. History of structure determination 
Structural understanding of complex I begun with X-ray crystal structures of bacterial 
homologues. In 2006, the structure of the peripheral arm of T. thermophilus was solved, which 
showed the organization of the redox cofactors (Sazanov and Hinchliffe, 2006). In 2011 this 
was followed by E. coli complex I membrane domain, which revealed a unique antiporter fold 
of antiporter-like subunits and their connections (Efremov and Sazanov, 2011). The crystal did 
not contain NuoH subunit (ND1 homologue), which is necessary for connecting the PA and 
MD. This was finally resolved in 2013 in a crystal structure of the entire T. thermophilus 
complex I (Baradaran et al., 2013). This structure revealed the connection between the PA and 
MD and the quinone binding cavity, which is a narrow and long tunnel extending up to ~20 Å 
above the lipid membrane surface.  
The crystal structure of Yarrowia lipolytica complex I was the first crystal structure (at 
3.6-3.9 Å) of eukaryotic complex I and revealed the architecture of several eukaryotic 
supernumerary subunits (Zickermann et al., 2015). The first complete structure of mammalian 
(ovine) complex I was solved in 2016 by the Sazanov group using cryo-EM (Fiedorczuk et al., 
2016). Since then cryo-EM structures of several mammalian complexes at resolutions up to 3.3 
Å, including bovine, mouse, human and porcine complex I have allowed ever more complete 
and accurate models to be built (Wu et al., 2016; Zhu, Jiapeng, Vinothkumar and Hirst, 2016; 
Guo et al., 2017; Agip et al., 2018). Structures of human, porcine and ovine complex I were 
solved also as parts of various supercomplexes, placing the complex I within the physiological 
context (Letts, Fiedorczuk and Sazanov, 2016; Letts et al., 2019). 
 




Complex I catalyzes NADH oxidation and ubiquinone reduction, the first reaction step 
in the electron transfer chain. In the peripheral arm (PA) of the enzyme, electrons from NADH 
are initially accepted by FMN and then passed along a chain of iron-sulfur clusters to the final 
acceptor ubiquinone (Figure 1.12). There are eight or nine FeS clusters, depending on the 
species. Two clusters are binuclear (N1a and N1b) while the rest are tetranuclear. Electron 
transfer between the iron-sulfur clusters occurs by electron tunneling, a process during which 
electron occupies either the donor or the acceptor but avoids the protein bridge between them. 
This ensures transfer to a specific location along a specific direction. The rate of tunneling falls 
sharply with the increasing distance between the donor and the acceptor and for electron 
transfer to occur at the enzymatically-useful timescales of milliseconds they need to be < 14 Å 
apart. Seven clusters lie directly on the electron path the connects the NADH and quinone 
binding sites, while N1a lies off-path “upstream” of FMN. Because it is close enough to FMN 
to be able to accept electrons its role could be to temporarily store an electron to prevent 
flavosemiquinone generation and reduce ROS generation. FeS cluster N7 occurs only in 
bacteria and is located too far off the main path (~20 Å) to be reducible and is probably an 
evolutionary vestige. In steady state with an excess of NADH, not all of the FeS clusters are 
reduced and one electron resides approximately on every other FeS cluster (Bridges, Bill and 
Hirst, 2012).  
 
Figure 1.12. Electron transport chain of complex I.  












Figure 1.14. Electron transport chain in the peripheral arm of complex I. 
Transport of electrons from NADH to quinone proceeds via the FMN and eight iron-sulfur clusters. 




FMN, NADH and quinone are two-electron carriers (NADH donates 2 e- and 1 H+, 
while FMN quinone donates 2 e- and 2 H+), while FeS clusters are one electron carriers. Partly 
reduced FMN or quinone are not stable and can react with oxygen to produce superoxide 
radicals. Because the quinone binding site is deep within the protein environment, while FMN 
is on the surface complex I has been suggested to mainly generate ROS at the FMN site, thus 
being a major contributor to ROS generation in the mitochondrial matrix. The quinone binding 
site is a narrow, ~25 Å long tunnel found at the interface between the peripheral and membrane 
domains that connects the lipid bilayer to the last FeS cluster N2 at the end of the redox chain.  
NADH-quinone oxidoreduction is coupled over a distance of more than 200 Å to 
pumping of four protons by four separate proton pumps from the matrix to the intermembrane 
space side. The closest to the quinone binding cavity is the E channel composed of ND1, ND6 
and ND4L subunits, followed by three antiporter-like subunits ND2, ND4 and ND5 (Figure 
1.13). These pumps are connected by a string of conserved charged residues along the center 
of the entire length of the membrane domain, forming the central hydrophilic axis, a distinct 
feature of complex I. The antiporter-like subunits contain an N-terminal proton-entry half-
channel and a C-terminal proton-exit half-channel that are related to each other by 
pseudosymmetry. Both entry and exit paths contain a conserved lysine residue (or glutamate 
in case of ND4 C-terminal half-channel), that is likely the key to proton pumping. In each 
antiporter, the N-terminal lysine forms a pair with conserved TMH5 glutamate, which is 
thought to modulate pKa of lysine (Efremov and Sazanov, 2011). The C- and N-terminal lysines 
are connected by a central lysine (or histidine in the case of ND5), which likely acts to transfer 
protons between the N- and C-terminal half-channels. All of these key residues sit on breaks 
in TM helices (N-terminal TMH7, connecting/central TMH8 and C-terminal TMH12), which 
likely renders the central hydrophilic axis flexible. This flexibility may have a role in the 





Figure 1.13. Proton pumps and the central hydrophilic axis of complex I.  
Membrane arm contains four separate proton pumping channels, three in the antiporter-like subunits and one in 
the E-channel. They all contain N-terminal and C-terminal entry points with a conserved lysine and one or more 
connecting lysines and histidines. E-channel consists of several conserved glutamate and aspartate residues.  
 
1.6.3. Open and closed conformations of complex I 
Both isolated complex I and complex I within supercomplexes have been observed in 
two conformations, the closed and the open conformation which differ in the angle between 
their peripheral and membrane arms (Vinothkumar, Zhu and Hirst, 2014; Fiedorczuk et al., 
2016). The opening coincides with unfolding of several loops that form the interface between 
the peripheral and membrane arms as is described in detail in Chapter 4.  
It has been argued that the open conformation of complex I corresponds to the deactive 
state in mouse and bovine complex I (Agip et al., 2018; Blaza, Vinothkumar and Hirst, 2018). 
The basis for this was that proportion of open complex I in the sample increases upon 
incubation at 37ºC without substrates. The authors argued that disordering of the quinone 
binding site loops (ND1, ND3, 49 kDa), TMH4 of ND6 and the amphipathic loops of 39 kDa 
in the open complex I is too extensive to be part of the catalytic cycle, hence the open structures 
must correspond to the deactive state.  
Deactive complex I is a catalytically inactive state present in many eukaryotic species 
that is probably important in vivo for the prevention of excessive ROS production and reverse 
electron transfer by complex I under ischemic conditions (Kotlyar and Vinogradov, 1990; 
Dröse, Stepanova and Galkin, 2016). Deactivation of mammalian complex I in vitro proceeds 
slowly at elevated temperatures (30-37ºC) in the absence of substrates and can be stimulated 
by increased pH (9.4), biguanides or divalent metal ions (Matsuzaki and Humphries, 2015). 



























Figure 1.15. Central hydrophilic axis and the proton translocating pathways in the complex I. 
Membrane arm contains four separate proton pumping channels, three in the antiporter-like subunits and 
one in the E-channel. 
Adapted from Kampjut & Sazanov, 2020.
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In Y. lipolytica both the deactivation and reactivation proceed with much faster kinetics and do 
not require elevated temperatures (Maklashina, Kotlyar and Cecchini, 2003).  
A number of recent experimental data question the notion that active complex I must 
necessarily exist in the closed state and whether opening only occurs during deactivation and 
not also during the catalytic cycle. Firstly, open and closed conformations complex I were 
observed within active preparations of ovine respiratory supercomplexes and indeed mixtures 
of open and closed complex were also observed in the mouse and bovine preparations that led 
to the notion of open complex I being deactive (Letts et al., 2016, 2019). Secondly, MD 
simulations predicted that unfolding and refolding of mobile loops can happen on a millisecond 
timescale and should not limit the reaction (Haapanen, Djurabekova and Sharma, 2019). 
Thirdly, a sample of Y. lipolytica complex I was solved in the deactive state and during turnover 
and both of these structures exhibited a disordered ND3 loop, indicating that it is in the open 
state (Parey et al., 2018). Trapping of the ND3 loop by reversible disulfide bridge to the nearby 
PSST subunit decoupled the complex I reaction (Cabrera-Orefice et al., 2018). This shows that 
subtle movements of the ND3 loop and potentially other structural elements in the vicinity are 
crucial for the coupling and activity of complex I and that closed and static complex I cannot 
catalyze the full reaction. Unlike the alkylation of ND3 loop, locking it in the closed state did 
not interfere with the A/D transition. Finally, all the observed bacterial complex I structures 
contain a π-bulge in the ND6 TMH3, which is in mammalian enzyme only observed in the 
open conformation (Efremov and Sazanov, 2011; Baradaran et al., 2013). 
 
1.6.4. Coupling mechanism in complex I 
Despite the accelerated advance in structural understanding of complex I from several 
different model species, the catalytic mechanism of complex I remains elusive. In particular 
the coupling between quinone reduction and proton pumping, which happen more than 200 Å 
apart from each other has so far not been satisfactorily explained. The precise mechanisms of 
quinone reduction, its binding and movement in the cavity also remain to be resolved. On the 
basis of the currently available structures of complex I, both conformational coupling 
mechanisms and “electrostatic wave” mechanisms have been proposed, as described below. 
However, the current experimental data is insufficient to discriminate between these proposals. 
None of the structures solved so far display different conformations that could be reliably 
mapped to different catalytic intermediates. Furthermore, most of the structures have been 
solved in the absence of substrates, with the exception of Y. lipolytica during turnover but only 




Nevertheless, several principles of the coupling mechanism can be worked out based 
on the midpoint potential measurements of complex I and the thermodynamics governing the 
redox reactions. In the absence of experimental data, our understanding of the coupling 
mechanism also relies heavily on the molecular dynamics (MD) simulations. There is no drop 
in mid-point electric potential until the electron reaches the final cluster N2 (Euro et al., 2008; 
Wikström, Sharma, Ville R I Kaila, et al., 2015). The mid-point electric potential of the mid-
chain Fe-S clusters was estimated to around -250 mV, of the terminal FeS cluster N2 -150 mV 
and of the Q/QH2 pair ~ +100 mV (for ubiquinone freely dissolved in lipid) (Euro et al., 2008). 
The crucial energy-releasing step in the reaction is therefore quinone reduction, quinone 
protonation or even its release out of the cavity as the mid-point electric potential of Q/QH2 
pair bound near N2 is likely close to the N2 potential (Wikström, Sharma, Ville R.I. Kaila, et 
al., 2015). The main challenge in understanding coupling is therefore to work out how quinone 
reduction happens and how it drives the proton pumps. 
Transmission of energy in the quinone binding cavity has been proposed to involve the 
key quinone-coordinating residues, H59/D160/Y108 of the 49 kDa subunit. They could act as 
proton donors for the quinone and their re-protonation would elicit conformational changes in 
the quinone binding cavity and further in the proton pumps (Wikström, Sharma, Ville R I Kaila, 
et al., 2015).  
The Sazanov group proposed that the negative charge within the quinone cavity, 
probably held on the 49 kDa subunit residues H59/D160/Y108, which coordinate the quinone 
headgroup, initiates conformational changes in the E-channel, propagating further into the 
antiporters via the central hydrophilic axis (Figure 1.14) (Baradaran et al., 2013; Sazanov, 
2015). These movements would influence interactions between the key lysine/glutamate 
residues within and between antiporters, leading to pKa changes and proton translocation 
(Efremov and Sazanov, 2011). This has since been observed also in MD simulations, which 
suggest that negative charge within the quinone cavity somehow couples quinone reduction to 
proton pumping, either via deprotonated 49kDa/Y108, negatively charged semiquinone or 
quinol radicals directly or by rearrangements of the ND1 loop, which contains many negatively 





Figure 1.14. “Single stroke” coupling mechanism of complex I based on T. thermophilus structure.  
Proton pumping is initiated by the negative charge accumulated in the quinone binding cavity during quinone 
reduction. Conformational changes propagate via the E channel into the rest of the membrane domain of 
complex I. Conformational coupling was proposed to be enhanced by concerted movements of the structural 
elements connecting the antiporters: long horizontal helix HL of ND5 and -hairpin loops between the 
antiporters. 
Adapted from Baradaran et al., 2013. 
 
Molecular dynamics (MD) simulations instead suggested that rapid diffusion of quinol 
within the cavity is accompanied by the rearrangement of the quinone-binding 49 kDa, ND1 
and PSST loops and that negative charge on the semiquinone/quinol radicals, deprotonated 
49kDa/Y108 or negatively charged ND1 loop initiates these changes (Sharma et al., 2015).  
Long time scale molecular dynamics (MD) simulations suggested that there are broadly 
two stable quinone binding sites, one in the deep part of the cavity next to the N2 (Qd, or MD 
sites #1-2) and one in the shallow part (Qs, or MD sites #4-5) next to the ND1 subunit close to 
the exit from the tunnel (Warnau et al., 2018; Haapanen, Djurabekova and Sharma, 2019). 
Based on the fact that many complex I preparations have been shown to co-purify with native 
quinone and the fact that the quinone cavity is so long and narrow, there has been a proposal 
that there is a stably bound quinone within the cavity that shuttles between the distal and 
proximal binding sites, where it reduces a second quinone molecule that eventually diffuses 
into the membrane (Wikström, Sharma, Ville R I Kaila, et al., 2015; Haapanen and Sharma, 
2018). Two full-length ubiquinone molecules could simply not fit into the cavity however, and 
there is at the moment no other direct experimental evidence for this proposal. MD simulations 
furthermore showed that quinones with long isoprenoid chains actually have fast 
Figure 1.1x. Coupling mechanism of complex I.
Role of conformational changes vs. electrostatic and HL.




binding/unbinding kinetics and that the diffusion of quinone within the cavity is not rate-
limiting the overall complex I reaction, casting doubt on this hypothesis (Warnau et al., 2018).  
Finally, a purely electrostatic mechanism has been proposed, whereby a wave of 
electrostatic signals sequentially breaks lysine-glutamate ion pairs along the membrane arm, 
leading to pKa changes of the lysines and pumping of protons, until the cascade reverses the 
direction to re-protonate the lysines (Figure 1.15) (Verkhovskaya and Bloch, 2013; Kaila, 
2018). This coupling mechanism could in principle co-exist with many of the postulates of the 
previous suggestions, especially with regards to the quinone reduction events. In the 
electrostatic spring model, however, the electrostatic interactions, and not conformational 
changes, are hypothesized to dominate the mechanism from quinone reduction onwards. 
Ultimately, it is likely that conformational and electrostatic components both contribute to 




Figure 1.15. Electrostatic spring mechanism of complex I.  
Quinone reduction in step I results in an electrostatic wave in steps IIa-Va, whereby proton moves from the 
connecting to the C-terminal lysine in each antiporter. In step Vb proton gets released from ND5 into the IMS, 
which enables the connecting lysine to become protonated from the matrix side (Via), starting the electrostatic 
cascade in the other direction (steps Via-IX), whereby protons get sequentially released from C-terminal lysines 
into the IMS and the connecting lysines get re-protonated from the matrix side.  
Adapted from Kaila, 2018. 
  
Figure 1.1x. Electrostatic spring mechanism of complex I.
Role of conformational changes vs. electrostatic and HL.





Structural biology investigates the structures of biological molecules and until recently, 
the most common method for obtaining atomic structures of proteins was X-ray 
crystallography. The technique was developed over a hundred years ago and involves obtaining 
diffraction images of ordered crystals. Since the structure of myoglobin was solved as the 
structure of the first protein in 1958, the Protein Data Base (PDB) has expanded to include 
145029 crystal structures at the time of writing this thesis (April 2020). This demonstrates the 
wide success and applicability of the method. However, X-ray crystallography is a laborious 
method because obtaining regular well-diffracting crystals requires extensive screening of 
crystallisation conditions. Many proteins do not form regular crystals whatsoever, especially 
large membrane protein complexes and flexible proteins, which might be too conformationally 
heterogeneous to pack into a regular crystal lattice.  
The most obvious advantage of cryo-EM is the removal of the need of crystals. 
Furthermore, proteins are imaged in vitreous ice in a state virtually identical to their state in the 
solution, which eliminates crystal-packing artefacts that have been observed in X-ray crystal 
structures. Electron cryo-microscopy has been used since the 1970s but its main applicability 
was low-resolution imaging of large protein complexes and 2D crystallography. Nevertheless, 
it has been envisaged for a long time that cryo-EM could in principle achieve atomic resolutions 
(Henderson, 1995). Based on the information content, contrast, electron dose and required 
resolution, Henderson estimated that in principle particles larger than 10-100 kDa could be 
aligned to yield an atomic-resolution reconstruction. In fact, because electrons interact much 
more strongly with matter than X-rays (represented by a higher atomic cross section, Figure 
1.16), the information content from electron scattering is much higher than from X-ray 
scattering per unit of radiation damage.  
In the early 2010s, it started to become increasingly obvious that the numerous 
technological advances have allowed resolutions achievable with cryo-EM to rival X-ray 
crystallography, an era since termed the resolution revolution (Kühlbrandt, 2014). Since 2012 
the number of cryo-EM structures deposited into the PDB has been exponentially increasing. 
From 439 structures available in 2012 there are now 4884 structures deposited and ever higher 
resolutions of ever smaller proteins are being achieved. Combined with heavy investments into 
the cryo-EM infrastructure, cryo-EM is now the method of choice for membrane structural 
biology. Below I summarize the main principles of cryo-EM and the recent developments 




Figure 1.16. Atomic cross-sections for X-ray, neutron and electron scattering. 
Adapted from Henderson, 1995.  
 
Sample preparation is a crucial step in cryo-EM. Initially electron microscopy of 
biological samples was done on stained and desiccated samples which destroys the delicate 
structure of proteins and limits the amount of information available. Nevertheless, although 
some insights could be made by studying negatively stained large molecules such as ribosomes 
and such samples were also instrumental for development of single particle reconstruction 
algorithms as described below. The main step forward was the development of methods that 
preserved the biological molecules in more native environments. On the one hand, Henderson 
and Unwin embedded bacteriorhodopsin crystals in glucose, which preserved the structure of 
protein much better than heavy metal stains. This led to the first 3-dimensional structure of any 
membrane protein (Henderson and Unwin, 1975). On the other hand, the group of Jacques 
Dubochet developed a method of rapidly freezing solutions of protein on the grid such that they 




insights were necessary for the development of this procedure, which remains largely 
unchanged to this day. Firstly, blotting of a water droplet sitting on a support using a filter 
paper creates a thin (several tens of nanometers) film that is stable for several seconds during 
which it can be vitrified. Secondly, flash freezing is required to cool the water film quickly 
enough to prevent formation of crystalline ice but transform it directly into vitreous ice. This 
requires plunging the cryo-EM grid into liquid ethane cooled by liquid nitrogen. The use of 
liquid ethane is crucial as it transfers heat much faster that liquid nitrogen. Since liquid ethane 
is close to its freezing point, isolating gas bubbles do not form around the grid being cooled, 
which happens in liquid nitrogen close to its boiling point. 
Development of high-end cryo microscopes also contributed significantly to the 
resolution revolution in cryo-EM. Microscopes need to be manufactured to provide stable 
parallel illumination with a highly coherent electron beam and the lenses should not introduce 
aberrations. Microscopes need to operate under a high vacuum to prevent grids from being 
contaminated. Furthermore, microscopes need to be stable over long periods of time during 
which automatic image acquisition takes place. Image acquisition must be done in “low-dose” 
mode, whereby all the alignments are done away from the area that is eventually imaged for 
collection. This is made possible by automatic collection software such as EPU and SerialEM, 
which enable automatic collection of images at speeds approaching 200 per hour which can 
yield a very good dataset in 24h under ideal conditions (Mastronarde, 2005). 
Arguably the most important advance was the development of direct electron detectors. 
Initially the best detector quantum efficiency was that of photographic film. CCD cameras 
require conversion of electrons into a photon that is detected by the CCD chip. This results in 
attenuation of the signal at high resolutions and leads to significant blurring. Direct electron 
detector is able to detect electrons directly on a thin silicon wafer resulting in much more 
accurate spatial detection of the electron impact event. The main engineering hurdle was 
making these chips durable enough to be used in cameras. Nowadays, several commercially 
available cameras exist which have very high detector quantum efficiencies (little or no noise 
resulting in high contrast and preservation of high-resolution signal) and very fast readouts 
(Figure 1.17) (McMullan et al., 2014; Nogales, 2015). 
Furthermore, during electron beam illumination, the sample moves substantially as a 
result of charging and simple averaged images are blurred as a result (Glaeser, 2016; Russo 
and Passmore, 2016). Cryo-EM images are therefore collected as “movies” of about 30-50 





Figure 1.17. Comparison of detector quantum efficiency (DQE) of photographic film and three commercially 
available direct electron detectors. 
Adapted from McMullan et al., 2014. 
 
Because of radiation damage, only small electron doses can be used in cryo-EM image 
collection (up to ~100 e-/Å2) before the sample starts to disintegrate. Even then, most high-
resolution information is lost after the first 10 e-/Å2 and the rest of the dose contributes only to 
low resolution features. This means that particle images are noisy and several thousands of 
them need to be averaged to achieve an appropriate signal-to-noise ratio. Processing of cryo-
EM dataset can be done by several software packages, including RELION, CryoSPARC, 
cisTEM and others (Scheres, 2012b; Punjani et al., 2017; Grant, Rohou and Grigorieff, 2018). 
The development of these packages made cryo-EM broadly accessible for the community but 
the algorithms they employ have been built on the several decades of development of the 
method of single particles reconstruction.  
The mathematical framework for reconstructing 2D projections of particles into a 3D 
object is the projection-slice theorem which states that a Fourier transform of a projection of 
an object is a central section of a 3D-Fourier transform of the original object. The main problem 
to be solved is to find the angles of projection for each of the projection images. The main step 
forward in the RELION package was the replacement of the discrete assignments of projection 




(Scheres, 2012a). This maximum a posteriori (MAP) algorithm uses a Bayesian approach to 
infer parameters of a statistical model from the data.  
The final strength of cryo-EM is the possibility to image heterogeneous protein samples 
containing multiple conformations of the same protein or even different proteins. Different 
conformations or molecules can then be separated in silico into the corresponding classes. This 
complicates particles reconstruction as adding to the lack of information about the relative 
orientations of the particles, we also lack information about the assignments of the particles to 
the classes. Perhaps the most powerful feature of cryo-EM image analysis that was 
indispensable in this work was classification of particles without prior knowledge about their 
conformations (Scheres et al., 2007). A single low-resolution average structure is used as a 
reference in the first iteration of likelihood optimisation for K randomly drawn subsets of the 
data. This results in bias-free seeds, which get updated an improved in each iteration. As the 
number of different classes in the data is not known, multiple calculations with different values 
of K need to be performed and carefully compared. Another heuristic value in this process is 
the T-value, which needs to be carefully adjusted to make use of the available signal in the 
dataset and prevent overfitting (Scheres, 2012b). 
So far many studies have established that occupancies and conformations of different 
classes of protein molecules in solution can be resolved by 3D classification during processing. 
One of the recent very convincing examples analysed time-resolved initiation of translation 
and the populations of 3D classes observed in cryo-EM grids corresponded closely to expected 
populations based on biochemical and trapping methods (Kaledhonkar et al., 2019). The 
interpretation that the percentage of different protein classes in the cryo-EM grids are 
representative of the distribution of those classes in solution is based on the assumption that 
other factors are not influencing this. One of the factors that could bias occupancies of different 
classes in cryo-EM is destructive interaction (unfolding/aggregation) of protein molecules at 
the air-water interface. However, this can be avoided by changing the preparation conditions 
and any particles that might have undergone air-water interface mediated degradation would 
have been sorted out by classification and their prevalence would likely be the same across all 






1.8. Aims of the project 
Understanding how the proton gradient is generated, maintained and used for metabolic 
reactions is a fundamental biological question and arguably the most evolutionarily conserved 
process in all of life. Using the cryo-EM technique in structural biology means that we can now 
solve structures of membrane proteins and structurally heterogenous proteins more easily than 
ever before. Solving structures in different states and at high resolutions (achieved with 
constantly improving microscopes, cameras and analysis software) allows us to start 
delineating the chemistry of redox and proton-pumping reactions.  
This project aimed to elucidate the redox-coupled proton pumping mechanisms of two 
fundamentally important but unrelated mitochondrial enzymes, transhydrogenase and complex 
I, which are discussed in Chapters 3 and 4, respectively. In the initial stages of the project I 
also investigated E. coli complex I and ovine F1Fo-ATPase as potential model systems but did 
not pursue them beyond optimising purification and cryo-EM grid preparation protocols. The 
results on these two proteins are briefly discussed in Chapter 2. Finally, in Chapter 5, I compare 
the common principles of proton translocation in two different ancient and widespread protein 
families and what they tell us about the protein function and evolution in general.  
The main aims of the project were: 
 
1. To determine the near-atomic resolution structure of intact NNT. 
The first aim of the present project was to provide the first, to our knowledge, high-
resolution structure of an intact transhydrogenase. The only reported structure of the complete 
transhydrogenase comes from X-ray studies of the T. thermophilus NNT at the resolution of 7 
Å (Leung et al., 2015). Failure to crystallise transhydrogenase to high resolution could reflect 
conformational heterogeneity, hence we chose a cryo-EM approach for this project which 
confirmed intrinsic conformational heterogeneity but also proved to be less limited by it. Near-
atomic resolution structure of an intact NNT presented an important advance for the structural 
understanding of this essential bioenergetic enzyme. It allowed a structural interpretation of a 
large amount of biochemical and mutagenesis data on bacterial model enzymes. Furthermore, 
structure of an intact transhydrogenase allowed a structural and mechanistic interpretation of a 
number of described mutations from patients. Perhaps further studies will shed some light on 
the phenotypic heterogeneity in transhydrogenase-deficient patients. As transhydrogenase is an 




drug discovery targeting transhydrogenase. This is particularly relevant in the light of the fact 
that no good specific inhibitors of transhydrogenase are currently known. 
 
2. To understand the coupling mechanism of NNT.  
Transhydrogenase operates by an entirely unique and poorly understood mechanism 
among the redox-driven proton pumps. There is evidence that large-scale conformational 
changes occur during its catalytic cycle. To understand the mechanism of NNT, one or more 
catalytic intermediates were structurally and biochemically characterised. Since it was shown 
that conformational changes occur upon binding of different substrates (NADP(H)), we 
characterised theses states which allowed us to propose a consistent catalytic mechanism for 
transhydrogenase. It explains all the previously described biochemical properties of the 
enzyme, its mutants and the structural data generated here.  
 
3. To understand the catalytic mechanism of complex I 
The near-atomic resolution structures of complex I have been becoming available from 
several species since 2013. However, our understanding of the mechanism is poor, firstly 
because the resolution achieved was not very high (up to 3.3 Å) and not many conditions were 
investigated. The aim of this project was to improve the resolution to be able to model water 
molecules, important for the proton pumping process. The active and stable preparation of 
ovine complex I in LMNG was used to achieve this. This was complemented by comparing 
cryo-EM structures of ovine complex I in several different conditions and describe the changes 
induced by substrate binding, turnover, inhibition, and deactivation. Finally, we collected a 
dataset during turnover and classified different conformations of complex I that exist during 
the catalytic turnover. This allowed us to describe the exact chemistry of the complex I coupling 
process and to provide experimental evidence for a coupling process in complex I that depends 




2. Materials and methods 
2.1.Materials 
Materials were obtained from Sigma-Aldrich Corporation (St. Louis, Missouri, USA) 
unless stated otherwise. All the detergents were obtained from Anatrace, Inc. (Maumee, Ohio, 
USA). 
Thio-NADP+ was purchased from Santa Cruz Biotechnology Inc. (Heidelberg, 
Germany). Bio-Beads SM-2 were obtained from Bio-Rad Laboratories, Inc. (Hercules, 
California, USA). 
Zeba spin desalting columns and Detergent Removal Spin columns were sourced from 
Thermo Fisher Scientific Inc. (Rockford, Illinois, USA). Chromatography columns were 
obtained from GE Healthcare (Chicago, Illinois, USA). Ovine hearts were obtained from a 
local butcher (Retz, Austria). Vivaspin concentrators were obtained from Sartorius Stedim 
(Göttingen, Germany).  




2.2.1. Protein concentration measurements 
2.2.1.1.BCA assay 
Protein concentration was measured using the colorimetric method with the Pierce 
bicinchoninic acid (BCA) assay kit (Thermo Fisher Scientific Inc., Rockford, Illinois, USA). 
A standard curve was obtained by preparing bovine serum albumin (BSA) at concentrations 
between 0.1 and 1 mg/mL in the same buffer as the unknown sample. Upon mixing samples 
with reagents in 96 well plates, they were incubated at 37 °C for 30 min and then read using a 
SpectraMax M2 plate reader (Molecular Devices, Wokingham, Berkshire, UK). Protein 
concentration in the sample was determined by comparison with the standard curve.  
 
2.2.1.2.Spectrophotometric method (A280) 
Aromatic amino acid side chains absorb UV radiation at 280 nm, a property that can be 
used to estimate protein concentration in pure samples for which extinction coefficients are 
known. This method was used because it is relatively precise in the ranges of 1-5 mg/mL 
required for cryo-EM grid preparation and because only a small volume (1 L) of the sample 




(Thermo Fisher Scientific Inc.). For transhydrogenase, which does not contain any bound 
cofactors, extinction coefficient at 280 nm in water was predicted in silico (with PredictProtein) 
to be 726601 M-1 cm-1 (Yachdav et al., 2014). 1 mg/mL NNT thus corresponds to absorption 
0.64 AU. For complex I, however, the absorption coefficient had to be estimated empirically 
due to the large size of the molecule and many cofactors bound. 1 mg/mL complex I 
corresponded to A280 of about 2.3 AU as determined by comparison with the BCA assay. 
UV-Vis spectra of protein samples measured on the NanoDrop were also used as a 
rough estimate of protein aggregation. A260/280 ratio is ~0.6 for pure monodisperse protein but 
rises to ~1 for aggregated protein because of the Rayleigh light scattering from protein 
aggregates (Fiedorczuk, 2017). Rayleigh scattering increases to the 4th power with dropping 
wavelength and results in a shift in the peak of absorbance (Penzkofer et al., 2007).  
 
2.2.2. Polyacrylamide gel electrophoresis 
SDS-PAGE 
Protein samples (~10-50 ng) were mixed in 4:1 ratio with sample buffer consisting of 
250 mM Tris pH 6.8, 10% (w/v) SDS, 10% (w/v) DTT, 50% (v/v) glycerol and 0.05% (w/v) 
bromophenol blue. 10-15 L samples were loaded into the pre-cast 4-20% gradient Novex 
Tris-Glycine polyacrylamide gel (Invitrogen, Thermo Fisher Scientific) which was run for 80 
min at 150 V in an electrophoresis buffer containing 25 mM Tris pH 8.3, 192 mM glycine and 
0.1% SDS. Molecular weights of the resulting bands were estimated by comparison to the 
Unstained Precision Plus Protein Standards (Bio-Rad) which were run alongside the lanes with 
unknown samples. Gels were stained using Instant Blue stain (Expedeon, Abcam, Cambridge, 
UK) for several hours and destained in water. For better resolution of small subunits, Novex 
Tricine 10-20% gels run according to the manufacturer’s protocol proved marginally better. 
Criterion XT Bis-Tris Precast Gels (Bio-Rad) were not appropriate for studies of multi-subunit 
protein complexes due to the poor resolution between bands.  
Blue native PAGE 
Blue native PAGE was done according to the manufacturers protocol (Invitrogen, 
Thermo Fisher Scientific). Briefly, protein samples were mixed with sample buffer (50 mM 
BisTris, 50 mM NaCl, 10% w/v Glycerol) and loaded on the NativePAGE 3-12% Bis-Tris 
Protein Gels. The gels were run at 4ºC for ~1h at 150 V with the dark blue cathode buffer (50 
mM BisTris 50 mM, Tricine pH 6.8, 5% Cathode Buffer additive (0.4% Coomassie G-250)) 
and another 1.5h at 250 V with the light blue cathode buffer (50 mM BisTris 50 mM, Tricine 
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pH 6.8, 0.5% Cathode Buffer additive). Anode buffer consisted of 50 mM BisTris 50 mM, 
Tricine pH 6.8.  
 
2.2.3. Detergent concentration measurement 
Detergents were measured using a colorimetric assay for quantifying sugars as 
described before (Urbani and Warne, 2005). A standard curve was prepared with 0-0.03% 
solutions of a detergent to be measured in 0.005% increments. 50 µl of standards and sample 
dilutions were mixed with 300 µl 5% Phenol in 2 ml capped tubes, to which 720 µl conc. 
sulphuric acid was immediately added drop-wise, mixed and cooled. Absorbance at 490nm 
was measured and compared to the standard curve to obtain the detergent concentration in the 
sample.  
 
2.2.4. Complex I activity measurements 
Complex I catalyses NADH:ubiquinone oxidoreduction in vivo, however, this reaction 
is not easy to measure in vitro due to the high hydrophobicity of ubiquinone. Potassium 
ferricyanide can be substituted as an electron acceptor, but the reaction happens at the FMN 
site, is not inhibited by rotenone and is therefore not physiologically relevant. It is nevertheless 
useful for determining the presence of complex I in impure samples. Decylubiquinone, a 
soluble analogue of the natural substrate ubiquinone can be used instead to assay the 
physiological reaction of complex I – DQ is soluble enough in an appropriate buffer and the 
reaction is fully inhibited by rotenone. 
 
2.2.4.1.NADH:DQ oxidoreductase activity 
Complex I NADH:quinone oxidoreductase activity was measured at 30°C 
spectrophotometrically by following the NADH ( = 6.1 mM-1 cm-1) oxidation at 340 nm using 
a Shimadzu UV-2600 UV-VIS spectrophotometer (Shimadzu UK Ltd., Milton Keynes, 
Buckinghamshire, UK) fitted with a temperature controller and automated sample changer 
(Shimadzu DPS-240A) with a magnetic stirring unit (Electronic Stirrer Model 300, Rank 
Brothers Ltd. Cambridge, UK). Reaction buffer was optimized for the ovine CxI purified in 
LMNG before (20 mM HEPES, pH 7.4, 50 mM NaCl, 1 mM EDTA, 0.1% CHAPS, 0.1% 
LMNG, 0.25 mg/mL lipids (1:4 mixture of cardiolipin and dioleoyl phosphatidylcholine), 100 
M NADH and 200 M DQ)  (Letts et al., 2016). Complex I was added to the above buffer 




addition. Reaction was measured for 120 s and the initial activity was calculated from the slope 
of the absorbance curve in the interval between 30 and 90 s using a Beer-Lambert law and 
expressed as M NADH consumed per mg protein per minute, i.e. U/mg. 
When SMPs or non-solubilised samples from various stages of purification were used, 
10 M CCCP (10 mM stock in ethanol) was added to prevent proton gradient formation. When 
inhibitors were used, they were prepared as stocks in DMSO (100 mM imiquimod or 1 mM 
rotenone). 
 
2.2.4.2.NADH:Potassium Ferricyanide oxidoreductase activity 
Complex I NADH:FeCy oxidoreductase activity measurement was done at 30ºC in the 
same buffer (20 mM HEPES, pH 7.4, 50 mM NaCl, 2 mM EDTA, 0.1% LMNG, 1 mM 
KFe(CN)6, 100 M NADH) as described before (Letts et al., 2016). This reaction was also 
followed spectrophotometrically by measuring the NADH ( = 6.1 mM-1 cm-1) oxidation at 340 
nm.  
 
2.2.4.3.Superoxide production assay 
Superoxide production assay was done under the same conditions as the above assays. 
The buffer used consisted of 20 mM HEPES, pH7.4, 100 mM NaCl, 0.25 mg/mL DOPC:CL 
4:1, 0.1% CHAPS, 400 M KCN. 20 g/mL complex I was added to this buffer and after 5 
min incubation, 240 g/mL of cytochrome c was added, followed by 100 s measurement of 
background. 100 M NADH was added, followed by 200 s measurement of the activity and 
finally, 40 U/mL of superoxide dismutase were added followed by 120 s measurement of 
residual activity. If inhibitors were used, they were added as a DMSO stock to 15 nM (rotenone) 
or 36 M (imiquimod). KCN was added to the buffer to inhibit cytochrome c oxidation by 
miniscule amounts of residual complex IV in the purified complex I sample. Our ovine 
complex I preparation produced ~20nmol/min/mg superoxide. 
 
2.2.4.4.NEM labelling assay 
Labelling with NEM was performed by incubating a sample of 1 mg/mL of purified 
complex I with 1 mM NEM on ice for 5 min, after which NEM was neutralized by the addition 





2.2.5. Transhydrogenase activity measurements  
Transhydrogenase can catalyse reverse, forward and cyclic transhydrogenation, which 
can be followed spectroscopically. Because NAD(H) and NADP(H) both have absorption 
maximum at 340 nm, different analogues need to be used for these assays. NAD+ analogue, 3-
acetylpyridine adenine nucleotide, is used in the reverse transhydrogenation reaction and thio-
NADP+ is used to follow forward transhydrogenation.  
 
2.2.5.1.Optimisation of the transhydrogenation assay 
In the literature, several different buffer conditions (Wu, Alberta and Fisher, 1986; 
Sazanov and Jackson, 1995) have been used in the transhydrogenase assay, which mostly 
contained Brij-35, a detergent for which we showed that it modestly inhibits transhydrogenase. 
When solubilized in LMNG or FOM, transhydrogenase has more than twofold higher activity 
than in Brij-35 which was previously reported as the most activity-compatible detergent 
(Figure 2.1d) (Hu, Zhang and Rydström, 1998). Hence, we substituted it for CHAPS and 
determined optimal concentrations for other components as well. Detergent and lipids in 
reaction buffer significantly increase activity – 0.1% CHAPS and DOPC:CL mixture used 
routinely. pH of the buffer had a broad maximum pH6.5-pH7.5 (Figure 2.1a). Salt 
concentration had a similar broad maximum between 50-100mM NaCl (Figure 2.1b). As 
shown before, buffers can also inhibit transhydrogenase and because MES/HEPES slightly 
decreased the activity, we used Tris in the activity assay buffer. 100 M substrates were optimal 







Figure 2.1. Optimisation of transhydrogenase activity assay. 
 a. Reverse transhydrogenation activity has a broad pH optimum between 6.5 and 7.5. b. Reverse 
transhydrogenation activity has a [NaCl] optimum between 50 and 100 mM. c. NADPH and APAD+ in equimolar 
ratio were added to the reaction and the reaction has the optimum at 100 𝜇M each. d. Detergents have a 
profound effect on reverse transhydrogenation activity. The highest activities were achieved in CHAPS, 







2.2.5.2.Reverse transhydrogenation activity 
Reverse transhydrogenation activity was measured at 30°C spectrophotometrically by 
following the APAD+ (3-acetylpyridine adenine dinucleotide; NAD+ analogue;  = 5.1 mM-1 
cm-1) reduction at 375 nm using a Shimadzu UV-2600 UV-VIS spectrophotometer. 
Background absorption at 455 nm was subtracted from absorption at 375 nm. Final optimised 
reaction buffer consisted of 20 mM Tris-HCl, pH 6.8, 50 mM NaCl, 0.5 mM EDTA, 0.1% 
CHAPS, 0.25 mg/mL lipids, 100 M NADPH and 100 M APAD+. For lipids we used soybean 
asolectin or DOPC:CL 4:1 mixture with similar results. When membrane-containing samples 
were measured, 10 M CCCP was added to prevent pmf formation. Reaction was started with 
the addition of NNT.  
When done with NNT reconstituted into proteoliposomes, reaction was started by 
substrate additions (NADPH and APAD+ at 100 M). CCCP (10 M) was added after 1 min 
to decouple the proton gradient across proteoliposomes to assess the dependence of the 
transhydrogenation reaction on the proton motive force. After another 1 min, CHAPS (0.05%) 
was added to solubilise proteoliposomes and give a total decoupled reverse transhydrogenation 
activity of both inward and outward facing transhydrogenases. The degree of reaction 
acceleration reflects the degree of coupling between the hydride and proton transfer reactions 
and the leakiness of the proteoliposomes (negligible).  
 
2.2.5.3.Cyclic transhydrogenation activity 
Cyclic reaction was measured in the same buffer as above by following APAD+ 
reduction by NADH at 375 nm. Because our NNT preparation was devoid of nucleotides, 30 
M NADPH was added to the protein sample first and incubated on ice for 10 min. 
Alternatively, it was added directly in the reaction cuvette and after it was consumed as 
confirmed by a stable baseline, 100 M NADH was added to start the cyclic reaction. 
 
2.2.5.4.Forward transhydrogenation activity 
Forward transhydrogenation was measured in the above buffer. Instead of NADH, 
NADPH was added and instead of APAD+, thio-NADP+ was added ( = 11.7 mM-1 cm-1) and 






2.2.6. ATP-ase activity measurement 
ATP-ase activity was measured as described previously (Runswick et al., 2013). Buffer 
used consisted of 50 mM Tris-HCl pH 7.4, 50 mM KCl, 2 mM MgCl2, 0.1% CHAPS, 0.4 
mg/mL soybean asolectin, 400 M NADH, 1 mM PEP, 2 mM ATP, 12 U/mL LDH and 12 
U/mL PK. Reaction was measured at 37ºC and was started by the addition of ATPase. 
Consumption of NADH was followed spectrophotometrically at 340 nm ( = 6.1 mM-1 cm-1) 
using a Shimadzu UV-2600 UV-VIS spectrophotometer. Coupling between F1 and Fo was 
probed by measuring sensitivity of this reaction to oligomycin (added to 0.1 mg/mL from an 
ethanol stock).  
 
2.2.7. Trypsinolysis of NNT 
Trypsinolysis of NNT was performed as described previously with a few changes 
(Yamaguchi, Wakabayashi and Hatefi, 1990). NNT at 0.05 mg/ml in GF buffer with only 1 
mM HEPES pH 7.4 was incubated with 0.4 mM nucleotides, trypsin (at different mass ratios) 
and 60 mM BAT buffer (1:1:1 Bis-Tris, acetate, tricine) at pH 5-8. Due to the pH optimum of 
trypsin being ~8, trypsin:NNT mass ratio between 1:400 and 1:40 and incubation times 
between 30 and 60 min were used at different pH values 5-8.  
 
2.2.8. Unfolding assay 
It has been demonstrated that optimal buffer conditions are crucial for obtaining stable 
monodisperse protein samples suitable for high-resolution structure determination by cryo-EM 
(Chari et al., 2015). An unfolding assay can detect shifts in melting temperature of multi-
subunit protein complexes and thus give the most optimal buffer system and pH (Chari et al., 
2015). Unfolding at higher temperatures exposes hydrophobic regions of the proteins which 
can be detected using a fluorescent SYPRO orange dye. Because some of our samples were 
purified in detergent, the contribution of detergent to the signal had to be subtracted. 0.1mg/mL 
protein was used for all samples (NNT in FOM, NNT-1E3 or F1Fo in LMNG).  
For NNT in FOM, the best five buffer conditions were: HEPES pH 7.2, MES pH 5.7, 
SPG (succinic acid, NaH2PO4, glycine) pH 7.2 and pH 6.8 and Na-phosphate buffer 5.8. The 
first two conditions were almost identical to the buffers used during purification as described 
later. For F1Fo-ATPase in LMNG, the best five buffer conditions were: Na-citrate pH 5.5 or 
7.0 or 7.25, Bis-Tris pH 5.8 and MES pH 6.9. Differences in melting temperatures between 
different buffers were very small, however.   
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2.3. Sample preparation 
All the protein purification procedures described below were done at 4°C. All the 
proteins were purified from ovine heart mitochondria as described below. During protocol 
optimisation, several proteins (transhydrogenase, F1Fo-ATPase and complex I) were 
sometimes purified from the same starting material. However, during the final stages of sample 
preparation optimisation and preparation of final grids for high resolution data collection, only 
one protein was purified from a single batch of mitochondria. This is because the proteins of 
interest elute over a large range of ionic strengths. Complex I elutes the last at ~250 mM NaCl 
and is subjected to a long gradient wash required to elute transhydrogenase (at ~110 mM NaCl) 
and ATPase (at ~150 mM NaCl). Such a long wash actually increased the yield of complex I 
(due to its release from supercomplexes) but also reduced the activity of complex I, potentially 
due to the delipidation as a result of extensive washing (Figure 2.2b-c). Avoiding a long 
gradient elution and eluting ATP-ase and transhydrogenase containing material with a step 
gradient before complex I elution led to too impure transhydrogenase and ATPase fractions. 
They would require another loading on the anion exchange column, potentially also resulting 
in suboptimal final protein samples. The best approach was thus to purify CxI separately and 
NNT and ATPase together from the same batch of mitochondria.  
Purifications 1-6 which were mainly used for protocol optimisation were done on a 
single batch of mitochondria stemming from sheep hearts obtained in Chelmsford, UK. All the 
subsequent purifications were done on a single batch of mitochondria from sheep hearts from 
Retz, Austria. All the samples used for high resolution were therefore collected from Austrian 
sheep mitochondria. 
 
2.3.1. Mitochondrial isolation 
Purification procedures were done as described before (Letts et al., 2016). Briefly, 
mitochondria were purified from fresh ovine heart tissue; the hearts were cooled on ice within 
an hour of slaughter. Subsequent transport and mitochondrial isolation took ~10 hours. 
Mitochondria were purified from fresh ovine heart tissue by differential centrifugation and 
stored at –80°C according to the Procedure 3 by Smith (Smith, 1967). Briefly, heart muscle 
tissue was minced and washed in 1.4 L of buffer (250 mM sucrose, 10 mM Tris-HCl pH 7.8, 
5 mM 2-mercaptoethanol) per 1 kg of tissue. Washed tissue was blended for 30 s using a 
Wahring blender and then centrifuged at 1800 g for 15 min to remove large debris and then the 
supernatant was centrifuged at 20000 g for 27 min to pellet mitochondria. Dry mitochondrial 





2.3.2. Isolation of inner mitochondrial membranes 
On the day of purification, inner mitochondrial membranes were isolated as described 
before (Letts et al., 2016). Briefly, 10 g of mitochondria were ruptured by homogenisation 
(Potter-Elvehjem homogeniser, ~50 strokes) in 100 mL milliQ water. Upon addition of 150 
mM KCl (from 2 M stock), membranes were separated by 45 min centrifugation at 50000 g, 
supernatant was discarded and the pelleted membranes were resuspended in 100 mL of buffer 
M (20 mM HEPES, pH 7.4, 40 mM NaCl, 1 mM EDTA, 10% v/v glycerol, 2 mM DTT and 
0.002% PMSF). After another round of resuspension and centrifugation, membranes were 
resuspended in 50 mL of buffer M. 
 
2.3.3. Complex I preparation 
2.3.3.1. Anion exchange chromatography 
Inner mitochondrial membranes were solubilised in 50 mL of buffer M (20 mM 
HEPES, pH 7.4, 40 mM NaCl, 1 mM EDTA, 10% v/v glycerol, 2 mM DTT and 0.002% PMSF, 
1% LMNG) for 45 minutes. Upon centrifugation (50000 g, 45 min) the supernatant (~50 mL, 
depending on the purification) was filtered with a 0.22 m filter and loaded onto a 45 mL Q-
sepharose HP anion exchange column equilibrated in buffer Q-A (20 mM HEPES pH 7.4, 40 
mM NaCl, 2 mM EDTA, 10% v/v glycerol, 1 mM DTT, 0.05% LMNG). The column was then 
washed with 75 mL Q-A buffer, 50 mL of 10% Q-B buffer (Q-A with 1 M NaCl), 125 mL of 
20% Q-B buffer and finally complex I was eluted by a 200 mL linear gradient with 20-27% Q-
B buffer (Figure 2.2a). Complex-I containing fractions (~50 mL) were pooled, concentrated to 
~15 mg/mL (~1 to 2 mL) using a Millipore 100-kDa cut-off filter and stored at 30% glycerol 
under liquid nitrogen in aliquots of 250 L.  
SDS-PAGE profile of selected fractions from the anion-exchange column elution 
reveals the pattern of elution of the major respiratory chain complexes and some other abundant 






Figure 2.2. Purification of complex I from ovine heart tissue.  
a. Anion exchange elution profile for a typical long-method complex I purification. b. Yield and purification table 






Figure 2.3. SDS-PAGE profile for a typical purification of complex I from ovine heart tissue. 
Aconitate hydratase and ATP/ADP translocase were annotated by MS/MS, and the rest of the proteins were 
annotated based on the SDS-PAGE pattern, A280 and A420 and activity assays. 
   
53 
 
2.3.3.2. Size exclusion chromatography 
After anion exchange chromatography, complex I was ~50% pure and size exclusion 
chromatography was used as the last step of the purification mainly to exchange the detergent 
or to lower the LMNG concentration. It also removed the remaining contaminants: pyruvate 
dehydrogenase (PDH) and 2-oxoglutarate dehydrogenase (OGDH) complexes (as shown by 
MS/MS) and complex IV (as determined by SDS-PAGE and activity measurements) (Figure 
2.4f).  
A 250 L sample of complex I after anion exchange was thawed on ice on the day of 
cryoEM grid preparation, loaded onto a Superose 6 10/300 gel filtration column equilibrated 
in buffer GF (20 mM HEPES, pH 7.4, 50 mM NaCl, 1 mM EDTA, 0.002% LMNG) to remove 
excess detergent and remaining protein contaminants. The purest and the most concentrated 
fractions of complex I eluted at ~11.5 mL and were concentrated to 3 mg/mL and used 
immediately for cryo-EM grid preparation (Figure 2.4a,f). 
Additionally, complex I samples were also prepared by gel filtration in the following 
detergents: Cymal-7 (0.02%), FOM (0.05% or 0.1%), LMNG (0.05%, 0.01%) and sample 
reconstituted into amphipol A8-35 (Figure 2.4b-d). The gel filtration pattern in these conditions 
did not change with the exception of cymal-7 in which the peak had a slightly asymmetric 
shape, potentially indicating breaking of the complex.  
Changing glycerol concentration also did not alter the appearance of the gel filtration 
profile or the SDS-PAGE pattern of the fractions. Glycerol concentrations at 0, 1, 2, and 10% 
were tested. In the final preparations for high-resolution data collection, glycerol was omitted 
to decrease the background noise during cryo-EM image collection. Changing NaCl 
concentration (50, 100 or 200 mM) also did not change the outcome of the gel filtration. Final 
grids for data collection were prepared at 50 mM NaCl to minimize background noise.  
It was noted that to minimize aggregation of particles on the grid, protein sample needs 
to be applied to the grid and frozen immediately after gel filtration. Freezing sample aliquots 
before the gel filtration step did not seem to have this effect. Any freeze-thaw cycles after the 







Figure 2.4. Final preparations of ovine complex I.  
Gel filtration profile reveals elution of CxI in (a) LMNG-containing buffer, (b) Cymal-7-containing buffer, (c) FOM-
containing buffer, (d) A8-35 reconstituted CxI. e. Comparison of CxI in naodiscs and reconstituted into MSP2N2 
nanodiscs. f. SDS-PAGE profile of a typical gel filtration preparation. Void volume contains the remaining 
contaminants 2-oxoglutarate dehydrogenase complex (OGHD) and pyruvate dehydrogenase complex (PDH) 
which were identified by MS/MS and labelled on the gel. 
   
Figure 2.4. Final preparations of ovine complex I. a. Gel filtration profile reveals elution of CxI in (a) LMNG-containing buffer, (b) Cymal-7-
containing buffer, (c) FOM-containing buffer, (d) A8-35 reconstituted CxI. e. Comparison of CxI in naodiscs and reconstituted into MSP2N2 











































2.3.3.3. Deactive complex I preparation 
Deactive complex I was prepared by incubating the concentrated aliquot of complex I 
after anion exchange at 32ºC for 30 min. To prevent delipidation and proteolysis, 0.5 mg/mL 
of 1:4 mixture of cardiolipin and dioleoylphosphatidylcholine and 0.0075% PMSF were added 
to the sample. Afterwards, the sample was cooled on ice and injected to the gel filtration as 
described above.  
 
2.3.3.4. Preparation of complex I using sucrose gradient 
Complex I in digitonin was purified on a hand-made 10-45% sucrose gradient to which 
a sample of complex I after anion exchange chromatography in LMNG was loaded. The buffer 
was the same as for gel filtration with additional 0.1% digitonin. Tubes with gradients were 
centrifuged at 4ºC for 21 h at 130000 g in a swing-bucket rotor before collecting the complex 
I-containing fractions. On cryo-EM grids, the sample in digitonin looked monodisperse but 
contained micelles. It also displayed slightly lower activity in digitonin compared to 
FOM/LMNG, hence this preparation was not optimized further. 
 
2.3.3.5. Nanodisc preparation 
Nanodiscs are protein-enveloped lipid bilayer discs into which membrane proteins can 
be reconstituted to allow their structural characterization in close-to-native lipidic environment 
(Bayburt and Sligar, 2010). Nanodisc preparation might prove superior to detergent because it 
allows the protein to reside in the lipid environment which was demonstrated to have a 
stabilizing effect on membrane proteins and lead to higher resolution structures (Jin et al., 
2017).  
Complex I purified in LMNG was reconstituted into nanodiscs by mixing complex I, 
scaffold protein MSP2N2 and 1:4 CL/DOPC lipid mixture in a 1:2:100 stoichiometry. The 
mixture was incubated on ice for 15 min, upon which 400 mg/mL washed BioBeads SM-2 
were added in two batches 2 hours apart. The mixture was incubated overnight with constant 
stirring and then injected on a Superose 6 column equilibrated in a gel filtration buffer without 
any added detergent. Complex I eluted in a symmetric peak at around 11.5 mL, almost 






2.3.4. Transhydrogenase preparation 
Ovine heart tissue is an excellent native source of mitochondria and has been used in 
the Sazanov group as a starting material for the purification of the respiratory complex I as 
described above and elsewhere (Fiedorczuk et al., 2016; Letts et al., 2016). Transhydrogenase 
is sufficiently abundant in ovine mitochondria to allow purification of adequate amounts of the 
enzyme for cryo-EM analysis. Purification from a native source is often superior to 
heterologous expression because it surpasses the need for expression and provides a highly 
functional and properly post-translationally modified enzyme. Ovine transhydrogenase also 
exists in only one described isoform and its sequence identity to human NNT is 97%, hence 
the ovine enzyme can be considered a very good model of the human enzyme.  
Previous protocols reported anion exchange chromatography or affinity 
chromatography using NAD+-linked agarose (Wu, Alberta and Fisher, 1986; Sazanov and 
Jackson, 1993). However, these procedures resulted in poor yields and activities. Hence, we 
developed a new procedure that resulted in pure, highly active and stable transhydrogenase 
from the ovine heart tissue suitable for further biochemical and structural analyses. Choice of 
detergent was one of the critical factors for stability and activity and the results from activity 
assay optimization gave initial detergents to screen. LMNG was used in the first purification 
steps that were adapted from complex I purification protocol. Other detergents that did not 
inhibit NNT were CHAPS, FOM, fFC8 and Cymal7-neopentylglycol. Detergents which 
inhibited NNT were DDM, digitonin, A8-35, cymal6, GDN and brij35 (Figure 2.1).  
 
2.3.4.1.Anion exchange chromatography 
The first step of purification was adapted from the complex I purification protocol 
described before (Letts et al., 2016). Two crucial changes were made (Figure 2.5). Firstly, to 
achieve complete binding of NNT to Q-sepharose NaCl concentration in buffer A was 
decreased from 50 mM to 40 mM. Secondly, an additional gradient elution step was added 
between 40 mM and 200 mM NaCl. The final protocol for anion exchange purification of NNT 
was the following. LMNG (10 %) was added dropwise to this suspension to 1 % and after 
stirring for 45 min, the sample was centrifuged at 50000 g for 45 minutes. The supernatant was 
filtered with a 0.22 m filter and loaded onto a 45 mL Q-sepharose HP anion exchange column 
equilibrated in buffer Q-A (20 mM HEPES pH7.4, 40 mM NaCl, 2 mM EDTA, 10% v/v 
glycerol, 1 mM DTT, 0.05% LMNG). Proteins were eluted with a 400 mL linear gradient with 
0-17% Q-B buffer (Q-A buffer with 1 M NaCl). NNT eluted as a broad peak (~150mL) around 
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110 mM NaCl and fractions containing significant amounts of NNT based on the activity assay 
and the SDS-PAGE profile were pooled. 
It quickly became apparent that a single round of anion exchange did not yield 
sufficiently pure NNT for cryo-EM studies. Changing the pH of buffers A and B to pH 8 or pH 
8.5 did not change the separation of the components significantly. A second round of 
purification by anion exchange was tried on partially purified fractions from the first round. 
Binding of partially purified NNT fractions to MonoQ, ANX-sepharose and DEAE-sepharose 
columns equilibrated in buffers A and B at pH 7.4 did not significantly improve the purity of 






Figure 2.5. Optimising NNT anion exchange step.  
a. Elution profile of NNT in high salt buffer. b. elution profile of NNT in low salt buffer. 
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2.3.4.2.Cation exchange chromatography 
Purifying NNT-containing fractions by cation exchange chromatography using MonoS 
column at pH 6.0 gave encouraging results because NNT eluted separately from other 
contaminants (Figure 2.6b). Because there was some evidence of NNT dissociating on the 
MonoS column and in particularly in order to scale up the preparation, SP-sepharose was used 
in further preparations with indistinguishable results (Figure 2.6c,d). Further tests also showed 
that because NNT binding to cation exchange column is relatively weak, it is important to load 
NNT in a buffer with NaCl concentration below 10 mM (or conductivity < 2 mS/cm) and at 
pH less or equal to 6. This was effectively achieved by dilution or dialysis.  
The final protocol for cation exchange of NNT involved the following steps. Fractions 
containing transhydrogenase from Q-sepharose column were dialysed overnight against a 10-
fold volume excess of buffer D (20 mM MES, pH 5.8, 2 mM EDTA, 10% v/v glycerol, 1 mM 
DTT, 0.01% LMNG). This lowered the pH and conductance of the sample below 6 and 2 
mS/cm, respectively, and made it suitable for loading onto a 45 mL SP-Sepharose HP cation 
exchange column equilibrated in buffer SP-A (20 mM MES pH5.8, 10 mM NaCl, 2 mM 
EDTA, 10% v/v glycerol, 1 mM DTT, 0.025% LMNG). Elution with a 100 mL 0-20% linear 
gradient with buffer SP-B (SP-A with 1 M NaCl) gave a sharp elution peak of relatively pure 
NNT at around 35 mM NaCl (conductance 4 mS/cm). Fractions containing NNT were 
concentrated to 4 mg/mL using a 100 kDa cut-off concentrator and stored at 30% glycerol 







Figure 2.6. Optimising NNT second ion exchange step.  
a. Elution profile of pooled fractions containing NNT from Fig. 2.5. when loaded on a second anion exchange 
column MonoQ. b. Elution profile of pooled fractions containing NNT from Fig. 2.5. when loaded on a second 
cation exchange column MonoS at pH 6.0 gives much better separation. c. Scaled-up cation exchange step using 
a 50 mL SP-sepharose column. d. Yield table for SP-sepharose preparation. 










pooled fractions 5.64 13.40
Figure 2.6. Optimising NNT second ion exchange step. a. Elution profile of pooled fractions containing NNT from Fig. 2.5. when loaded on a 
second anion exchange column MonoQ. b. Elution profile of pool d fractions containing NNT from Fig. 2.5. when loaded on a second cation 







































1-7 mL 12-14 mL 14-16 mL 16-20 mL
30-50 mL 60-64 mL 65-69 mL 70-74 mL 77 mL
420-600 mL 790 mL
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2.3.4.3.Size exclusion chromatography and polishing 
Gel filtration of NNT after the cation exchange step was crucial to exchange the buffer 
and adjust the pH and to lower the LMNG concentration or to exchange the sample into a 
different detergent. On the day of cryo-EM grid preparation, a sample of NNT was thawed on 
ice and loaded onto a Superose 12 10/300 gel filtration column equilibrated in buffer GF (20 
mM HEPES, pH 7.4, 50 mM NaCl, 1 mM EDTA, 0.002% LMNG) to remove excess detergent 
and remaining protein contaminants (Figure 2.7b,c). The purest and the most concentrated 
fractions of NNT eluted at ~10.7 mL and were concentrated to 5 mg/mL using a Millipore 100-
kDa cut-off filter and used immediately for cryo-EM grid preparation.  
In some purifications, 0.002% LMNG in GF buffer was substituted by 0.05% FOM, 
which gave a monodisperse and highly active NNT but grids suitable for cryo-EM data 
collection could not be prepared from FOM preparations as the protein started to aggregate on 
the grid at concentrations higher than 2 mg/mL (Figure 2.7a). If NNT was purified using 
Superose 6 column, the peak of elution was at ~14 mL. 
Preparations in FOM had a slightly higher activity (~20 U/mg) compared to LMNG 
(~15 U/mg) but were considerably less stable: after 1 week at 4ºC almost 90% of activity of 
LMNG sample was retained, while the FOM sample lost any detectable activity.  
NNT prepared in this way contained a small but persistent amount of complex II 
contaminant (as determined by SDS-PAGE and UV-Vis spectrum), which due to similar mass 
(~160 kDa) did not separate completely from transhydrogenase (~220 kDa) on the gel filtration 
column and required one to carefully exclude CxII-containing fractions from samples used for 
cryo-EM grid preparation (Figure 2.7c).  
To remove complex II contamination additional purification steps were tried. Adapting 
the SP-Sepharose preparation by eluting with a pH gradient instead of salt gradient was tried 
but did not work well. Loading of SP-Sepharose in buffer with pH 6.1, collecting the 
flowthrough and reloading it a pH 5.8 gave slightly higher purity at the expense of a lower 
yield. Similarly, NNT seemed to bind to reactive red agarose preferentially over complex II, 
but the preparation was not easily reproducible, required high salt concentration for elution 
(500 mM NaCl) and resulted in a decreased yield. Furthermore, F1Fo also appeared to bind to 
this substrate. Overall, any additional purifications steps did not increase the purity 
significantly to justify prolonged purification times and lower yield.  
Transhydrogenase prepared in this way was devoid of nucleotides, as confirmed by the 






Figure 2.7. Final NNT purification step and reconstitution into liposomes.  
a. Gel filtration of NNT in two different detergents, FOM and LMNG. Absorbance at 420 nm is due to the succinate 
dehydrogenase (complex II, SDH) as shown by SDS-PAGE. c. SDS-PAGE shows the presence of a ~110 kDa 
polypeptide of NNT. Highest purity fractions around ~10.5 mL were pooled and concentrated for cryo-EM sample 
preparation. A major contaminant SDH (bands in red) was identified based on A420 and SDS-PAGE profile. Minor 
contaminants (bands in blue) were identified by MS/MS. d. Comparison of gel filtration elution profiles for NNT 
in FOM and several nanodiscs. BN-PAGE shows a difference in the apparent molecular weight as well. e. Total 
number of DOPC lipids predicted in silico to assemble into differently sized nanodiscs with bacterial NNT (PDB 
4O9U).  
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1E3D1 1D1 1D1 H5 FOM
Elution 
volume [mL] 9.75 10.25 10.25 10.8
1E3D1 1D1 1D1 H5
MW [kDa] 35 25 21
Diameter [Å] 120 100 80




upper leaflet 98 47 25
lower leaflet 89 38 16
Figure 2.7. Final NNT purificaiton step and reconstitution into liposomes. a. in two different detergents, FOM and LMNG, is shown. SDS-
PAGE shows the presence of ~110 kDa polypeptide of NNT. Highest purity fractions around ~10.5 mL were pooled and concentrated for cryo-EM 
sample preparation. b. SDS-PAGE shows the presence of ~110 kDa polypeptide of NNT. Highest purity fractions around ~10.5 mL were pooled 
and concentrated for cryo-EM sample preparation. Total number of DOPC lipids predicted (for bacterial NNT)
SDH










Nanodisc preparation was done as described above for complex I. We varied the time 
of reconstitution (speed of detergent removal), and different ratios of components. Overnight 
reconstitution (two additions of 200 mg Biobeads per 400 g NNT) and a unit stoichiometric 
ratio between NNT and scaffold protein was the best. At ratios of NNT to MSP to lipids 1:2:200 
we observed many empty nanodiscs, at ratio 1:1.2:100 less so and at 1:1:100 almost none and 
we also did not observe any decrease in NNT yield or increased void volume elution that would 
signal too little MSP or lipids were added.  
The choice of membrane scaffold protein depends on the size of the transmembrane 
region and should be large enough to allow at least two layers of lipids to bind between NNT 
and MSP. On the other hand, it should be small enough not to add significant additional 
heterogeneity and unstructured density into the sample, which would complicate subsequent 
image analysis. The size of nanodiscs was modelled using CHARMM-GUI online server 
(Figure 2.7e) (Jo et al., 2008).  
The choice of lipids should resemble natural membrane lipid composition and should 
have a melting temperature below 4 ºC at which the protein was purified. DOPC:CL in 4:1 w/w 
ratio was used, which was determined to be adequate based on activity measurements.  
NNT was reconstituted into MSP1E3D1, MSP1D1 and MSP1D1H5 nanodiscs and 
injected on the Superose 12 gel filtration column equilibrated in gel filtration buffer without 
any additional detergent. NNT-1E3 eluted at ~9.7 mL and had activity ~20 U/mg, while NNT-
1D1 and NNT-1H eluted at ~10.25 mL and had activities ~12 U/mg. NNT-1E3 migrated 
significantly higher on BN-PAGE than NNT-FOM and based on the gel filtration profile, the 
nanodisc adds about 200 kDa to the overall apparent molecular weight of the particles (ferritin 
which is 440 kDa elutes at 9.7 mL from Superose 12 column) (Figure 2.7d).  
 
2.3.4.5.Proteoliposome reconstitution 
NNT was reconstituted into proteoliposomes using a detergent dilution procedure as 
described before (Sazanov and Jackson, 1995). Briefly, NNT purified in FOM or in LMNG 
was mixed with a 500-fold molar excess of DOPC solubilised in 1% CHAPS. Following a 10 
min incubation on ice, the solution was diluted 100-fold in GF buffer and incubated on ice for 
3-5 hours before used for measuring the activity directly. Activity measurements confirmed 
that proteoliposomes prepared in this way were well coupled (~10x stimulation of 




NNT activity, NNT was also reconstituted into proteoliposomes with different lipid 
compositions, in particular POPC, asolectin, and DOPC:CL, DOPC:PS, DOPC:PE, DOPC:PI 
in 4:1 w/w ratios, respectively. Activity was the highest in DOPC/POPC liposomes, slightly 
lower in DOPC/CL, DOPC/PS or DOPC/PI and the lowest in DOPC/PE. POPC liposomes 
were slightly leakier than the others (Chapter 3). 
 
2.3.5. ATPase purification 
2.3.5.1.LMNG extracts ATPase dimers 
F1Fo ATPase is another abundant inner mitochondrial protein that was observed to elute 
from the Q-Sepharose anion exchange column as a broad but relatively pure peak at a slightly 
higher NaCl concentration (140 mM) than NNT during the purification of the latter. Curiously, 
when the sample of ATPase was gel filtrated in the following buffer, 50 mM Tris-HCl, pH 7.4, 
50 mM KCl, 2 mM MgCl2, 0.05% LMNG, the resulting profile displayed a main peak at ~12 
mL and a distinct shoulder at ~10.7 mL. Blue-native PAGE confirmed that the low-molecular 
weight peak corresponded to a monomer of ATPase, while the high-molecular weight 
corresponded to dimeric ATPase. Previously, it was reported that only weak detergents such 
as digitonin are able to extract ATPase from mitochondria in the dimeric form.  
Gel filtration was done with similar results also in 0.02% LMNG and 200 mM KCl. 
When LMNG was substituted for FOM or ATPase was exchanged into amphipol A8-35, the 
high-molecular weight peak practically disappeared.  
To improve separation between monomer and dimer, several purification methods were 
tried. Density gradient purification was done in 5-45% sucrose gradient along with an opposite 
0.003-0% LMNG gradient as described before in the GRADER approach (Hauer et al., 2015). 
Similarly, the gradient was also done with glycerol instead of sucrose. The separation was 
comparable to gel filtration. Finally, separation by MonoQ column at different pH values 
(pH7.4, 8, 9.2) was tried, but dimer and monomer peaks always overlapped. Gel filtration of 
the dimer-containing frozen fractions results in a monomer peak only. 
The final optimised GF buffer based on the results of ProteoPlex consisted of 50 mM 
Na-citrate buffer pH 7.0, 100 mM NaCl, 1% glycerol, 0.05% LMNG, 1 mM EDTA.  
ATPase was reconstituted into MSP2N2 and DOPC:CL 4:1 nanodiscs according to the 
procedure described above for complex I with a 72 h reconstitution procedure. F1Fo-ATPase, 
MSP, lipid ratio was 1:3:300, respectively. Only monomers reliably reconstituted, possibly 
because the complex has begun to dissociate during the long reconstitution procedure.  
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F1Fo prepared this way displayed activity between 4 and 8 U/mg and between 83 and 
97% oligomycin sensitivity. Reconstitution in to amphipols A8-35 and 10 mM CaCl2 fully 
inhibited the ATPase activity.  
 
 
Figure 2.8. Summary of ATPase purification.  
a-c. Gel filtration profiles in (a) 0.05% LMNG, (b) A8-35 reconstituted sample and (c) 0.05% FOM. d. SDS-PAGE 
analysis of purified ATPase using Tris-tricine and Tris-glycine gels and compared to the SDS-PAGE profile of bovine 
ATPase published in literature. e. Activity and oligomycin sensitivity of several different preparations as 
described. f. BN-PAGE analysis reveals a mixture of monomeric (~600 kDa) and dimeric (~1.2 MDa) ATPase. In 
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2.4.Electron cryo-microscopy  
2.4.1. Grid preparation 
Unless stated otherwise, grids were prepared by applying 2.7 L protein sample to a 
freshly glow-discharged (7x10-1 mbar and 30 mA for 2 min in the ELMO Glow Discharge unit, 
Agar Scientific, Stansted, UK) Quantifoil 0.6/1 copper grid and blotted for 4-10 s using a 
blotting force of 25 at 4°C and 100% humidity in an FEI Vitrobot Mark IV. Grids were flash-
frozen in liquid ethane and stored in liquid nitrogen until data-collection. 
 
2.4.2. General lessons on grid preparation 
Cryo-EM grids suitable for high-resolution data collection must satisfy a number of 
criteria and achieving grids suitable for high resolution cryo-EM structure determination is 
currently the most important bottleneck of many projects. Most importantly, protein needs to 
be pure, monodisperse, sufficiently concentrated, show random orientations and not be 
disassembled or aggregated (Orlova and Saibil, 2011). Moreover, the ice thickness needs to be 
low – both to minimize background noise and to limit distribution of protein particles along the 
z-axis.  
To achieve this grid preparation protocol needs to be iteratively optimized and a number 
of different conditions screened. The first crucial component is isolating the protein of interest 
under the right conditions, especially with respect to the choice and concentration of detergent, 
buffer and protein concentration. The second crucial component is optimization of conditions 
during the vitrification process itself, e.g. the grid type and blotting time. Many optimised 
parameters will be unique for each protein examined, as confirmed during the preparation of 
this thesis which included cryo-EM grid optimisation for four different proteins and several 
different preparations of each of them. However, some patterns in the grid optimisation process 
did emerge which will be briefly discussed here. The most common problems encountered 
included: aggregation, problems with ice thickness, breaking of particles, presence of detergent 
artefacts and heterogeneity within or between grids. 
 
2.4.2.1.Achieving consistent results 
The first requirement for consistency is a pure, stable and fresh protein sample that 
behaves in a predictable way when concentrated and applied on a cryo-EM grid. Grid 
preparation was always done from freshly gel-filtrated sample. Diluting and then re-
concentrating protein samples from thawed glycerol-containing stocks resulted in aggregation 
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of protein on the cryoEM grids (Figure 2.9). In general, the fewer the handling steps of protein 
between gel filtration and grid freezing, the better the grids. 
 
 
Figure 2.9. Effects of gel filtration on grid preparation in ATPase (top) and E. coli complex I (bottom).  
ATPase in LMNG, fresh grid was prepared immediately after gel filtration without any further concentration or 
additons. E. coli complex I, fresh grid was prepared by gel filtration in DDM and concentration to ~5 mg/mL. 
ATPase and CxI frozen grids were prepared by diluting-concentrating a sample of protein frozen with 30% 
glycerol. 
 
The other critical step for achieving consistency are blotting conditions. Care was taken 
to operate the Vitrobot as consistently as possible on different sessions. This included setting 
the temperature, blotting “force” and blotting “time” parameters, maintaining the same 
orientation of the tweezers and insertion of blotting paper right before the actual grid 
preparation and not during Vitrobot equilibration. This achieved a satisfactory reproducibility 
but a representative grid from the same batch was always still checked in-house before the 




Sometimes it was observed that particle coverage varied quite strongly within the same 
grid. Ultimately, this seems to be an effect of too low protein concentration and higher protein 
concentration solved the variability.  
 
2.4.2.2.Aggregation 
Aggregation was one of the most persistent problems encountered during cryo-EM grid 
preparation. Membrane proteins tend to aggregate easily because of the exposed hydrophobic 
regions normally embedded in the membranes. The most obvious solution for aggregation is 
therefore a change of detergent. Typically, detergents in which proteins easily aggregate can 
be discarded already during the purification optimization step, by stability and activity 
screening. However, that is not always the case as demonstrated by NNT in FOM, as described 
later. Another possible solution is including a secondary detergent, which was beneficial in 
many cases, especially if the primary detergent had a low critical micelle concentration (CMC) 
and the secondary detergent had a high CMC (e.g. FOM, CHAPS, OG) (Figure 2.10). High-
CMC detergent molecules orient themselves at air-water interface and prevent protein from 
interacting with it, but some partitioning of secondary detergent into primary detergent micelles 
also probably happens and contributes to different sample properties (Chen et al., 2019). 
 
Figure 2.10 Effects of secondary detergents on aggregation of ATPase on cryoEM grids. 
 
Secondly, salt concentration determined the aggregation of particles in solution. Salt 
shields charges as the cations arrange themselves around negatively charged protein surfaces 
and anions arrange around positively charged protein surfaces. Salt can have two opposing 
effects on aggregation behavior. Simple colloidal particles can be induced to aggregate by 
increasing salt concentration as the dissolved ions shield repelling charges on their surfaces 
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(Dill and Bromberg, 2010). Proteins, however, have large and heterogeneous surfaces with 
both positively and negatively charged patches. Opposing charges on the surfaces will also be 
shielded by increased salt concentrations and associate less readily. The effect of salt on protein 
aggregation was documented for E. coli complex I, which was very prone to aggregate at 50 
mM NaCl, but when this was increased to 250 mM NaCl, aggregation was more or less gone 
and increase to 400 mM did not improve monodispersity further (Figure 2.11).  
 
 
Figure 2.11. Effects of salt on aggregation of E. coli complex I on cryoEM grids. 
 
An alternative method for modulating surface charges is a change of pH. This can 
modulate the protein surface charges by changing protonation states of amino acid residues. 
The effects of pH change on the aggregation of F1Fo-ATPase sample are not as easy to explain, 
however (Figure 2.12). Surface charge properties of large protein assemblies are complex and 
consist of regions of opposing charges which will behave in unpredictable ways at different pH 
values. Varying pH could also affect protein activities and conformations in unpredictable ways 






Figure 2.12. Effects of pH on aggregation of ATPase on cryoEM grids. 
 
2.4.2.3.Detergent artefacts 
Protein samples after gel filtration are rather diluted and need to be concentrated several 
fold before they can be used for grid preparation. Transhydrogenase in particular, for which 
the yield was not high, had to be concentrated 20-30 fold after gel filtration to reach ~5 mg/mL 
suitable for grid preparation. For samples without detergent this is not a problem (in amphipols 
or nanodiscs) but concentrating of samples with detergent also concentrated detergent, because 
detergents exist in a form of large molecular weight micelles in aqueous solutions.  
The optimal concentration of total detergent for cryo-EM grids is probably around 0.2-
0.4%. Anything above this results in artefacts: either free micelles visible or long threads 
(Figure 2.13). For some detergents, such as LMNG, artefacts were apparent even at lower 
concentrations, above 0.1%. Too low concentration of detergents, or more precisely, too low 
concentration of free detergent (not in micelles), resulted in denaturation of protein particles at 
the air-water interface.  
For samples purified in LMNG, the final concentration of detergent was controlled by 
gel filtration at 2xCMC = 0.002%, so even several-fold concentration of samples did not result 
in [LMNG] > 0.1%. For NNT purified in FOM, however, excess detergent was removed using 
Detergent removal columns (ThermoFisher Ltd.) that bind detergents and other hydrophobic 
contaminants. Typically, 750 L NNT was concentrated to 20uL ([FOM] ~ 2%), and after a 
single passage through a detergent removal column according to the manufacturer’s 
instructions, 0.075% remaining FOM was measured.  Detergent removal by dilution and re-






Figure 2.13. Detergent artefacts observed at high detergent concentrations. 
 
2.4.2.4.Breaking of particles 
Particles were sometimes observed to break or disintegrate into smaller pieces. It has 
been described that this is due to the denaturing effects of the air water interface on proteins 
(Glaeser et al., 2016). This can be avoided by using a high-CMC secondary detergent, as 
described above, which binds at the air-water interface and prevents protein adsorption and 
denaturation there. This was observed to be particularly useful for samples without primary 
surfactant (nanodiscs) or with primary surfactants with very low CMC values (amphipols, 
LMNG) (Figure 2.14 and 2.15). Addition of secondary detergent also seemed to make the ice 
thickness less variable across the grids. On the negative side, as described below, higher 




The most important factors to tune for achieving thin ice is blotting time. This varied 
between 5 and 10 s for most of the samples. Blotting times up 20-30 s also worked sometimes, 
especially for samples with high concentrations of detergent. 
Samples without or with little detergent were more prone to “over-blotting”, as were 
the samples set up on gold grids. A persistent problem of many preparations was the partial 
overblotting, where the centres of the holes became too thin and excluded the particles from 
that region. This was partly avoided by increasing protein concentration and concentration of 




easily using Quantifoil 0.6/1 grids, which were less prone to overblotting than Quantifoil 
1.2/1.3 grids with larger hole size. 
Ice thickness was qualitatively assessed based on the contrast between the particles and 
the background in the acquired images. Another semi-quantitative method for estimating ice 
thickness is measuring electron fluence over an empty hole and a full hole, the ratio of which 
is approximately related to the ice thickness according to d/ = ln (Ii / Io), where d is the mean 
electron path in vitreous ice at 120kV (~600 Å), is the ice thickness, Ii is the incident fluence 
and Io is the fluence after the sample (Feja and Aebi, 1999). Another semi-quantitative method 
for measuring ice thickness is the channel-method from tomography, which involves burning 
a narrow channel into the vitreous ice when the grid is tilted at 45º (Feja and Aebi, 1999). When 
the sample is not tilted anymore, the edges of the channel reveal the thickness of the sample. 
The method was useful for ice thicknesses above 50 nm but became increasingly imprecise 
below that as the vitreous ice around the channel became less stable. Ultimately, each cryo-EM 
grid displayed a range of ice thicknesses at different grid squares and also within the same grid 
square and it was important to choose the suitable holes during the collection itself.  
 
2.4.2.6.Achieving adequate particle coverage 
Ideal outcome of cryo-EM grid preparation is a single layer of tightly packed particles 
embedded in thin ice (Figure 2.14 and 2.15). Packing can be as tight as possible, to the point 
where proteins seemingly touch, as long as they are not overlapping. The resulting dataset will 
thus contain the highest number of particles per image. This required a high concentration of 
protein, reaching 5 mg/mL in most conditions and seemed to be dependent on the concentration 
of detergent present in the sample: the more detergent, the higher the protein concentration 
required to reach the desire coverage. As concentrating the protein to such high concentrations 
may not always be achievable due to propensity for aggregation or to avoid concomitant 
concentration of detergent, we investigated the use of graphene-oxide covered grids. As protein 
molecules get adsorbed on the solid graphene oxide support, an order of magnitude lower 
concentrations are required to achieve the same coverage. This comes at the expense of lower 
signal-to-noise ratio as graphene oxide contributes to the background. This has been reported 
to be quite minimal compared to amorphous carbon covered grids and should not interfere with 
image analysis of large (>0.5 MDa) protein complexes. Presence of support could even help 
with initial CTF parameters estimation and should limit beam-induced movement (Russo and 
Passmore, 2016).  
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Graphene oxide-covered grids were prepared as described previously. Graphene oxide 
solution (3 L, 0.5 mg/mL) was applied to freshly glow discharged Quantifoil grids, incubated 
for 1 min and then washed with 20 L water, twice from the front and once from the backside 
of the grid and air-dried (Bokori-Brown et al., 2016). Grids prepared in this way were however, 
not covered very evenly and because of the fear that multiple layers of graphene oxide over 
some squared would detrimentally affect image quality, efforts were focused on optimising 
grid preparation in ice. Nevertheless, complex I from a small dataset on graphene-oxide-
covered grids reached 4 Å. A further complication from supported grids is preferential 
orientation of particles because molecules tend to adsorb to the film with the largest or the most 
charged surface. Additionally, overblotting such grids results in complete dehydration of 
protein – freeze drying – precluding high resolution data reconstruction.  
 
2.4.3. Optimized grid preparation: Transhydrogenase 
2.4.3.1.FOM preparation 
For FOM-solubilised transhydrogenase, several ten-fold concentration of fractions after 
gel filtration was required, which increased FOM concentration above 1%. This was not 
compatible with preparation of grids for cryo-EM, for which optimal FOM concentration was 
determined to be between 0.2 and 0.4%. As described above excess FOM was removed using 
detergent removal columns (Thermo-Fisher Scientific Inc.) which typically removed ~90% of 
free detergent. It was important to measure detergent concentration of each preparation 
prepared this way and adjust FOM concentration back to 0.2-0.4%. Detergent removal columns 
did not decrease activity or cause aggregation of the sample. Zeba columns, dilution-
reconcentration and microdialysis on the other hand did not remove more than ~25% of the 
detergent.  
Ultimately it was discovered that concentrating NNT in FOM above ~2.5-3 mg/mL 
results in aggregation – seen on cryoEM grids and UV-Vis spectra (A260/280 > 1) (Figure 2.14). 
This aggregation preceded detergent removal and seemed to happen very fast. At 2 mg/mL 
before the protein started to aggregate, a small dataset was collected which showed 2D classes, 








Cryo-EM grids were prepared from NNT in MSP1E3D1 nanodiscs (large nanodisc) 
and MSP1D1H5 nanodisc (small nanodisc).  Due to the lack of detergent in these samples, 
addition of secondary detergent was necessary to prevent aggregation of particles and 
denaturation at the air-water interface (Figure 2.14). Both samples were prepared in the 
presence of 5 mM NADP+. NNT- MSP1E3D1 sample included 0.05% CHAPS and NNT-
MSP1D1H5 nanodisc included 0.1% OG and was prepared using Ultrafoil Gold 0.6/1 grids. 
Despite excellent cryo-EM grids prepared with nanodisc sample, this preparation was also 
abandoned due to the fear that the large nanodisc density around the membrane domain is 
interfering with cryo-EM image alignment. 
 
2.4.3.3.LMNG preparation 
Ultimately, NNT in LMNG was used directly for grid preparation. It was critical to 
perform gel filtration in minimal (0.002%) LMNG and not to concentrate fractions more than 
30-fold to avoid too high LMNG.  Care was also taken to prepare a fresh LMNG stock on the 
day of purification. 0.05% CHAPS was added to the protein sample before grid preparation to 
improve the ice quality and the particle distribution (Figure 2.14). For samples with substrates 
added, these were added at 5 mM concentration to the protein sample 15-30 min before the 











2.4.4. Optimised grid preparation: complex I 
As described in chapter 4, high resolution datasets for complex I were also collected on 
a sample purified in LMNG. Nevertheless, cryo-EM grids of complex I were prepared also 
with complex I reconstituted into amphipols and nanodiscs or dissolved in FOM, digitonin or 
Cymal-7 detergents and all of these preparations could in principle be used for data collection 
(Figure 2.15). Grid preparation procedure for CxI-LMNG was ultimately relatively similar to 
NNT. After gel filtration in 0.002% LMNG-containing buffer, complex I containing fractions 
were concentrated to ~3 mg/mL. 0.2% CHAPS was added to the protein sample before grid 
preparation to improve the ice quality and the particle distribution (Figure 2.15). The native 
and the deactive complex I samples were frozen without further substrate additions. For 
NADH-only dataset NADH at 5 mM was added to the protein 20 min before the grid 
preparation and the samples were incubated on ice. For NADH and rotenone dataset, NADH 
(5 mM) was added to complex I sample, followed by 300 M rotenone (dissolved in DMSO) 
and 20 min incubation on ice. For NADH&DQ turnover dataset, a mixture of substrates and 
CHAPS was prepared at 2x working concentration (2 mM DQ, 2 mM NADH and 0.4% 
CHAPS) which was mixed in 1:1 ratio with 6 mg/mL complex I at room temperature 
immediately before applying on grid, blotting and freezing. With this simple procedure, 
complex I was active for 20 s before being frozen and less than 10% of substrates would have 











2.4.5. Initial grid screening 
Initial images for screening purposes were collected on a Tecnai T12 electron 
microscope (FEI) operating at 120 kV in a low-dose mode. Images were recorded using either 
a CCD camera or a TemCam-XF416 CMOS camera (TVIPS, Gauting, Germany). Grids were 
mounted on a pre-cooled single tilt side-entry cryo-transfer holder (Fischione Instruments, Inc., 
Export, PA, USA). Images were recorded at a nominal magnification of 42000x. Defocus was 
set for -3.5 μm, electron dose 20-50 e-/s/Å2 and exposure time 1-3 s.  
 
2.4.6. Data collection: Transhydrogenase 
NNT-NADP+ grids were imaged using a 300 kV Titan Krios electron microscope 
equipped with a Gatan energy filtered K2 summit camera with a slit width of 20 eV at The 
Astbury Centre for Structural Molecular Biology of the University of Leeds.  
NNT-NADPH grids were imaged using a 300 kV Titan Krios electron microscope 
equipped with a Gatan energy filtered K2 summit camera with a slit width of 20 eV at the 
CM01 beamline, ESRF, Grenoble.  
Images were collected with EPU in a K2 super-resolution mode with a nominal 
magnification of 130000x and a physical pixel size of 1.065 Å for NNT-NADP+ and 1.07 Å 
for NNT-NADPH dataset. Total dose of 72 e/Å2 (NNT-NADP+) or 70 e/Å2 (NNT-NADPH) 
was fractionated into 40 frames of 250 ms each.  
Apo-NNT grids were imaged using a 300 kV Titan Krios electron microscope equipped 
with a Gatan energy filtered K3 camera with a slit width of 20 eV at the Institute of Science 
and Technology Austria. Physical pixel size was 0.84 Å and the total dose of 90 e/Å2 was 
fractionated into 88 frames of 36 ms each. 
NNT samples in nanodiscs were imaged using a 300 kV Polara electron microscope 
equipped with a K2 camera at the Vienna Biocenter Electron Microscopy Facility. Images were 
collected with SerialEM in a super-resolution mode with a nominal magnification of 39000x 
and a physical pixel size of 0.98 Å. Total dose of 80 e/Å2 was fractionated into 40 frames of 
250 ms each. NNT-1E3D1 samples were collected from Quantifoil Carbon grids and NNT-
H5 from Quantifoil Ultrafoil gold grids. 
 
2.4.7. Data collection: complex I 
Native, NADH, rotenone and turnover grids were imaged using a 300 kV Titan Krios 
electron microscope equipped with a Falcon III camera operating in an integrating mode at 
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Cryo-Electron Microscopy and Tomography Core Facility in CEITEC, Brno. Turnover, NADH 
and rotenone datasets were imaged at a nominal magnification of 130000x with a physical pixel 
size of 1.061 Å. Total dose of 89 e/Å2 was fractionated into 40 frames of 21 ms each. Native 
dataset was imaged at a nominal magnification of 165000x with a physical pixel size 0.83 Å. 
Total dose of 98 e/Å2 was fractionated into 40 frames of 25 ms each. Images were collected 
from 3x3 patches of holes using image shift – resulting beam tilt error was small and refined 
during processing and this mode of acquisition allowed for a high speed of collection.  
Deactive complex I was imaged using a 300 kV Titan Krios electron microscope 
equipped with a K3 camera operating in a super-resolution mode at the Institute of Science and 
Technology Austria. Grids were imaged at a nominal magnification of 81000x and physical 
pixel size of 1.10 Å. Total dose of 78.5 e/Å2 was fractionated into 50 frames of 88 ms each. 
The deactive dataset was collected using SerialEM with an active beam tilt compensation, 
hence beam tilt error was not refined separately for each of the nine holes imaged using the 
image shift method. 
Complex I samples in nanodiscs were collected using a 300 kV Polara electron 
microscope equipped with a K2 camera at the Vienna Biocenter Electron Microscopy Facility. 
Images were collected with SerialEM in a super-resolution mode with a nominal magnification 
of 39000x and a physical pixel size of 0.98 Å. Total dose of 80 e/Å2 was fractionated into 40 
frames of 250 ms each.  
 
2.5.Image processing: Transhydrogenase 
We collected 2272 movies for the NADP+ dataset, 1722 movies for NADPH dataset 
and 786 movies for the apo-NNT dataset. The processing was done in RELION 2.1 (Scheres, 
2012b) unless otherwise stated. Movie frames were aligned using MotionCor2 (Zheng et al., 
2017) and initial CTF parameters were estimated from averaged images using CTFFIND 
(Rohou and Grigorieff, 2015). Autopicking with 2D class averages as references resulted in 
516395 particles for the NADPH dataset, 1076677 particles for the NADP+ dataset and 500001 
particles for the apo dataset. Multiple rounds of 2D classification and 3D classification were 
performed to classify considerably heterogeneous particles. CTF parameters and per-particle 
trajectories in the best two classes from the NADP+ dataset were estimated and corrected 
(particle polishing) using RELION 3.0 (Zivanov et al., 2018). Local resolution was estimated 
using Resmap 5.0 (Kucukelbir, Sigworth and Tagare, 2014).  
For the NADP+ dataset we performed one round of 2D classification followed by two 




eight classes containing 342284 particles from which it was obvious that there is a considerable 
heterogeneity in the conformations of dI2 and dIIIb. To address this, the particles were re-
extracted without binning and refined with a dII2dIII2 mask to 3.5 Å and then classified into 
ten classes without searches and without a mask to separate the particles based on the relative 
position of the dI2. By combining similar classes and auto-refining them, we separated six 
different states of NNT which differ from each other with respect to the positions of dI2 and 
dIIIb. Two of these classes were resolved to 13 Å, further two to 7 Å and the best two classes 
to 3.7 and 3.2 Å. From the latter two maps it was obvious that the density for dI2 was still 
weaker than for the rest of the particle, indicating remaining heterogeneity in the positions of 
dI2, hence the final maps for these two classes were produced by combining focus-refined maps 
of dII2dIII2 and dI2 parts. This gave the final map for class 1 (closed) with 2.9 Å resolution in 
the dII2dIII2 and 3.2 Å resolution in the dI2 and for class 2 (open) 3.5 Å resolution for the 
dII2dIII and 4.1 Å resolution for the dI2. Due to the poor quality of the map for the open class 
in some regions of dIIb (CL6,7,8), we hypothesised that there is still remaining conformational 
heterogeneity present in this class and we performed another round of classification of these 
particles with a mask around dIIb to sort out any particles with dIIIb attached/semi-attached to 
dII. This procedure removed 52% particles and we performed an auto-refinement with a 
dII2dIII mask of the remaining 28498 particles with dIIIb unambiguously detached. This 
resulted in a 3.7 Å map with dIIb density much better resolved and clearly different from the 





Figure 2.16. Processing of NNT-NADP+ dataset.  
Thorough classification of particles resulted in six distinct classes with different domain orientations and 
resolutions. Best-resolution class (“double face-down” NNT) is almost symmetric with both dIIIs bound in the 
‘face-down’ position while the other five have only one dIII bound in the face-down position and the other dIII 
detached and the dI2 tilted at different angles. Simultaneous opening of dI2 and dissociation of dIIIb is probably 
necessary to permit full dIIIb rotation during the catalytic cycle. Monomers with dIII detached from dII also show 
weak or no density for dI-dII linker which suggests that it detaches from dIII to allow dI2 to open.  
Adapted from Kampjut & Sazanov, 2019. 
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Figure 2.14. Processing of NNT-NADP+ dataset. Thorough classification of particles resulted in six distinct classes with different domain 
orientations and resolutions. Best-resolution class (“double face-down” NNT) is almost symmetric with both dIIIs bound in the ‘face-down’ 
position while the other five have only one dIII bound in the face-down position and the other dIII detached and the dI2 tilted at different angles. 
Simultaneous opening of dI2 and dissociation of dIIIb is probably necessary to permit full dIIIb rotation during the catalytic cycle. Monomers with 




For the NADPH dataset, we performed one round of 2D classification followed by one 
round of 3D classification on 510073 3x binned particles with the same parameters as in the 
NADP+ dataset, which failed to yield any class with visible secondary structural features. We 
performed extensive classifications of these particles into 4-20 classes with T values between 
4 and 12 and different filtering of the reference volumes which all failed to give a single well-
defined class with secondary structural features. Nevertheless, we selected 405141 particles 
from the best 4 classes from a classification with T=8 and k=6 (same as for NADP+ dataset) 
for further classification attempts. Another round of extensive classifications was performed 
on this particle stack with the best results obtained from a T=8, k=20 run. Even in this run only 
~6 classes had well-defined features corresponding to the domains of NNT. These 6 classes 
were re-extracted and refined which gave structures at 8.3, 9.2, 13, 16, 16, and 16 Å and 
revealed a high degree of dI2 and dIII mobility (Extended Data Fig. 4a). To address this, we 
tried to refine the 405141 particles together into one consensus structure at 13 Å, followed by 
focused refinement of either dI2 or dII2 but neither of these strategies yielded structures better 
than 9 Å, probably due to the too large conformational heterogeneity within the consensus 
refinement. Furthermore, dI2 and dII2 are only 80 kDa each and dII2 is obscured by a micelle 
which further complicates the alignment of such a heterogeneous dataset. Finally, we 
performed multi-body refinement in RELION 3.0 starting from the consensus refinement of 
405141 particles and using masks for the two bodies: dI2 and dII2. This yielded a 9 Å 
reconstruction of dI2 and 10 Å reconstruction of dII2 but more importantly, the principal 
component analysis showed the striking degree of dI2 mobility in these particles (Fig. 2de). 
This is not unexpected as upon dIII dissociation, dI2 remains only loosely tethered to the rest 





Figure 2.17. Processing of NNT-NADPH dataset.  
NNT bound to NADPH exhibited a large degree of conformational flexibility, which prevented a high- resolution 
(beyond 8 Å) refinement of any class of particles. Classification into 20 classes revealed that only a small 
proportion (~5%) of particles have one dIII bound to dII in the face-down orientation (class C). Another ~10% have 
partially detached dIII (classes A and B). A vast majority, however, have both dIIIs dissociated from the other 
domains leading to a large degree of freedom of movement of dI2 and both dIIIs independently of each other 
(see classes D, E and F). 
Adapted from Kampjut & Sazanov, 2019.  
 
The apo-NNT dataset was fully processed in RELION 3.0. We manually selected 643 
good images and extracted 3x binned particles. Only one conformation of NNT could be 
observed using various 3D classification schemes, hence the 283706 particles corresponding 
to it were extracted without binning and auto-refined to 4.5 Å. From this structure it was clear 
that dI2 exhibits the same heterogeneity as in the NADP+ dataset. To improve the resolution in 
the dII-dIII, we focus-refined around this region and classified the particles without searches 
into 6 classes. The best class with 67908 particles was auto-refined and polished to reach the 
resolution of 3.7 Å. Further polishing or subclassification of this class did not improve the 
resolution further. Attempts at focus-refinement of dI2 did not improve its resolution compared 
to the polished full structure of the final selected particles in which local resolution in dI2 was 
~5 Å. We conclude that dI2 without bound nucleotide exhibits even more disorder than when 
NAD+ is bound, possibly allowing NAD(H) exchange and dI2 binding/release.  
2nd 3D classification with k=20, T=8
1603 good images selected 
516395 particles extracted 
510073 particles retained after 2D classification
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Processing of NNT-NADPH dataset. NNT bound to NADPH exhibited a large degree of conformational flexibility, which prevented a high-
resolution (beyond 8 Å) refinement of any class of particles. Classification into 20 classes revealed that only a small proportion (~5%) of particles 
have one dIII bound to dII in the face-down orientation (class C). Another ~10% have partially detached dIII (classes A and B). A vast majority, 
however, have both dIIIs dissociated from the other domains leading to a large degree of freedom of movement of dI2 and both dIIIs 





Figure 2.18. Processing of Apo-NNT dataset.  
Apo-NNT exhibited a single conformational class similar to the “double face-down” NNT class in the presence of 
NADP+.  
Adapted from Kampjut & Sazanov, 2019.  
 
NNT in MSP1E3D1 nanodisc sample (NNT-1E3D1) was processed in RELION 2.0. 
Collection yielded 2153 micrographs, of which 1664 displayed Thon rings beyond 6 Å and 
were used for further processing. Most micrographs displayed a signal cut-off in one direction 
in Fourier space, which later became apparent was a defect of the microscope. 230466 particles 
were autopicked. After several rounds of classification, two distinct classes were separated, 
class 1 contained 40670 particles (10.3 Å) and class 2 contained 34247 particles.  
NNT in MSP1D1H5 nanodiscs (NNT-H5) was processed in RELION 2.0. 879 
micrographs were collected, but only 272 gave Thon rings beyond 6 Å because of the 
microscope defect. 138515 particles picked and classified. 3D classification resulted in one 
best class containing 38912 particles (12 Å) similar to Class 1 from 1E3D1 nanodiscs, apart 
from a noticeably smaller nanodisc density. No minor (class2-like) conformation could be 
classified from this dataset.  
Particles from the best classes of nanodisc datasets were combined and several focus 
refinements tried: whole, without nanodisc, dI2dII2dIII, dI2dIIdIII, dI2dIII, dI2, dI2dIII2, 
Figure 2.15. Processing of Apo-NNT dataset. Apo-NNT exhibited a single conformational class similar to the “double face-down” NNT class in 
the presence of NADP+. 
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643 good images selected 
500001 particles extracted
283706 particles, pixel size = 0.84 Å
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dII2dIII. None of this worked, either because of technical problems with Polara at VBC or 
nanodisc density interference. In fact, only a few examples of small proteins in nanodiscs have 
so far been solved. Finally, conformational heterogeneity combined with nanodisc density 
could have been the problem. Refinements and classification were also tried in cisTEM 
software (Grant, Rohou and Grigorieff, 2018), but the results were almost the same as from 
RELION. 
 
2.6. Image processing: Complex I 
We started with 2284 movies for the native dataset, 1443 movies for NADH dataset, 
4239 movies for the turnover dataset, 2323 movies for the rotenone dataset and 2065 movies 
for the deactive dataset. The micrographs were included in the further processing steps if the 
Thon rings extended to 4 Å (turnover dataset) or 5 Å (all other datasets) according to CTFFIND 
maximum resolution estimate. Processing was done in RELION 3.0 and 3.1 (Zivanov et al., 
2018) unless otherwise stated. Movie frames were aligned using MotionCor2 (Zheng et al., 
2017) and initial CTF parameters were estimated from averaged images using CTFFIND 4.1.13 
(Rohou and Grigorieff, 2015). Autopicking with 2D class averages as references was done in 
RELION and resulted in 295630 particles for the native dataset, 364499 particles for NADH 
dataset, 938197 particles for the turnover dataset, 354690 particles for the rotenone dataset and 
740026 particles for the deactive dataset.  
For the sake of consistency processing steps were done as similarly as possible for all 
the datasets. Particles were extracted at 3x the physical pixel size and processed using one 
round of 2D classification and one round of 3D classification (Supplementary Figures 1-3). 
Good classes were then extracted at full pixel size and autorefined into a single “consensus” 
structure. CTF parameters and per-particle trajectories were then refined in an iterative manner 
(one round of CTF refinement followed by Bayesian polishing and another CTF refinement).  
This led to a consensus refined complex I structure of all particles, reaching nominally high 
resolutions (up to 2.5Å in turnover dataset) but with blurring around the edges and some weaker 
subunits (42 kDa and B14.7) suggesting a large degree of conformational heterogeneity and 
presence of partially disassembled particles. Particles were therefore 3D classified without 
searches to remove damaged particles and then focus-reverse-classified to sort out the 
heterogeneity as done earlier (Letts et al., 2019). Briefly, all the intact particles were focus-
refined using a peripheral arm mask and then classified without searches using a loose 
membrane mask to finely classify states with slightly different angles between the two arms. 




on which atomic models were built, analyzed and compared. In most datasets finer sub-
classification of classes with different masks, in particular around the quinone binding cavity, 
was tried but did not result in finding additional conformational states of complex I. Further 
classifications of consensus refinements of MD or PA of all particles also did not result in 
finding additional conformational classes.  
In the native dataset, the first round of 3D classification was done with k = 6 classes 
and regularization parameter T = 6, which resulted in 148307 good particles. Upon duplicates 
removal, consensus refinement and two rounds of CTF refinement and Bayesian polishing, 
128964 particles were refined around the matrix arm and subjected to final classification 
without searches around the membrane arm with k = 6 and T = 20. This resulted in four good 
classes with 91979 particles in total and two partially broken classes. The good classes were 
refined and post-processed separately to give final maps for model building.  
 
 
Figure 2.19. Processing pipeline of the native dataset.  
FSC plots and local resolution of the closed and open2 classes are shown as well as local resolution plot of the 
focus-refined PA and MD.  
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Processing pipeline of the native dataset. FSC plots and local resolution of the closed and open2 classes are shown as well as local resolution 
plot of the focus-refined PA and MD. 
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In the NADH dataset, the first round of 3D classification was done with k = 6 and T=4, 
which resulted in 276169 good particles. After duplicates removal, consensus refinement, two 
rounds of CTF parameter refinement and Bayesian polishing, another 3D classification with k 
= 6 and T=8 without searches was performed to remove damaged particles. Remaining 182053 
particles were refined around the PA and subjected to classification around the membrane arm 
with k = 6 and T = 8. This resulted in 4 good classes with a total of 140630 particles and two 
classes with bad density and partially disassembled complex. Particles from the four good 




Figure 2.20. Processing pipeline of the NADH dataset.  
FSC plots and local resolution of the closed and open2 classes are shown as well as local resolution plot of the 
focus-refined PA and MD.  
Adapted from Kampjut & Sazanov, 2020.  
 
In the deactive dataset, the first round of 3D classification was done with k = 6 and T = 
4 and resulted in 458556 good particles. After a consensus refinement, another 3D 
classification step without searches and with k = 6 and T = 10 was performed to remove further 
damaged particles. This resulted in 272990 particles, which were refined around the PA and 
Figure 2.17. Processing and further characterization of the NADH samples. FSC plots and local resolution of the closed and open2 classes 
are shown as well as local resolution plot of the focus-refined PA and MD. 
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classified around the membrane arm using 3D classification without searches and k = 4 and T 
= 10. This resulted in four classes that differed from each other by the degree of openness. They 
were subjected to two rounds of CTF parameter refinement, Bayesian polishing, refinement 
and post-processing to obtain the final density maps used for model building.  
 
 
Figure 2.21. Processing pipeline for the deactive dataset.  
FSC plots and local resolution of the closed and open2 classes are shown as well as local resolution plot of the 
focus-refined PA and MD.  
Adapted from Kampjut & Sazanov, 2020.  
 
In the rotenone dataset the first round of 3D classification was done with k = 6 and T = 
4 and resulted in 175658 good particles after duplicate removal. After two rounds of CTF 
parameter refinement, Bayesian polishing and auto-refinement, another 3D classification 
without searches and with k = 6 and T = 8 was performed to remove bad particles, which 
resulted in 142565 good particles, which were focus-refined around the membrane domain. 
Because of the low abundance of the closed class in this dataset, the closed class was separated 
by 3D classification around the membrane arm with k = 6 and T = 10. The rest of the particles 
were 3D classified separately with k = 6 and T = 6 to better separate different open classes. 
The resulting particles were refined, post-processed and used for model building.  
auto-refine  
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a. Processing pipeline for the deactive dataset. FSC plots and local resolution of the open2 and open4 classes are shown as well as local 





Figure 2.22. Processing pipeline for the rotenone dataset.  
FSC plots and local resolution of the closed and open2 classes are shown as well as local resolution plot of the 
focus-refined PA and MD.  
Adapted from Kampjut & Sazanov, 2020.  
 
In the turnover dataset, the initial 3D classification was done with k = 6 and T = 4 and 
resulted in 518117 good particles after duplicated removal. After two rounds of CTF parameter 
refinement, Bayesian polishing and auto-refinement, another 3D classification without 
searches and k = 6 and T = 8 was performed to remove damaged particles, resulting in 344541 
good particles retained.  These were then 3D classified around the membrane arm without 
searches and with k = 6 and T = 8. Four of the resulting classes contained good particles with 
a total of 257669 particles, which were refined and post-processed for model building. The 
density within the quinone cavity of the closed class appeared broken, hence this class was 
further classified without searches and with k = 3 and T = 50. This resulted in one major class 
with about 55% particles that had better defined density in the quinone cavity and elsewhere 
and another minor class with about 30% of particles that had worse density overall but 
Figure 2.18. Processing pipeline for the rotenone dataset. FSC plots and local resolution of obtained classes. FSC plots and local resolution of 
the closed and open2 classes are shown as well as local resolution plot of the focus-refined PA and MD.
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otherwise no significant differences to the major class. Only the major closed class was used 
for model building.  
 
 
Figure 2.23 Processing of the turnover cryo-EM dataset.  
Processing pipeline of the turnover dataset. FSC plots and local resolution of the closed and open2 classes are 
shown as well as local resolution plot of the focus-refined PA and MD.  
Adapted from Kampjut & Sazanov, 2020. 
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Figure 2.16. Processing of the turnover cryo-EM dataset. Processing pipeline of the turnover dataset. FSC plots and local resolution of the 
closed and open2 classes are shown as well as local resolution plot of the focus-refined PA and MD.
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In the complex I in nanodiscs dataset, 1080 images were collected and 629 images 
displayed Thon rings beyond 5 Å and were used in further processing. 189035 particles were 
picked in total, subjected to one round of 2D classification and the resulting 170091 particles 
were 3D classified into 6 classes (T = 4). One of the classes (54233 particles) displayed high 
resolution features and was refined to 4.5 Å (Figure 2.24a). This was further classified into 
23532 particles in the open3 state without the B14.7 subunit (4.45 Å) and 30791 particles in 
the the open state with the B14.7 subunit (4.26 Å). The open state was focus refined around 
PA and MD separately. Counterintuitively, comparison of the angular distributions of this 
dataset which was collected on the graphene oxide support with the LMNG-datasets without 
support revealed better angular distribution with support (Figure 2.24b). The thickness of the 
nanodisc belt was barely larger than the thickness of the LMNG micelle (Figure 2.24c).  
 
 
Figure 2.24 Processing of complex I in nanodiscs.  
a, 3D classification reveals different conformations of complex I in the sample. Open and closed state were refined 
separately. There appears to be some additional flexibility in each state as focused refinement of the matrix and 
membrane arm of the complex reach slightly higher resolution. b, Comparison of angular distribution on 
graphene (top) and in ice (bottom). Angular distribution of particles is slightly improved on graphene support. c, 
Comparison of micelle thickness in graphene (left) and in LMNG (right). Density in nanodiscs is only slightly thicker 
and the overall structure of membrane arm of complex I is the same in both conditions.  
 
Figure 2.24. Processing of the CxI in nanodiscs. a, 3D classification reveals different conformations of 
complex I in the sample. Open and closed state were refined separately. There appears to be some 
additional flex bility in each state as cused refinement of the matrix and membrane arm of the complex 
r ach slightly higher es lution. b, Comparison of angular dis ributi n on graphene (top) and in ice 
(bottom). Angular distribution of particles is slightly improved on gra hene support. c, Comparis  f 
micelle thickness in grapehen (left) and in LMNG (right). Density in nanodiscs is only slightly thicker and 










































2.7. Model building and refinement: transhydrogenase 
The initial model was built into the “double face-down” NADP+ class density by 
starting with the bovine dIII crystal structure (PDB 1D4O) with substituted ovine sequence and 
the dI homology model that was generated using Phyre2 server (Kelley et al., 2015). dII model 
and the linkers were built manually in Coot (Emsley et al., 2010). Manually adjusted models 
were refined using PHENIX software (Adams et al., 2010) using an adapted method for refining 
cryo-EM structures which uses two rounds of a single cycle of group ADP refinement followed 
by three cycles of global minimization. This allows optimization of B-factors so that electron 
radiation-damaged carboxylate side-chains acquire high B-factors and do not lead to main-
chain distortions (Letts et al., 2019). The final model for NNT is of very high quality in terms 
of geometry and fit to density (Appendix 1).  
Densities for several lipid molecules were observed in each of the half-closed cavities 
formed by helices TM1, TM2 and TM6. They were modelled in the structure as 
phosphatidylcholines based on their density appearance and the fact that only 
phosphatidylcholine could reactivate lipid-depleted insect NNT (Vandock et al., 2011).  
A density corresponding to the adenylate part of NAD+ was observed in the NAD(H) 
binding site of the dI. We propose that this density is NAD+ which remained bound to the 
enzyme during purification or, more likely, was introduced into the sample as a contaminant 
from the NADP+ solution. Our NADP+ was only 98% pure and at 2% NAD+ contamination, 
NAD+ concentration would be 100 M which is in the range of the Kd for the enzyme 
(Yamaguchi and Hatefi, 1993; Bizouarn et al., 2005). The latter is supported by the fact that in 
our structure the conserved R139 is in the same extended conformation as in the E. coli dI2 
with bound NAD+ and differs significantly from the apo or NADH-bound forms (Johansson et 
al., 2005). Nevertheless, our structure is a bona fide oxidised ground state conformation of 
NNT and earlier biochemical work suggests that nucleotide exchange in dI subunit can happen 
during any stage of the catalytic cycle and does not influence the global conformation of the 
enzyme (Yamaguchi and Hatefi, 1989; Yamaguchi, Wakabayashi and Hatefi, 1990; Tong, 
Glavas and Bragg, 1991; Hu et al., 1995). Models for the open NADP+ class and the apo NNT 
were based on the closed NNT as the starting model. Due to the lack of reliable amino acid 
side chain information in the cryo-EM density, apo-dI was modelled as a polyalanine model 





2.8. Model building and refinement: complex I 
The models presented here are based on the initial 3.9 Å structure of ovine complex I 
determined previously (PDB 5LNK) (Fiedorczuk et al., 2016). Membrane domain and 
peripheral arm were built on the basis of 2.5 Å and 2.3 Å focus-refinements of all the particles 
belonging to the open classes from the turnover dataset. This allowed us to improve the 
geometry, fit and completeness of the models significantly (Appendix 2-6). We were also able 
to model additional lipid molecules, as well as several known post-translational modifications, 
including N-terminal acylations of subunits B18, B14.5b and B14.7, N-formyl methionines in 
ND6, ND5 and ND4L, symmetric dimethylation of 49 kDa Arg85 and phosphorylation of 42 
kDa Ser36 (Carroll, Fearnley and Walker, 2006) (see Chapter 4). For accurate modelling of 
water molecules, particularly to avoid false positives, we filtered the maps by local resolution 
and resampled them at 0.5 Å per pixel in Relion. After this procedure, water molecules 
displayed strong signal (~2 rmsd), had nearly spherical densities, were not clashing with other 
atoms and participated in hydrogen bonds, which are all strongly indicative of real water 
molecules (Prisant et al., 2020). This allowed automatic placement of water molecules in 
COOT, which were then all checked and corrected manually, to leave only waters with clear 
density and fulfilling geometry criteria. Using this procedure, we could reliably place water 
molecules not only into 2.3-2.8 Å structures but also into the closed MD focus refined map 
(overall resolution 2.9 Å, higher in the center). The two highest resolution open PA and open 
MD models were then rigid-body fit into all the classes, corrected in Coot (Emsley et al., 2010) 
and refined using PHENIX software (Adams et al., 2010). We used two rounds of a single cycle 
of group ADP refinement followed by three cycles of global minimization to optimize B-
factors so that electron radiation-damaged carboxylate side-chains acquire high B-factors and 
do not lead to main-chain distortions as described previously (Letts et al., 2019). To maintain 
consistency, we performed this procedure first with rotamer fit option enabled, checked and 







2.9. Model analysis and figure preparation 
Evolutionary conservation scores were projected onto the transhydrogenase structure 
using ConSurf (Landau et al., 2005). Buried water molecules in transhydrogenase were 
modelled using the original Dowser software (Zhang and Hermans, 1996). Proton translocation 
pore was predicted and analysed using a MOLEonline server (Pravda et al., 2018). Interdomain 
contacts and binding energy of nucleotides were analysed using the PISA server (Krissinel and 
Henrick, 2007; Evgeny, 2010). Models were evaluated using MolProbity and EMRinger (Chen 
et al., 2010; Barad et al., 2015). Clustal Omega was used for sequence alignment (Larkin et 
al., 2007; Goujon et al., 2010). Models and density maps were visualised for analysis and figure 




3. Structure and mechanism of transhydrogenase 
3.1.Biochemical characterisation 
3.1.1. Catalytic activity 
A novel way of purification of transhydrogenase from ovine mitochondria described in 
Chapter 2 led to a highly active preparation. Crucial for the development of this was screening 
detergents based on their effects on enzyme activity (Figure 2.1) and optimising the buffer 
conditions by a ProteoPlex method (Chari et al., 2015).  
Activity depended on the type of detergent used during the final size exclusion 
chromatography step. We prepared transhydrogenase in two different detergents, LMNG and 
FOM and three different nanodiscs. In FOM and the largest nanodiscs (1E3) the activity of the 
enzyme was the highest at ~20 U/mg (Figure 3.1). In smaller nanodiscs or LMNG, the activity 
of NNT was around 10 U/mg. These values are comparable to previous measurements on the 
bovine NNT, which also range between 10 and 25 U/mg (Wu, Alberta and Fisher, 1986; 
Sazanov and Jackson, 1995).  
The fact that nanodiscs displayed one of the highest activities is not surprising as they 
provide a more native lipidic environment than detergent. It was also demonstrated that 
transhydrogenase requires specific phospholipids for its function (Rydström et al., 1976; 
Vandock et al., 2011). The fact that the activity decreased slightly in smaller diameter 
nanodiscs could mean that the transmembrane region was becoming constricted in those 
nanodiscs, interfering with the protein dynamics required for reaction catalysis.  
The fact that NNT-FOM had high activity can be explained by FOM being a uniquely 
mild and non-disruptive detergent having a relatively low affinity for proteins and lipids due 
to its fluorinated acyl chain (Frotscher et al., 2015). This could on the other hand lead to the 
low stability of NNT purified in FOM (Chapter 3.1.2). The fact that LMNG did not inhibit 
activity, while DDM was a strong inhibitor can potentially be explained by three facts (Figure 
2.1). Firstly, LMNG has two acyl groups and two maltoside groups, making it very bulky and 
potentially unable to access an inhibitory site to which DDM binds. Secondly, DDM being 
smaller could better solubilise some tightly bound lipids in the tight binding sites. Thirdly, 
DDM inhibition could mimic palmitoyl-CoA inhibition, and the acyl groups of palmitoyl-CoA 
and DDM could access the same inhibitory site (Rydstrom, 1972). DDM inhibition was 






Figure 3.1. Catalytic activities of different NNT preparations.  
Ovine NNT catalyses all the known activities: (a) reverse activity, (b) forward activity and (c) cyclic activity. 
Reverse activity is generally slightly higher in large nanodiscs and FOM than in LMNG. No cyclic activity in the 
absence of added NADP(H) indicates absence of co-purified NADP(H) with the NNT.  
 
We also measured the cyclic transhydrogenation reaction, i.e. the reduction of APAD+ 
by NADH (Sazanov and Jackson, 1995). This reaction is not believed to be of physiological 
significance and is thought to be a result of tightly bound NADP(H) nucleotide in the dIII 
domain. After NADH reduces NADP+, the resulting NADPH stays bound to the dIII domain 
long enough to reduce APAD+ that will have bound to the same site as the NADH. This reaction 
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is not coupled to proton transfer and suggests that NADP(H) binding or release is coupled to 
the proton pump. The reaction rates of around 2 U/mg are similar to those reported in the 
literature for the bovine NNT (Figure 3.1) (Sazanov and Jackson, 1995). The fact that we could 
record no cyclic transhydrogenation in the absence of added NADP(H) also confirms that ovine 
NNT purified by the method described here does not contain any bound nucleotides and can 
be considered in the true apo form.  
Finally, we measured forward transhydrogenation activity, which was several fold 
lower than reverse transhydrogenation activity, consistent with the previous measurements and 
the fact that reverse transhydrogenation is coupled to proton pumping, while forward 
transhydrogenation is coupled to proton motive force consumption (Figure 3.1) (Eytan, Eytan 
and Rydström, 1987).  
 
3.1.2. Stability 
Transhydrogenation activity was highly stable at 4ºC in LMNG. After 14 days at 4ºC, 
NNT-LMNG samples still retained ~75% activity, indicating that the preparation in this 
detergent is highly stable (Figure 3.2). In contrast, in FOM, the preparation lost almost all the 
activity after 48 h.  
 
Figure 3.2. NNT is highly active and stable at 4ºC when purified in LMNG.  
Activity of NNT-LMNG remains undiminished over several days when stored at 4°C. Error bars represent standard 
deviations based on n=3 independent measurements.  








Proton pumping activity coupled to reverse transhydrogenation was measured to assess 
the coupling of the NNT preparation. NNT was reconstituted into proteoliposomes as described 
in Chapter 2 and reverse transhydrogenation activity was measured before and after the 
addition of the protonophore (CCCP). About 10-fold acceleration of the reaction by the 
addition of protonophore indicates that NNT generates a large proton motive force which 
inhibits transhydrogenation reaction, but this inhibition is released by the protonophore (Figure 
3.3). It also indicates that the proteoliposomes were well-coupled and not leaky.  
To assess the influence of lipid composition on the activity of NNT, we reconstituted it 
into liposomes of varying lipid compositions and measured the activity. The highest activity 
was recorded in POPC and DOPC liposomes with or without the addition of cardiolipin, while 
the lowest activity was recorded in asolectin liposomes and liposomes containing phosphatidyl 
ethanolamine (Figure 3.3). This is consistent with mitochondrial inner membrane lipid 
composition as it includes large amounts of phosphatidyl choline and cardiolipin. Recently it 
was also demonstrated that NNT from cestodes requires PC for optimal activity, although PS 
and PE could also save a bit of activity (Fu, Ma and Fioravanti, 2019). The downside of this 
study is, however, that the assay was done on DDM-purified NNT and DDM is a known 
inhibitor of NNT. 
 
Figure 3.3. Proton pumping assay.  
Reconstitution of purified NNT into DOPC liposomes shows that the reverse transhydrogenation reaction is tightly 
coupled to proton transfer as it is stimulated ~10-fold by proton gradient uncoupler CCCP and by solubilisation in 
CHAPS detergent. Error bars represent standard deviations based on n=3 independent measurements.  
Panel (a) adapted from Kampjut & Sazanov, 2019.  
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3.1.4. Inhibitors of NNT 
There are few known inhibitors of NNT and essentially none very specific micro-molar 
small molecule inhibitors (Rydstrom, 1972; Bragg and Hou, 1999). It was described that 
divalent cations are inhibiting transhydrogenase, potentially by binding at the proton-
translocation site (Sazanov and Jackson, 1993; Whitehead et al., 2005). With the ovine NNT-
LMNG preparation we were able to reproduce this effect in 10 mM MgSO4, which inhibited 
NNT by about 50% (Figure 3.4). Furthermore, we observed a slight inhibition of NNT-LMNG 
by prolonged incubation in NADPH (5 mM, on ice), an effect which is easy to explain by the 
structural changes induced by NADPH. Such inhibition was not observed with NADP+. 
Finally, because NNT is involved in redox regulation and because cysteine-893 was 
shown to be susceptible to alkylation before we hypothesised that glutathione could regulate 
NNT activity by glutathionylation (Yamaguchi and Hatefi, 1989). We could observe that 
oxidized glutathione, but not reduced glutathione, inhibits NNT by about 50%.  
 
Figure 3.4. Inhibitors of NNT.  
The strongest inhibitors were oxidised glutathione (GSSG) and Mg. Reduced glutathione did not inhibit NNT, while 






3.2. Overall structure of transhydrogenase 
3.2.1. Model of intact mammalian transhydrogenase 
We solved the structure of complete and intact ovine NNT at up to 2.9 Å resolution 
using cryo-EM (Appendix 1). The highest resolution was reached with the double face-down 
conformation in the presence of NADP+ (Figure 3.5). Excellent EM maps resulted in high 
quality full atomic models of mammalian NNT including modelling of almost entire 
polypeptide chain, bound dinucleotides and several lipid molecules (Figure 3.6).  
 
 
Figure 3.5. Model and density of double-face down NNT.  
a, The cryo-EM density of transhydrogenase in the “double face-down” NADP+ state, with two monomers 
coloured differently. b, Atomic model of mammalian NNT with domains coloured as in panel a, and mammalian-
specific elements dI-dII linker, TM1 and TM5 highlighted in blue. Bound nucleotides are shown in black. 






Figure 3.6. Cryo-EM density examples of the “double face-down” class in the presence of NADP+.  
a, Density of the transmembrane helices lining the proton channel (TM3 and 13). Density comparison of the TM2 
between the “double face-down” and “single face-down” (dIII-detached monomer) NADP+ classes, as well as apo 
class, which remains in the same conformation in all states. b, Beta sheet density of dI (top) and dIII (bottom). c, 
Alpha-helical segments of dI (top) and dIII (bottom). d, Two phosphatidyl-cholines bound in the cavity enclosed 
by TM1, 2 and 6. e, dIIIa-NADP+ density. f, dIIIb-NADP+ density. g, Partial NAD+ density in dIa. h, Partial NAD+ 
density in dIb. The density for lipids and putative NAD+ is discussed in Methods.  
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Figure 3x. Cryo-EM density examples of the “double face-down” class in the presence of NADP+. 
a, Density of the transmembrane helices lining the proton channel (TM3 and 13). Density comparison of 
the TM2 between the “double face-down” and “single face-down” (dIII-detached onomer) NADP+ 
classes, as well as apo class, which remains in the same conformation in all states. b, Beta sheet density of 
dI (top) and dIII (bottom). c, Alpha-helical segments of dI (top) and dIII (bottom). d, Two phosphatidyl-
cholines bound in the cavity enclosed by TM1, 2 and 6. e, dIIIa-NADP+ density. f, dIIIb-NADP+ density. 
g, Partial NAD+ density in dIa. h, Partial NAD+ density in dIb. The density for lipids and putative NAD+ is 
discussed in Methods. 




The arrangement of the domains and organisation of the dimer in ovine NNT is similar to the 
T. thermophilus NNT, apart from the fact that both dIIIs are bound to dII, resulting in an almost 
symmetric structure. The symmetry is broken due to the slight tilting of dI2, which interacts 
loosely with dIII in one monomer (dIIIa) and not at all in another (dIIIb) (Figure 3.7). This 
tilting of dI2 also resulted in the local resolution of dI2 to be worse than in dIIdIII part of the 
molecule. The final structure is thus composed of two focus-refined maps (Figure 3.8). 
 
Figure 3.7 Comparison of the two monomers in the double-face down NADP+ class.  
The view from the dimerization interface reveals a tilt of dI2 and asymmetry in dI-dIIIa/b contacts.  
Adapted from Kampjut & Sazanov, 2019. 
  
 
Figure 3.8. Local resolution and FSC curves for the “double face-down” NNT-NADP+ structure.  
Adapted from Kampjut & Sazanov, 2019.  
 
chain A chain B
Comparison of the two monomers in the double-face down NADP+ class. 
The view from the dimerization interface reveals a tilt of dI2 and asymmetry in dI-dIIIa/b contacts. 
Adapted from Kampjut & Sazanov, 2019. 
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Local resolution and FSC curves for the “double face-down” NNT-NADP+  structure. 




3.2.2. Comparison of conformations in different datasets 
To define the mechanism, we solved the structures of ovine NNT at pH 7.4 in the apo, 
NADP+-bound and NADPH-bound forms. We focused on the comparison between NADP+ 
and NADPH bound states because these two nucleotides were shown to promote distinct 
conformations in early biochemical work. The coupling mechanism of transhydrogenase likely 
involves large-scale conformational changes that were shown to be induced by NADPH (but 
not NADP+ or NAD(H)) in the mammalian enzyme. Upon incubation with NADPH, some parts 
of the protein (dI-dII linker and TM6-7 loop on the matrix side of dII, as now shown by our 
structure) become susceptible to tryptic hydrolysis and Cys-893 becomes more susceptible to 
alkylation (Yamaguchi and Hatefi, 1989; Yamaguchi, Wakabayashi and Hatefi, 1990). In 
contrast to the mammalian enzyme, both NADP+ and NADPH can induce these long-range 
conformational changes in E. coli (Tong, Glavas and Bragg, 1991; Fjellström, Johansson and 
Rydström, 1997). Furthermore, the Jackson mechanism did not explain why NADP+ and 
NADPH would promote different conformations of the entire enzyme. NADH and NAD+ on 
the other hand do not lead to different global conformations of the NNT. 
The only observed 3D class of particles in the apo-NNT dataset adopted an unexpected 
and previously unobserved “double face-down” conformation with both dIII domains tightly 
attached to dII in the “face-down” orientation, as described above (Figure 3.9). This means that 
the overall architecture of the dimer does not allow for tight interactions between dI and dIII 
in both monomers, whether dIII is facing “up” or “down”. On the other hand, dIII-dII 
interaction is permitted in both monomers simultaneously.  
In the NADP+ dataset the main class showed a similar conformation, but with higher 
resolution, possibly due to the stabilising effects of the bound nucleotide (overall resolution 3.2 
Å, focused refinement of dII2dIII2 to 2.9 Å and dI2 to 3.2 Å) (Figure 3.9). NADP+ dataset also 
resulted in the structure of the less populated class (“single face-down”) in which one dIII is 







Figure 3.9. Structures and relative abundances of different conformations of NNT observed in the datasets.  
“Double face-down” conformation was the only form observed in apo-NNT and the major form in the NADP+ 
datasets, “single face-down” or “one dIII-detached” conformation was a minor form in NADP+ and NADPH 
datasets and “double dIII-detached” was a major form in NADPH dataset.  
Adapted from Kampjut & Sazanov, 2019.  
 
 
Figure 3.10. Comparison of NNT conformations  
a, Overall comparison of “double face-down” (cyan) and “single face-down” (green) classes of NNT. An increased 
dI tilt, dIIIb detachment and dIIb conformation change are visible. b, Overall comparison of “double face-down” 
NNT-NADP+ (cyan) and apo NNT. dII-dIII are in the same conformation and dI2 is slightly more tilted in the apo-
NNT.  
Figure adapted from Kampjut & Sazanov, 2019.  
 
 






















Structures and re ative abundances of diffe ent co formations of NNT observed in the datasets. 
“Double face-down” conformation was the only form observed in apo-NNT and the major form in the 
NADP+ datasets, “single face-down” or “one dIII-detached” conformation was a minor form in NADP+ 
and NADPH datasets and “double dIII-detached” was a major form in NADPH dataset. 
Adapted from Kampjut & Sazanov, 2019.
Figure 3.3. Compariso  of NNT conformations
a, Overall comparison of “double face-down” (cyan) and “single face-down” (green) classes of NNT. An 
increased dI tilt, dIIIb detachment and dIIb conformation change are visible. c, Overall comparison of 
“double face-down” NNT-NADP+ (cyan) and apo NNT. dII-dIII are in the same conformation and dI2 is 
slightly more tilted in the apo-NNT. 
Figure adapted from Kampjut & Sazanov, 2019.
b “Double face-down”: NADP+ vs. apoa




Finally, in the presence of NADPH, NNT underwent a drastic global conformational 
change, as predicted before (Yamaguchi and Hatefi, 1989; Yamaguchi, Wakabayashi and 
Hatefi, 1990). We did not observe any “double face-down” class and only ~11 % of particles 
had one dIII weakly bound to dII and the rest of the particles corresponded to many different 
“double-detached” classes with both dIII domains detached and tethered only by a dII-dIII 
linker (Figure 3.9). In particles with both dIIIs detached, dI exhibited a particularly striking 
degree of tilting in all directions as revealed by multibody refinement and principal component 
analysis in RELION 3.0 (Figure 3.11). None of these NADPH classes reached resolution better 
than 9 Å.  
 
Figure 3.11. High degree of freedom of dI2 in double-detached NNT.  
NNT-NADPH particles were analysed using multibody refinement in RELION 3.0 using dI2 and dII2 masks which 
revealed a high degree of tilting of dI2 domain in all directions, consistent with both dIII being dissociated from 
the rest of the particle and disrupting the overall solidity of the enzyme. Two bins of particles from the extreme 
ends of the distribution along two principal components are aligned by dII2 and the difference in dI2 tilt is 
depicted in different shades of yellow and green.  
Adapted from Kampjut & Sazanov, 2019.  
 
Interestingly, we did not find any evidence for an asymmetric conformation as observed 
in T. thermophilus. In none of the classes did we observe the face-up dIII conformation, 
although such a conformation is clearly necessary for hydride transfer to take place during 
catalysis. Previous studies suggest that the dI-dIII interface formation requires binding of the 
corresponding nucleotide to dI and, once formed, has a very short life span as the hydride 
transfer is fast (Hutton et al., 1994; Venning et al., 1998, 2000). Alternatively, the architecture 
of the mammalian NNT with its dI-dII linker may prevent the observation of a stable face-up 
dIII conformations, although this remains to be established in future studies.  
Because we did not observe a distinct asymmetric class with one dIII in face-down and 
another one in face-up orientation, we conclude that NADPH on its own is not sufficient for a 
stable dI-dIII (face-up) interface formation and promotes dIII detachment. NADP+ and 
NADPH on their own promote dIII detachment to various degrees but do not lead to a stable 
90°90°
High degree of fr edom o  dI2 in double-detache  NNT. 
NNT-NADPH particles were analysed using multibody refinement in RELION 3.0 using dI2 and dII2 
masks which revealed a high degree of tilting of dI2 domain in all directions, consistent with both dIII 
being dissociated from the rest of the particle and disrupting the overall solidity of the enzyme. Two bins 
of particles from the extreme ends of the distribution along two principal components are aligned by dII2 
and the difference in dI2 tilt is depicted in different shades of yellow and green.




dI-dIII (face-up) interface formation. Most of these conformations (apart perhaps from apo-
NNT, where we could only observe one class) would be expected to be transient during the 
turnover as dIII must shuttle between dI and dIII. 
To summarize, transhydrogenase can exist in other conformations with different 
combinations of dIII in “up”, “down” or detached positions (Figure 3.12). 
 
 
Figure 3.12. Conformations of transhydrogenase.  
a, Schematic representation of the domains, linkers, binding sites and conformation of the mammalian 
transhydrogenase in the “double face-down” (both dIII attached to dII) conformation (apo and NADP+ datasets). 
Other possible conformations of NNT include one or both dIII detached, the asymmetric conformation in T. 
thermophilus (N.B. the absence of dI-dII linker) and the sterically prohibited double-face-up conformation. 
Adapted from Kampjut & Sazanov, 2019 
 
 
3.2.3. Changes of domain interfaces and comparison to T. thermophilus NNT 
We modelled the ovine asymmetric class by rigid-body fitting separate domains of 
ovine NNT to the T. thermophilus architecture of NNT to understand and compare interfaces 
that dIII forms with dI and dII (Figure 3.13). dIII forms the interface with dII and dI with 
roughly the same surface – helix 4 of dIII makes contacts with both dI and II (lower left and 
upper right panels of Figure 3.13). The size of the buried interface and free energy of binding 
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of dIII interfaces is smaller than of dimer-forming interfaces dII-dII and dI-dI in both T. 
thermophilus and O. aries (Table 3.1). dIII-dII interfaces seems stronger than dI-dIII, probably 
because it is slightly larger and contains a salt bridge R544-D942, which is an important 
stabilising element (lower left panel of Figure 3.13). This suggests that a conformational or 
electrostatic signal is needed to break the dIII interfaces during the catalytic cycle, which will 
be discussed in Chapter 3.3. 
In contrast to what has been suggested for the T. thermophilus enzyme, dIII attachment 
to dII does not change the conformation of the short lateral helix CL8 nor does it disrupt the 
conserved salt bridge R839-D787 (Leung et al., 2015). The importance of this salt bridge could 
be purely to stabilise the dII or the interface, or to transmit conformational changes from dIII 
to dII via the peptide linker. Either way, the detrimental effects of mutating either of the 
participating residues are expected.  
 
 O. aries T. thermophilus 
Interface Area [Å2] G [kcal/mol] Area [Å2] G [kcal/mol] 
dI-dI 1527.5 -16.3 1867.1 -20.1 
dII-dII 2602.9 -65.2 1369.2 -27.3 
dIII-dI 738.4 -9.0 794.8 -11.8 
dIII-dII 1225.5 -21.7* 1004.2 -16.5 
 
Table 3.1. Surface area and free energy of binding of the inter-domain interfaces in ovine and T. thermophilus 
NNT.  





Figure 3.13. Various interfaces of dIII in the asymmetric model of transhydrogenase.  
A homology model of the asymmetric ovine NNT based on the T. thermophilus dI2dIII heterotrimer structure (PDB 
4J16). N.B. putative interacting residues at the dIIIup-dIIIdown interface. dI-dII linker contacts the loop D of dIII 
in the face-down conformation. D942 and Y941 from dIII form hydrogen bonds with R544 on CL2 loop stabilising 
the dII-dIII interface. Helix 4 and loop D also contribute towards formation of the dI-dIII interface but Y941 is too 
far to interact with dI. R839 and D787 always form a salt bridge, regardless of dIII conformation.  
Adapted from Kampjut & Sazanov, 2019.  
 
 
3.2.4. Mammalian-specific features 
The fold of the three domains in ovine NNT is conserved with the bacterial structures, 
as expected based on the sequence similarity of ~ 40% and conserved function. The 
mammalian-specific supernumerary helices TMH1 and TMH5 form an unexpected extended 
dII dimer interface (dark blue in Figures 3.5, 3.7 and 3.13). Relatively large tilt of the TMH1 
allows it to contact the entire TMH5 of the opposite monomer, possibly stabilizing dimer 
formation in mammals.  
The linker between dI and the additional helix TM1 in dII contacts dIII in the ‘face-
down’ orientation (upper left panel of Figure 3.13). C-terminal part of the dI-dII linker (residues 
410-424) forms a loosely defined  helix in the face-down state, while the N-terminal region 
(400-410) is a flexible loop and only displays very weak density. V412 and T411 from the 
linker are forming van der Waals interactions with the N974-P977 stretch of the loop D 
(residues 974-986) on dIII. This explains why K410-T411 bond is protected from trypsinolysis 














Various interfaces of dIII in the asymmetric model of transhydrogenase. 
A homology model of the asymmetric ovine NNT based on the T. thermophilus dI2dIII heterotrimer 
structure (PDB 4J16). N.B. putative interacting residues at the dIIIup-dIIIdown interface. dI-dII linker 
contacts the loop D of dIII in the face-down conformation. D942 and Y941 from dIII form hydrogen 
bonds with R544 on CL2 loop stabilising the dII-dIII interface. Helix 4 and loop D also contribute towards 
formation of the dI-dIII interface but Y941 is too far to interact with dI. R839 and D787 always form a salt 
bridge, regardless of dIII conformation.
Adapted from Kampjut & Sazanov, 2019.
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detached state, the density for the C-terminal part of the linker disappears, which could indicate 
partial unfolding of the helix to accommodate an increased distance between dI and dII. The 
role for the dI-dII linker is not clear and the sequence is not well conserved but connection 
from the dI domain via TM1 to TM5 of the opposing monomer could help in the coordination 
of the catalytic cycle events between the monomers as discussed below. 
 
3.2.5. Structure in lipid nanodiscs 
Structures of NNT in MSP1E3D1 or MSP1D1H5 nanodiscs in the presence of NADP+ 
were refined to between 10 and 13 Å. Overall the protein exhibited the same global 
conformation as in LMNG (Figure 3.14). This confirms that detergent solubilisation does not 
radically change the conformation of NNT. In NNT-1E3D1 we could classify a major class 
(54%) and a minor class (46%). The minor class had a slightly lower resolution and appeared 
to have more dissociated dIII. Major class could correspond to the double face-down and the 
minor to the single-face down, although this is hard to establish at this resolution and also the 
major class had dIIIb density weaker than dIIIa. In NNT-H5 we could only classify a major 
class. The nanodisc density was noticeably smaller, but only by about 10 Å. Elution at 10.3 mL 
still suggests an apparent molecular weight of 440 kDa. This again underscores the finding that 
the global conformation of NNT is not dependent on the choice of surfactant. The fact that 
higher resolution could not be achieved could be due to the microscope hardware used for this 
project, because of the heterogeneity of the protein conformations or because of the large 
unstructured density corresponding to the lipidic nanodisc interfering with alignment.  
 
Figure 3.14. Overall conformation of NNT-NADP+ in lipidic nanodiscs. 
In all of the structures, dIIIb has a weaker density than dIIIa, suggesting that these structures are mixtures of 
double- and single-face down conformations as observed in NNT-LMNG. In NNT- H5 nanodiscs the nanodisc 
diameter is about 10 Å smaller than in NNT-1E3D1 nanodiscs.  
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3.3.Detailed comparison of NNT conformational states 
3.3.1. Structure of the dII and the proton translocating pathway 
The ovine dII forms a dimer of 14 transmembrane helices each (Figure 3.15a). The 
twelve conserved transmembrane helices adopt the same fold as demonstrated in the isolated 
T. thermophilus dII domain (Leung et al., 2015; Padayatti et al., 2017). Two supernumerary 
helices form the outer part of the dimer interface and contribute to a formation of a semi-
enclosed lipid binding pocket in which two molecules of phosphatidyl choline were observed 
(Figure 3.15c). The IMS-facing side of the dII has several exposed glutamate residues which 
contribute to a strong negative charge, relevant for proton binding (Figure 3.15b).  
The likely proton translocation pathway is formed by a hexagram of TM3-4, TM9-10, 
and TM13-14, as proposed earlier based on the mutagenesis studies in E. coli, structures of T. 
thermophilus dII and molecular dynamics (MD) simulations (Glavas, Hou and Bragg, 1995; 
Leung et al., 2015; Padayatti et al., 2017). These are the most conserved helices of the entire 
structure that contain several polar residues. Furthermore, the architecture around TMH13 and 
TMH14 is highly unusual and completely conserved between O. aries and T. thermophilus. 
TMH13 and 14 are significantly shorter than the rest and connected with a very short loop on 
the IMS side and by a highly conserved salt bridge on the matrix side (R893-D787). TMH14 





Figure 3.15. Architecture of the transmembrane domain dII.  
a, Organisation of transmembrane helices in the NNT dimer. The monomer on the left is coloured blue-to- red 
from N- to C-terminus and the monomer on the right has the inner proton channel-lining TM helices highlighted 
in magenta and the outer scaffolding helices in pink. The dimer interface consisting of eight helices is significantly 
larger than the four-helix interface of T. thermophilus. b, Electrostatic surface potential of the proton entry 
cavities on the matrix (bottom) and IMS sides (top) as well as that of the membrane-facing side (right). c, 
Hydrophobicity of residues on the surface of dII2 (coloured white to red from hydrophobic to hydrophilic). Surface-
exposed tyrosine and tryptophan residues, which often delineate lipid membrane surface, are highlighted in 
green and the lipid-binding pocket is circled. d, The architecture of mammalian dII. Supernumerary helices TM1 
and TM5 are coloured in a darker shade of blue. Residues of the proton transfer pathway are shown in circles. 
310-helix stretch within TM3 is depicted as a triangular helix.  
Adapted from Kampjut & Sazanov, 2019.  
 
The proton translocation pathway was proposed to have two protonatable residues: one 
on either side of the membrane, connected by a dry channel. In ovine NNT, N-side (matrix) 
part of the proton channel consists of a single protonatable histidine and two asparagine 
residues (H664 on TMH9, N489 on TMH3 and N796 on TMH13), while the P-side (IMS) part 
Figure 3.x. Architecture and alignments of the transmembrane domain. 
a, Organisation of transmembrane helices in the NNT dimer. The monomer on the left is coloured blue-to-
red from N- to C-terminus and the monomer on the right has the inner proton channel-lining TM helices 
highlighted in magenta and the outer scaffolding helices in pink. The dimer interface consisting of eight 
helices is significantly larger than the four-helix interface of T. thermophilus. b, Electrostatic surface 
potential of the proton entry cavities on the matrix (bottom) and IMS sides (top) as well as that of the 
membrane-facing side (right). c, Hydrophobicity of residues on the surface of dII2 (coloured white to red 
from hydrophobic to hydrophilic). Surface-exposed tyrosine and tryptophan residues, which often 
delineate lipid membrane surface, are highlighted in green and the lipid-binding pocket is circled. c, The 
architecture of mammalian dII. Supernumerary helices TM1 and TM5 are coloured in a darker shade of 
blue. Residues of the proton transfer pathway are shown in circles. 310-helix stretch within TM3 is 
depicted as a triangular helix. 
Adapted from Kampjut & Sazanov, 2019.
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was proposed to consist of a single glutamate (E806 on TMH13) (Figure 3.16). The dry 
connecting channel is composed of helices 3, 9 and 13 and strikingly, this is where a clear and 
significant distortion of helix TM3 occurs: two turns of 310 helix, the only such distortion in 
dII. A similar distortion in a similar position is also present in the TM3 of T. thermophilus dII 
structure (PDB 5UNI and 4O93), exactly where the key 2H42 is located. Such disruptions of 
secondary structure in TM helices happen almost exclusively in functionally important sites, 
where flexibility of otherwise rigid TM helices is required (Cooley, Arp and Karplus, 2010; 
Efremov and Sazanov, 2011). Additionally, secondary structure is disrupted also in TM9 
around His664, with backbone oxygen atoms of residues 661, 662 and 667 facing away from 
the helix-forming hydrogen bond network. Therefore, it is likely that these key TM3 and TM9 
residues undergo conformational changes during the catalytic cycle, promoting proton 
translocation. 
 
Figure 3.16 The transmembrane dII domain and the proton translocation pathway.  
a, Conserved residues of the proton transfer pathway. Dowser-predicted water molecules are shown as red 
spheres. The distorted α-helical area is indicated as 310 helix. b, Proton translocating pore features a narrow block 
close to the matrix (N) side and a dry stretch in the middle of the membrane. Four of the predicted water 
molecules lie within the central pore. c, Detailed view of the matrix proton entry site with conserved residues and 
hydrogen bonding network shown.  
Figure adapted from Kampjut & Sazanov, 2019.  
 
Modelling of water molecules by Dowser revealed that both the N-side and P-side 
residues coordinate two water molecules each and that the channel between them is separated 
by a dry stretch. MD simulations of T. thermophilus dII (Padayatti et al., 2017) showed that 
protonation of the histidine induces a transient wetting of the transmembrane proton channel 































Figure 3.4. The transmembrane dII domain and the proton translocation pathway. 
f, Conserved residues of the proton transfer pathway. Dowser-predicted water molecules are shown as red 
spheres. The distorted α-helical area is indicated as 310 helix. g, Proton translocating pore features a 
narrow block close to the matrix (N) side and a dry stretch in the middle of the membrane. Four of the 
predicted water molecules lie within the central pore. h, Detailed view of the matrix proton entry site with 
conserved residues and hydrogen bonding network shown.
Figure adapted from Kampjut & Sazanov, 2019.
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of the threonine could be played by the ovine homologue S799 or by S492, a homologue of T. 
thermophilus 2H42, or by a non-conserved T495 (Figure 3.16b) (Padayatti et al., 2017).  
 
3.3.2. Conformation of the proton translocation channel depends on the dIII 
attachment 
dIII domain forms a large interface with dII and inserts the helix 4 (residues 929-937) 
and the NADP+-coordinating loop (residues 920-927) deeply between the key TM helices 3, 9 
and 13, pushing them apart (Figure 3.17a). This induces a significant shift of the loops 
CL6/CL7, helix CL8 and the matrix-facing sides of TM9, 10, 11, 13 and 14 away the centre of 
the dII, with up to 3.5 Å displacements (Figure 3.17a).  
Dramatically, when dIII attaches H664 flips “up” (towards N-side) and S799 “down” 
(towards P-side), in line with the MD predictions (Padayatti et al., 2017) (Figure 3.17b). This 
affects the dimensions and chemical properties of the proton translocation channel. In the dIII-
attached dII the channel starting from the N-side (i.e. facing bacterial cytoplasm or 
mitochondrial matrix) consists of a narrow block followed by a group of conserved polar 
residues (His664, Asn796 and Asn489) and a dry hydrophobic stretch. There is also a cluster 
of negatively charged residues at the exit, appropriate for proton “gathering” from the P-side 
in the forward reaction. Analysis of the structure with dIII attached failed to reveal any water-
permeable channels leading towards the N-side. The nicotinamide-binding loop, NADP+ and 
M485 very effectively plug the N-side opening of the proton channel. We consider this quite a 
definitive feature of the structure. dIII binding to dII may also allow temporary wetting of the 
dry patch in the middle of the channel (Figure 3.16c) and thus His664 protonation from the P-
side. 
With dIII detached, the proton channel adopts a more closed conformation from the P-
side. dII from apoNNT appears similar to the dII from NNT-NADP+, suggesting that binding 
of dIII is enough to open the channel, and that nucleotide binding to dIII is not important. 
Additional restriction points appear between H664 and the P-side (Figure 3.17e,f). However, 
from the N-side (matrix) the channel is more open in this case. Overall, in the dIII-detached 
conformation, H664 appears to be more accessible for protonation from the matrix side, partly 
due to the re-arrangements in the channel and partly due to the removal of the dIII “plug”, 





Figure 3.17. Comparison of proton translocation channel in dIII-attached and dIII-detached conformations. 
a, Comparison of dII in dIII-associated (cyan) and dissociated (green) states from “single face-down” structure. 
dIII dissociation results in the tilting of TM helices towards the central axis. Expanded views show rearrangement 
of the N-side proton entry side in dII. Notably, H664 and S799 flip and the surrounding N489 and N796 change 
conformations significantly, opening the channel to the N-side when dIII is detached. b, Comparison of the TM9 
density in the “double face-down”, “single face-down” (dIII-detached monomer) and apo dII clearly displaying a 
H664 flip in the dIII-detached dII. c, Comparison of Dowser-predicted waters in the dIII-attached (cyan) and dIII-
detached (green) dII. The dIII-attached structure has two water molecules, one below and one above the N-side 
proton gate while the dIII-detached structure only has one water molecule above the gate, consistent with the 
proposal that channel is open to P-side when dIII is attached. d, Density for a water molecule coordinated 
between H664 and S492, consistent with Dowser-predicted water is beginning to show in our cryo-EM density. 











































































Figure 3.5. Comparison of proton translocation channel in dIII-attached and dIII-detached 
conformations.
a, C ris  of dII in dIII-associated (cy ) and dissociated (green) states from “single face-down” 
structure. dIII dissociation results in the tilting of TM helices tow rds the central axis. Expanded views 
show rearrangeme t of the N-side proton entry si e in dII. Notably, H664 and S799 flip and the 
surrounding N489 and N796 change conformations significantly, opening the channel to the N-side when 
dIII is detached. b, Comparison of the TM9 density in the “double face-down”, “single fac -down” (dIII-
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side and H664, a hydrophobic stretch between H664 and E806 and a negatively charged P-side proton entry site. 
f, Proton pathway profile in the dIII-detached dII. Additional constriction appearing between H664 and P-side 
upon dIII detachment is indicated. 
Figure adapted from Kampjut & Sazanov, 2019. 
 
Modelling of water molecules with Dowser (Zhang and Hermans, 1996) is consistent 
with this conclusion.  In the dIII-attached dII one water molecule is bound above and one below 
the H664-N489-N796 ring while in the dIII-detached state, the P-side water molecule 
disappears and the S799 flips “downwards” (Figure 3.17c). Cryo-EM density of the highly 
coordinated P-side water molecule is visible in our 2.9 Å map (Figure 3.17d). Overall this 
shows that the part of the channel between H664 and the P-side is less hydrated when dIII is 
detached. 
The conclusion is that the channel is open to N-side in the dIII-detached state and open 
to the P-side in the dIII-attached state. When dIII is detached, H664 is more accessible for 
protonation from the matrix side, both due to the re-arrangements in the channel and, 
importantly, the removal of the dIII-NADP(H) “plug”, exposing the dII surface to the solvent. 
 
3.3.3. Comparison of proton translocation machinery with T. thermophilus NNT 
We noted that T. thermophilus dII resembles the dIII-detached ovine dII much more 
than the dIII-attached dII (Figure 3.18a,b). However, a direct comparison of the fine details of 
the proton channel between these two species is difficult because the protonatable histidines sit 
on different TM helices and at a different depth within the proton translocation pathway in the 
two species. This is because while all transhydrogenases have a single key protonatable 
histidine at the N-side of dII, the histidine sits either on TM3 (2H42 in T. thermophilus) or on 
TM9 in E. coli and mammals (H91/H664) (Figure 3.18c). 
The differences between the ovine and T. thermophilus dII are also in the P-side 
(intermembrane space) cavity, gated by a conserved residue E806 which in ovine dII is in an 
extended conformation in contrast to the T. thermophilus structures, with T674 and E678 
allowing access to the P-side. Residues at the P-side of the proton transfer path are generally 
much less conserved between species than at the N-side. The P-side entry cavity in mammals 






Figure 3.18. Comparison of ovine and T. thermophilus dII.  
a, Comparison of T. thermophilus dII (salmon, PDB 5UNI) and “double face-down” (dIII attached) ovine dII (cyan, 
supernumerary TM1 and TM5 in blue). Residues in the N-side cavity display markedly different conformations. b, 
Comparison of T. thermophilus dII (salmon, PDB 5UNI) and “single face-down” (dIII detached monomer) ovine dII 
(blue). Residues in the N-side cavity match more closely as both of these dII structures are detached from dIII. c, 
Alignment of conserved residues on TM3, TM9, TM13, TM14 and CL7 and CL8 important for proton translocation 
and reaction coupling in T. thermophilus (Tt), R. rubrum (Rr), E. coli (Ec), O. aries (Oa) and H. sapiens (Hs). T. 
thermophilus and a handful of other species with an NGXGG motif on TM9 have the protonatable histidine on 
TM3 (2H42 in T. thermophilus) while most other species that share an HSXXG motif on TM9 have the protonatable 
histidine on TM9 (H91 in E. coli and H664 in O. aries).  
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d, Comparison of T. thermophilus dII (salmon, PDB 5UNI) and “double face-down” (dIII attached) ovine 
dII (cyan, supernumerary TM1 and TM5 in blue). Residues in the N-side cavity display markedly different 
conformations. e, Comparison of T. thermophilus dII (salmon, PDB 5UNI) and “single face-down” (dIII 
detached monomer) ovine dII (blue). Residues in the N-side cavity match more closely as both of these dII 
structures are detached from dIII. d, Alignment of conserved residues on TM3, TM9, TM13, TM14 and 
CL7 and CL8 important for proton translocation and reaction coupling in T. thermophilus (Tt), R. rubrum 
(Rr), E. coli (Ec), O. aries (Oa) and H. sapiens (Hs). T. thermophilus and a handful of other species with 
an NGXGG motif on TM9 have the protonatable histidine on TM3 (2H42 in T. thermophilus) while most 
other species that share an HSXXG motif on TM9 have the protonatable histidine on TM9 (H91 in E. coli 




3.3.4. dII-dIII interface formation opens dIII nucleotide binding pocket 
The overall conformation of dIII in our structures revealed important differences to the 
crystal structures of isolated dIII at the interface-forming sites and in the nucleotide binding-
pocket (Prasad et al., 1999; Mather et al., 2004). These changes can be explained by the fact 
that in our structures, dIII was bound to dII, while in previous crystal structures dIII was solved 
either in isolation or in complex with dI. This gives us an unexpected insight into the nucleotide 
exchange process. dII-dIII interface formation in effect opens the nucleotide binding pocket, 
structurally explaining how the dIII can transition from “occluded” into “open” state. 
In ovine NNT, helix 4 and loop D, which are conserved transhydrogenase-specific 
elements flanking the central Rossmann fold, formed extensive contacts with the cytoplasmic 
loops of the dII (Figure 3.19a). They also form contacts with dI domain in the face-up 
orientation as evident from the dI2dIII heterotrimeric structures (Figure 3.13) (Cotton et al., 
2001; Leung et al., 2015).  
Loop E (residues 1002-1010) is another transhydrogenase-specific element that closes 
over the nucleotide to impede its exchange with solution. In all the previous dIII structures 
(isolated or in complex with dI), loop E was closed, indicating that dIII was in the “occluded” 
state (Prasad et al., 1999; White et al., 2000; Sundaresan et al., 2003). In ovine dIII bound to 
dII, however, loop E was displaced by the dII CL7 and had only very weak density in our 
“double face-down” NADP+ structure, which allowed NADP+ to insert deeply into the dII 
(Figure 3.19c). In the apo-NNT structure, loop E was completely disordered allowing free 
exchange of nucleotide (Figure 3.19d). Some opening was also observed around the ribose 
diphosphate moiety of NADP+, namely the breaking of the R925-Y890 stacking interactions 
and the R925 coordination bonds with the diphosphate which have so far not been observed in 
any known dIII or dI2dIII crystal structures and must be induced by dII binding (Figure 3.19b) 
(Prasad et al., 1999; White et al., 2000; Sundaresan et al., 2003). In apo-NNT, R925 was rotated 
outwards into the solvent.  
These changes strongly suggest that dIII bound to dII should be considered in the 
“open” state. In the absence of nucleotide dIII appeared even more open and disordered than 
in the presence of NADP+, because NADP+ was partially occluded by the dII loops in the face-
down binding site, but far less so than in the detached dIII. This arrangement and the disorder 
of the loop E strongly suggest that dIII-dII interaction is important for opening of the dIII and 






Figure 3.19. dIII attachment to dII opens the NADP(H) binding pocket.  
a, The interface between dIII and dII. Helix 4 and loop D, which are conserved transhydrogenase-specific elements 
flanking the central Rossmann fold, form extensive contacts with the cytoplasmic loops of the dII. Loop E is 
displaced by dII binding. b, NADP(H) binding pocket comparison between ovine dIII-dII and human dIII-NADP+ 
(PDB 1djl, in grey) reveals breaking of R925 interactions with diphosphate and Y890. c, NADP(H) binding site in 
“double face-down”-NNT. d, NADP(H) binding pocket in apo-NNT. Loop E, K999 and R1000 are disordered and 
R925 flips into an outward-facing orientation, opening the site to the solvent  
Figure adapted from Kampjut & Sazanov, 2019.  
 
 
3.3.5. Electrostatic interaction between H664 and dinucleotide controls dIII 
attachment 
To ensure the entire catalytic cycle to take place, dIII must sequentially associate and 
dissociate from dII and this process needs to be meaningfully coupled to proton transfer to 
ensure coupling between the redox and proton pumping reactions. Protonatable H664 and the 
nicotinamide ring of the dinucleotide bound in the dIII come to within 13 Å when dIII is bound 
to dII (Figure 3.20). This is much closer than 19 Å predicted previously (Leung et al., 2015). 
The short distance between H664 and nicotinamide immediately suggests that the electrostatic 
interaction between them directly influences the strength of the dII-dIII interaction. 
Figure 3.6. dIII attachment to dII opens the NADP(H) binding pocket.
a, The interface between dIII and dII. Helix 4 and loop D, which are conserved transhydrogenase-specific 
elements flanking the central Rossmann fold, form extensive contacts with the cytoplasmic loops of the 
dII. Loop E is displaced by dII binding. b, NADP(H) binding pocket comparison between ovine dIII-dII 
and human dIII-NADP+ (PDB 1djl, in grey) reveals breaking of R925 interactions with diphosphate and 
Y890. c, NADP(H) binding site in “double face-down”-NNT. d, NADP(H) binding pocket in apo-NNT. 
Loop E, K999 and R1000 are disordered and R925 flips into an outward-facing orientation, opening the 
site to the solvent. f, Comparison of ovine dIII (red) with R. rubrum isolated dIII (PDB 1PNO: chain A in 
blue and chain B in green). Helix 4, loop D and loop E are all more open around the nucleotide in the 
ovine structure but the nucleotide is occluded by the interactions from the dII residues (not shown) in the 
ovine “face-down” structure. 







































Figure 3.20. Nicotinamide ring is bound 13 Å away from H664.  
Their electrostatic interaction influences the strength of the dII-dIII interface.  
Adapted from Kampjut & Sazanov, 2019. 
 
The effect of a Coulombic interaction of a unit charge at a distance r can be estimated 
as G = 332 -1r-1 kcal mol-1. Dielectric constant for the protein is ε = 4. Unit charge 
(protonated histidine) at 13 Å distance from nicotinamide thus contributes ~6 kcal/mol, which 
is a whole order of magnitude more than thermal fluctuations, which are on the order of a few 
kBTs (1 kBT at T = 310 K is ~0.616 kcal/mol). This proposal is therefore thermodynamically 
feasible, despite the fact that the dIII-dII interface is relatively large and strong as shown above.  
This proposal is also experimentally supported by the phenotypes of mutants of H664 
and R544. Mutations of the conserved H664 to arginine/lysine, thereby introducing a 
permanent positive charge within dII, lead to the dissociated conformation mimicking our 
NADPH structures. They also exhibit an elevated cyclic reaction rate (suggesting dIII spends 
more time dissociated from dII and being in the occluded state, preventing nucleotide 
exchange). When dII-dIII interface is destabilised by mutating R544, disrupting its salt bridge 
with D942, we observe the same phenotype. Change of a single charge at the dII-dIII interface 
drastically influences its stability, giving strong support for the hypothesis that dIII attachment 
and detachment is regulated by electrostatic interactions between H664 and nicotinamide.  
The electrostatic interactions can also be paraphrased in terms of changes of pKa. It has 
been shown that mutations can change pKa of residues which are 10 Å away by up to two units 
(Tynan-Connolly and Nielsen, 2006).  dIII-NADP(H) attachment modifies the pKa of H664. 










pKa values of protein residues are notoriously difficult to predict. The only reference to the 
H664 pKa in the literature was predicted to be 5.5-6 based on pH profile of cyclic reaction 
(Sazanov and Jackson, 1995). This is consistent with ProPka calculations on our structures 
(suggesting pKa ~5). It would also allow H664 to exist in a protonated state in sufficiently large 
proportion of molecules to allow reverse reaction. However, dII-dIII interface itself may be 
sensitive to pH changes especially far away from the optimum pH values, regardless of 
histidine protonation state. Since our datasets were collected at pH 7.4, when H664 is mostly 
de-protonated, we observed mostly attached dIII-NADP+ and mostly detached dIII-NADPH, 
consistent with this proposal. dIII detachment from dII in the presence of NADP+ and H664+ 
is also validated by low pH-stimulation of NADP+-dependent cyclic reaction (hydride transfer 
from NADH to NAD+ via occluded NADP+) (Hutton et al., 1994; Sazanov and Jackson, 1995).  
This is further validated by our data where some dIII-NADP+ were dissociated 
compared to virtually none of apo-dIII being dissociated. In the apo state, dIII can bind to dII 
regardless of the H664 protonation status, while dIII-NADP+ cannot bind to dII if H664 is 
protonated. 
Based on the structural data presented here, supported by previous biochemical work 
we conclude that the H664 and nicotinamide interact electrostatically. Protonated H664 
interacts unfavourably with NADP+, while neutral H664 interacts unfavourably with NADPH. 
dIII-NADP+ is detached from protonated H664+ but is attached to the neutral H664. Vice versa, 
dIII-NADPH is detached from H664 and is attached to H664+. Thus, both NADP(H) binding 
and histidine protonation/deprotonation (depending on the direction of the reaction) are 





3.4.Mechanism of NNT 
3.4.1. Principles 
On the basis of the structural observations and previous functional and mutagenesis 
results we proposed a revised catalytic mechanism of transhydrogenase, involving dIII flipping 
as proposed earlier (Jackson et al., 2015). For the sake of clarity I will outline the principles of 
NNT reaction that have been proposed earlier and those that have been proposed or confirmed 
based on the structural work described in this thesis. 
 
Previous work established the following:  
a) dI remains open to nucleotide exchange throughout the reaction cycle. This is 
confirmed by high rates of binding of NAD(H) to dI during the catalytic cycle (Yamaguchi and 
Hatefi, 1997; Venning et al., 2000).  
b) The dI-dIII interface is transient, hydride transfer is fast and does not limit the 
reaction (Venning et al., 1998).  
c) When dIII is detached, bound NADP(H) is occluded, as shown by a decreased Kd for 
NADP(H) in isolated dIII (~10-9 M) compared to the intact enzyme (~10-6 M), copurification 
of bound nucleotide with isolated dIII and well-ordered and closed loop E in dIII structures 
(Fjellström, Johansson and Rydström, 1997; Prasad et al., 1999; Sundaresan et al., 2003; 
Bizouarn et al., 2005). H664 and R544 mutations which lead to dIII detachment also lead to 
co-purification with NADP(H) (Glavas and Bragg, 1995; Glavas, Hou and Bragg, 1995).  
 
The following principle was speculatively proposed earlier (Jackson et al., 2015) and 
is now validated by our structures:  
d) The formation of the dII-dIII interface is necessary for nucleotide exchange, as 
shown by our structures demonstrating loop E opening. It is further validated by R544 mutants 
which disrupt the dII-dIII interface (Glavas and Bragg, 1995).  
 
Crucial new insights from the structural data presented here are:  
e) Apo-dIII is attached to dII (regardless of the protonation state of His664) and can 
detach only when bound to NADP(H).  
f) The proton channel is open only to the N-side when dIII is detached and only to the 
P-side when dIII is attached. 
g) The dIII-NADP(H) detachment from dII depends on the protonation state of the key 





On the basis of these principles we propose a robust and elegant mechanism which 
explains the full reversibility of NNT, pH dependencies of reverse and cyclic reactions, effects 
of NADP+ and NADPH on the NNT conformation and is validated by the phenotypes of 
various mutants, particularly within the proton translocation pathway, E loop and dII-dIII 
interface. Proton translocation and nucleotide exchange are tightly coupled by direct 
interactions between H664 and NADP(H): attachment/detachment of NADP(H)-bound dIII is 
strictly dependent on the protonation state of H664 and opens the proton channel to the opposite 
sides of the membrane. “Slipping”, or uncoupling, is prevented because proton translocation 




3.4.2. Forward transhydrogenation reaction 
The forward reaction occurs under conditions with high pmf and excess of NADP+. 
With dIII detached, H664 is unprotonated as it is exposed to the matrix with its relatively high 
pH (step 1, Figure 3.21). After hydride transfer, dIII-NADPH swivels down and attaches to 
dII-H664, opening it to the P-side (step 2, Figure 3.21). This allows H664 protonation from the 
P-side, where pH is lower (and His pKa is shifted higher due to interaction with NADPH). 
Nucleotide exchange follows, due to NADP+ excess and opened dIII (step 3, Figure 3.21). dIII-
NADP+ detaches from dII-H664+, which opens dII to the N-side where H664+ is de-protonated 
(step 4, Figure 3.21). dIII-NADP+ associates with dI, allowing for hydride transfer (back to 
step 1).  As described below, all the steps can be easily reversed in the appropriate conditions 




Figure 3.21. The catalytic mechanism of transhydrogenase  
NNT always works as a dimer. Key steps in the mechanism for the monomer in colour are described in the main 
text. The other monomer (grey) works in the anti-phase fashion. Key check-point in the mechanism is that proton 
translocation across the membrane cannot proceed to completion without nucleotide exchange in step 3. The 
dIII-NADP(H) and dII-H664 interactions, ensuring this coupled reaction, can be summarised as follows, with (*) 
meaning strong interaction and (<->) weak interaction or repulsion: NADP+ * H; NADP+ <-> H+; NADPH * H+; 
NADPH <-> H. Reverse transhydrogenation reaction consumes NADPH and NAD+ and results in proton pumping, 
supporting proton motive force (pmf). The driving forces for this reaction are the nucleotide ratios and pmf which 
promotes protonation of H664 from the matrix side. 
Figure adapted from Kampjut & Sazanov, 2019.  
 
 
3.4.3. Comparison to the Jackson mechanism 
This mechanism is quite different, and in many ways simpler, to the previously 
proposed Jackson mechanism (Figure 1.8). Firstly, the Jackson model assumed that dIII exists 
face-down in either occluded or open state depending on H664 protonation and nucleotide 
bound to dIII, whereas we show that essentially any dIII in face-down conformation is open. 
Secondly, the Jackson model assumes that dII can exist in no less than four different states: 
open to N-side, open to P-side and occluded with or without the proton bound, whereas we 
observe only two states of dII, depending on the dIII attachment, which satisfactorily explain 
the mechanism. Thirdly, the Jackson model postulated that NADP+- or NADPH-bound dIII 




with our data and mechanism, which does not require such specificity and operates on simpler 
principles. Finally, Jackson model does not explain how exactly nucleotide exchange happens 
only in step 1 and not between steps 2 and 3 or 5 and 6.  
The Jackson mechanism also did not explain why NADPH and NADP+ have different 
effects on the enzyme (as demonstrated by trypsinolysis and C893 labelling experiments). 
According to the Jackson mechanism, NADPH and NADP+ should both stabilize the same, 
purely asymmetric state. This difference is now fully accounted for by the new proposal as the 
overall conformation of NNT depends on the protonation state of H664 and the nucleotide 
bound in dIII. 
 
3.4.4. Reversibility of the proposed mechanism  
In the reverse reaction, when pmf is low and there is an excess of NADPH, all the steps 
are naturally reversed, resulting in proton pumping into the P-side (Figure 3.22). After hydride 
transfer, dIII-NADP+ is dislodged by an incoming dIII from the opposing monomer and is 
attached to dII with protonated H664+ (as pH is now lower in the matrix) (steps 1-2). This 
opens the channel to the P-side and H664 loses its proton there, as its pKa is reduced due to 
interaction with NADP+ (step 2). Nucleotide exchange follows due to the excess of NADPH 
(step 3) and dIII-NADPH swivels “up”, due to its low affinity to neutral H664, back to step 1. 
In both forward and reverse reactions, NAD+/NADH formed in dI in step 1 would be exchanged 
for NADH/NAD+ before step 4 completes, so that the cycle can resume, since dI remains open 
throughout. 
In the reverse direction, due to the excess of NAPDH, dIII is mostly detached from dII 
and the channel is open towards the N-side. Once a hydride transfer event takes place, dIII-
NADP+ binds transiently to the dII and promotes NADP+ dissociation, followed by stronger 
binding of apo-dIII, H664 de-protonation into the P-side, which is facilitated by a cluster of 
negatively charged residues around the P-side opening. dII-dIII interface is broken by binding 
of NADPH, which causes dissociation of dIII and restarting of the cycle. Slipping in this 
direction is prevented by the fact that nucleotide exchange will only be stimulated when H664 





Figure 3.22. Reverse transhydrogenation. 
Adapted from Kampjut & Sazanov, 2019. 
 
3.4.5. Comparison of reverse and forward transhydrogenation 
In the forward direction, nucleotide exchange is stimulated by displacement of loop E 
from dIII-NADPH. In the reverse direction, nucleotide exchange is stimulated by unfavourable 
interaction between protonated H664 and NADP+ bound to dIII. This ensures that hydride 
transfer is always coupled to proton pumping, because nucleotide exchange will not happen 
unless H664 is protonated from N-side first.  
dIII detachment in the forward direction is stimulated by unfavourable interaction 
between protonated H664 (from P-side under the influence of PMF) and NADP+ bound to dIII. 
In the reverse direction, dIII detachment is stimulated by binding of NADPH to dIII (as 
supported by our structural evidence). 
These notions explain why the reverse and forward reactions are coupled to proton 
translocation in different directions. In the reverse direction, H664 is protonated from N-side 
and it is relatively close to the surface of the membrane. Deprotonation then involves the loss 
of the proton into the P-side across a relatively large depth of the membrane. Locally, this is 
stimulated by negatively charged residues at the P-side entry. In the forward direction, 
nucleotide exchange
hydride transfer
dIII flip and opening, proton 
channel opening to P-side
dIII detachment and closing, proton 


































protonation of H664 would have to happen from the P-side and cross a large proportion of the 
membrane depth. This is clearly only favourable when there is an already pre-existing pmf 
across the membrane. 
In the forward direction, dIII-NADP+ is mostly associated with dII and the channel is 
open towards the P-side (Figure 3.21, step 1). In the reverse direction, dIII-NADPH is mostly 
dissociated from dII and the channel is open towards the N-side. Since NADPH promotes dIII 
detachment and NADP+ promotes dIII attachment to dII, the relative concentration of 
NADP+/NADPH determines which side of the membrane the proton channel will spend most 
time open to. This is of course only valid at neutral pH when H664 is mainly deprotonated.  
Under typical conditions, forward reaction proceeds in the presence of high NADP+ 
and high pmf, which both ensure H664 protonation from the P-side. Conversely, reverse 
reaction happens at high NADPH and low pmf, when H664 protonation is more likely from 
the N-side. Excess of NADPH at zero starting pmf will drive build-up of pmf until the 
equilibrium is reached. 
 
3.4.6. Preventing slipping  
Ensuring a correct stoichiometry between hydride transfer and proton transfer requires 
a tight coupling between hydride transfer, nucleotide exchange and proton translocation. 
“Slipping”, or uncoupling, at any step is prevented because proton translocation cannot happen 
without nucleotide exchange. For example, step 3 (Figure 3.21) cannot progress to step 4 and 
switch proton channel access unless there is nucleotide exchange – only the dIII-NADP+ and 
H664+ combination will allow dIII dissociation and dII opening to the N-side. If nucleotide 
exchange does not happen, bound dIII-NADPH will interact strongly with H664+ and prevent 
dIII detachment and dII opening to the N-side. In other words, two half-paths of proton across 
the membrane (up to H664 and after) in both forward and reverse reactions are connected only 
by nucleotide exchange, excluding any uncoupling.  
The proposed mechanism ensures tight coupling also close to the equilibrium 
conditions because our mechanism does not assume certain protonation state of H664 in order 
for the reaction to proceed. The figures just illustrate the most abundant species under typical 
conditions of forward and reverse reactions. However, we can simply consider all the 
possibilities. After hydride transfer in step 1, dIII associates with dII, allowing nucleotide 




1. If it is dIII-NADP+ and H664+ (weak dIII-dII interaction), then dIII would be 
flipped up first, then dII is closed from periplasm and opened to cytoplasm, so that proton is 
released into the cytoplasm – this is forward reaction, when there is excess of NADP+.  
2. If it is dIII-NADP+ and H664 (strong dIII-dII interaction), dIII will remain 
attached to dII until H664 is protonated from the periplasm. This prevents slipping of forward 
reaction. After H664 protonation dIII will be flipped up and proton released into the cytoplasm, 
in the forward reaction as above. 
3. If it is dIII-NADPH and H664 (weak dIII-dII interaction), dIII will flip up first, 
then dII will close to the periplasm and open to cytoplasm, allowing H664 protonation from 
the cytoplasm - this is reverse reaction, when there is excess of NADPH.  
4. If it is dIII-NADPH and H664+ (strong dIII-dII interaction), dIII will remain 
attached to dII until H664 is de-protonated into the periplasm. This prevents slipping of reverse 
reaction. After H664 de-protonation, dIII can flip up and dII will close to the periplasm and 
open to cytoplasm, allowing H664 protonation from the cytoplasm, in the reverse reaction as 
above.  
5. In the apo state, dIII remains attached to dII, preventing proton leak.  
 
Thus, we achieve tight coupling between hydride transfer and proton translocation, 
without any slipping, at all conditions – either favourable for forward or reverse reaction, or 
close to equilibrium. Close to equilibrium the overall net direction of reaction will depend on 
the pmf value and nucleotide ratios. It is known that high pmf can drive (NADPH/NADP+) / 
(NADH/NAD+) ratio up to 500 from about 0.8 in the absence of pmf.   
 
3.4.7. Driving force for dIII dissociation from dI  
After a full cycle and hydride transfer back at step 1, subsequent dIII dissociation from 
dI in step 2 is unlikely to be initiated by hydride transfer itself as it is a fast step and dI2dIII 
structures were solved with many combinations of bound nucleotides (Cotton et al., 2001; 
Mather et al., 2004). However, NNT always operates as a dimer, in which the two dIII domains 
cannot simultaneously attach to the dI dimer, as noted above. Therefore, as the second 
monomer (in grey in Figure 3.21) goes through a similar cycle as the first monomer (in colour), 
the second dIII, swivelling up after detachment from dII, will clash with the already bound dIII 
from the first monomer and dislodge it, initiating its flip “down” in step 2, resuming the cycle. 
As shown in the literature, monomeric dI cannot catalyse reverse transhydrogenation reaction. 




monomer which will prevent dIII-NADP+ to reassociate with dII after proton has been lost into 
the N-side.  
 
3.5.Validating biochemical data 
3.5.1. Trypsinolysis at different pH shows opposing effects of NADP and NADPH 
It has been demonstrated before that NADPH and NADP+ have different effects on the 
trypsinolysis rate of dI-dII linker (Yamaguchi, Wakabayashi and Hatefi, 1990). This can be 
explained by our structural data which show that trypsinolysis of the dI-dII linker is possible 
only in the dIII-detached conformation. In the dIII-attached conformation dI-dII linker contacts 
dIII and is likely inaccessible to trypsin active site (Figure 3.13). To validate the proposal that 
dIII detachment depends not only on the NADP(H) binding but also on the H664 protonation 
state, we analysed the full pH dependence of trypsinolysis in the presence of all substrates 
(Figure 3.23). These data show that NADPH stimulates trypsinolysis with increasing pH, while 




Figure 3.23. Trypsinolysis of NNT at different pH in the presence of substrates.  
Trypsinolysis of ovine NNT confirms the interdependence between H664 protonation state, NADP(H) bound in dIII 
and dIII attachment to dII. 110 kDa full NNT and previously identified 66 and 43 kDa fragments are labelled with 
asterisks. As pH decreases from 8 to 6, NADPH- induced proteolysis diminishes relative to that induced by NADP+. 
At pH 5 trypsin produces different fragments, but stabilisation of the intact NNT by NADPH is evident. 
Trypsinolysis was performed independently three times with similar results. NNT purification was repeated 
independently ten times with similar results as shown in panels a-b.  




3.5.2. Cyclic reaction 
It has also been known for a long time that the pH dependence of the cyclic reaction is 
shifted towards the acidic range compared to the reverse reaction. Cyclic reaction has a pH 
optimum at around 5.5-6, very different from the pH optimum for reverse transhydrogenation, 
which is around pH 7 (Bizouarn and Jackson, 1993; Sazanov and Jackson, 1995). In the light 
of our structural data, it is easy to see that cyclic transhydrogenation will proceed the fastest 
when dIII spends as much time as possible dissociated from dII and thus in the occluded state. 
This will prevent loss of nucleotide from its binding pocket and reduce the time the enzyme 
spends in the “waiting” face-down conformation. The dII-dIII interface will be the weakest 
when pH is near pKa of H664, as that’s when dIII with either NADP+ or NADPH will be the 
most dissociated.  
Cyclic reaction therefore cannot inform us on specific NADP+ vs NADPH effects as 
the main species in the NADPH-initiated cycle is still the occluded dIII-NADP+ (Hutton et al., 
1994). The authors of the study above concluded that the release of either NADP+ or NADPH 
decreases the pKa of the key group in the enzyme based on their measurements of NADP(H)-
linked cyclic transhydrogenation. However, since the effects of either NADP+ or NADPH on 
the cyclic reaction would thus inevitably be the same, this conclusion does not contradict the 
proposed mechanism of NNT described here. Disentangling specific effects of NADPH and 
NADP+ on the protein conformation can be done using trypsinolysis as described above.  
 
3.5.3. Labelling of C893 
It has been established previously that NADPH, but not NADP+, increases the 
susceptibility of C893 to chemical labelling (Yamaguchi and Hatefi, 1989). Since C893 is 
buried in the dII-dIII interface, its accessibility to chemical modifiers is an independent 
measure of dIII attached/detached ratios. In chapter 3.1 I show that ovine NNT is inhibited by 
oxidised glutathione, the mechanism of which could be glutathionylation of the conserved 
C893. Because the inhibition depends strongly on the pH and redox potential it has so far not 
been possible to establish whether pH and different substrates (NAD(P)H or NAD(P)+) 
modulate glutathione inhibition appreciably.  
 
3.5.4. Residue conservation 
An additional piece of evidence for the proposed mechanism where the interfaces and 




organisms. When conservation scores are mapped on a model of transhydrogenase it becomes 
clear that the proton translocation pathway and the domain interfaces are the most conserved 
across the species, suggesting that they are indeed functionally significant (Figure 3.24).  
 
Figure 3.24. Conservation of transhydrogenase residues. 
Residue conservation scores (calculated in Consurf, coloured cyan to magenta from low to high conservation) 
mapped on the structure of a single monomer of transhydrogenase. The most highly conserved regions are the 
proton translocation pathway, nucleotide binding sites and dI-dIII, dII-dIII and dI-dI interfaces. 
Adapted from Kampjut & Sazanov, 2019. 
 
 
3.5.5. Review of available mutagenesis data 
There have been over 300 different point mutants of E. coli, R. rubrum and human NNT 
described in the literature, which have been collected and summarized elsewhere (Kampjut and 
Sazanov, 2019). Here I am going to discuss a few of the key mutants which support the 
proposed mechanism (Figure 3.25). 
The fact that dIII detachment depends on the electrostatic interaction between H664 
and nicotinamide has been demonstrated by mutants of H664 and other nearby residues 
involved in proton translocation (N796, N489, S799). The key protonatable H664 has been 
mutated to 16 different amino acids. The effects of this mutation on the reverse, cyclic and 
proton-pumping activity have been measured and replicated in up to four different laboratories. 
The proposal that dIII-NADP+ can stably bind to dII with H664 in neutral state and protonation 
of H664 causes dIII-NADP+ detachment  has been validated by H664K/R mutants in E. coli 









Figure 1.9. Conservation of transhydrogenase. 
Residue conservation scores (calculated in Consurf, coloured cyan to magenta from low to high 
conservation) mapped on the structure of a single monomer of transhydrogenase. The most highly 
conserved regions are the proton translocation pathway, nucleotide binding sites and dI-dIII, dII-dIII and 
dI-dI interfaces.
Adapted from Kampjut & Sazanov, 2019.
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protonated histidine and as predicted by our mechanism, binding of dIII to dII should be 
severely diminished, resulting in detached dIII with tightly bound nucleotide. NNT was trapped 
in the NADP(H)-induced conformation with nucleotide bound to dIII, i.e. with both dIII 
detached from dII. The mutant had inhibited reverse activity but increased cyclic activity. In 
H664N/S/T mutants, however, dIII is always attached because N/S/T are not protonatable. In 
this case both the cyclic and reverse activities were inhibited and the enzyme could not adopt 
the NADP(H)-induced conformation, i.e. was trapped with dIII attached to dII (Glavas, Hou 
and Bragg, 1995). This pattern has been replicated with other residues in the vicinity of H664: 
N796 and T709. Mutating these residues to positively charged residues locked NNT in the dIII-
detached state (Bragg and Hou, 2001; Yamaguchi, Stout and Hatefi, 2002; Yamaguchi and 
Stout, 2003). Additional complication is that sometimes mutations to large and neutral residues 
such as phenylalanine or tryptophan also stabilised the dIII-detached state, such as in the case 
of G826, but this can be attributed to the fact that insertions of large residues in the finely-tuned 
dII environment results in large scale conformational changes of the whole domain and its 
interaction surface with dIII. 
The fact that dII-dIII interface formation is important for nucleotide exchange has been 
elegantly validated by mutations that affect the dII-dIII interface but are not involved in proton 
translocation (R544, R839, D787). The effects of these mutations replicated the above-
described effects of H664K/R mutations and stabilised the enzyme in the dIII-detached 
conformation, as demonstrated by co-purification with NADP(H) and increased cyclic activity 
(Glavas, Hou and Bragg, 1995; Yamaguchi and Hatefi, 1995; Althage, Bizouarn and Rydström, 
2001). 
The fact that dII-dIII interface formation results in nucleotide exchange in dIII subunit 
and that this is connected to proton pumping has also been validated by mutations of loop E 
residues. In full transhydrogenase, loop E mutations result in decoupled phenotype, as 
predicted by the mechanism described here (Olausson et al., 1993; Bergkvist et al., 2000). In 
dI-dIII systems loop E mutations, however, increase the rates of reaction, as NADP(H) release 
from dIII becomes less limiting for the overall reaction. This validates the proposal that dIII is 
occluded when shuttling between dI and dII subunits, however, this has been known also from 
purification and structures of isolated dIII from several species. In all of them, NADP(H) is 
tightly bound and loop E is closed over the nucleotide (Prasad et al., 1999).  
Finally, mutations that disrupt the dimer by interfering with the dI-dI interface lead to 




2007). This confirms the fact that transhydrogenase must exist as a dimer, either for stability, 
but more likely for the catalytic reasons.  
 
Figure 3.25. Summary of previously published biochemical evidence and mutagenesis data validating the 
proposed mechanism. 






3.6.1. Role of the dimer 
Our revised mechanism implies anti-phase action of two monomers, or “division of 
labour” as suggested previously (Jackson et al., 2015). Such a mechanism is absolutely 
necessary for bacterial enzymes without the dI-dII linker, where one dIII has to be attached to 
dI2 at all times to prevent the loss of dI2. Based on our mechanism and structures, it would seem 
that a strict out-of-phase operation of NNT is not obligatory since all the catalytic steps apart 
from the hydride transfer could in principle proceed simultaneously on both sides of the dimer. 





Y158, F172  






R544, D787, R839 
decoupled phenotype or 
stimulated cyclic activity (locked in 
dIII-detached state)
proton translocation pathway 
H664, N796 
(small and/or neutral mutants) 
locked in dIII-attached state
trypsinolysis of dI-dII linker 
and CL4 stimulated by 
NADPH at high pH and 
NADP+ at low pH
C893 labelling 
stimulated by NADPH at 
high pH
NADP(H)-binding site 
H920, A923, E967, K999 




decoupled phenotype in full NNT 
increased reaction rate in dI-dIII system
proton translocation pathway 
H664, T709, N796, G826 
(bulky and/or charged mutants) 
locked in dIII-detached state
proton translocation pathway 
S799 
decoupled phenotype
Figure 3.9. Summary of literature experiments validating the proposed mechanism. 
a, Summary of the biochemical evidence and mutagenesis data supporting the proposed mechanism. Full 
description of mutants in E. coli, R. rubrum and human patient mutations are in Supplementary Tables 1-3. 
Figure adapted from Kampjut & Sazanov, 2019.
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catalytically inactive monomeric dI and negative cooperativity of NAD(H) and NADP(H) sites 
between monomers, strongly suggesting an anti-phase mechanism (Phelps and Hatefi, 1984; 
Yamaguchi and Hatefi, 1993; Obiozo et al., 2007). Even though the presence of dI-dII linker 
could make a strict anti-phase action less of a requirement for the mammalian enzyme, there 
are probably other advantages to operating an antiphase mechanism. Firstly, the coordinated 
anti-phase action of the two monomers would avoid steric clashes between independently 
functioning dIIIs. Secondly, swivelling “up” of one dIII is the best explanation for the initiation 
of the detachment, after hydride transfer, of the other dIII from dI2 (Step 2, Figure 3.21). 
Thirdly, operating as a dimer in an antiphase mode could potentially also prevent slipping 
(decoupling of proton pumping from hydride transfer) as hydride and proton transfer are not 
only coupled within one protomer but also between the two protomers. All of these reasons 
probably allow the dimer to secure a kinetic advantage over the monomer (Obiozo et al., 2007; 
Jackson et al., 2015). Nevertheless, further data will be required to determine the significance 
of the anti-phase action in NNT as well as to test all the implications of the proposed 
mechanism. 
 
3.6.2. Communication between the two protomers 
Our structures suggest different ways in which the two monomers can communicate 
with each other to structurally explain the basis of anti-phase dimer action. As described above, 
rotation of one dIII into the face-up position could help dislodge dIII from the opposite 
protomer from dI.  
Rotation of one dIII into the face-up position would bring it very close to the other dIII 
in the face-down conformation (Figure 3.13). They could form many hydrogen bonds without 
clashing and so interact when swivelling.  
dI dimer is stabilised by a large buried surface extended by an elongated hairpin (ovine 
residues 172-184) reaching out from each monomer into the neighbour (Prasad et al., 2002; 
Johansson et al., 2005; Sundaresan et al., 2005). The hairpin from one dI monomer interacts 
only weakly or not at all with the “face-down” dIII in another monomer (as seen in our 
structures), but strongly with the “face-up” dIII (as in dI2dIII crystal structures). This hairpin 
originates directly from the Rossmann fold coordinating the NAD(H) in the first monomer, 
which may allow for communication of the redox state from one dI monomer to the other.  
Additionally, the mammalian enzyme has another possibility for protomer 
communication. The dI-dII linker contacts the dIII from one monomer and is continued by the 




the TM5 (unique to metazoans) and the TM4-5 loop from another monomer, which in turn 
directly contact dIII from that monomer. This feature, in addition to the TM1/TM5 dimer 
stabilisation, may allow for more efficient dIII cross-talk. Together, all these possible routes of 
communication may allow for the two monomers to work more effectively in an anti-phase 
fashion. 
 
3.6.3. Comparison with the bacterial NNT  
In our datasets we did not observed a face-up dIII conformation since it is likely that 
the dI-dIII interface formation requires binding of the corresponding nucleotide to dI and once 
formed, has a very short life span as the hydride transfer step is several orders of magnitude 
faster than nucleotide exchange (Hutton et al., 1994; Venning et al., 1998, 2000). To explain 
the existence of a pure asymmetric dimer in T. thermophilus we need to note that a) this was 
observed in a crystal structure which is inherently more static than cryo-EM structures solved 
in solution and b) the lack of the dI-dII linker in T. thermophilus. We propose that the dI-dIII 
interface in bacteria is strengthened to prevent a simultaneous dissociation of both dIIIs which 
would lead to the loss of the dI2 in the absence of the dI-dII linker. This is supported by studies 
of the hydride transfer activity which is two orders of magnitude faster in the isolated mixtures 
of R. rubrum and E. coli dI/dIII than in the mixtures of isolated bovine dI/dIII (Yamaguchi and 
Hatefi, 1995, 1997; Fjellstrom et al., 1999). This notion explains why NADP+ affects the 
structures of mammalian and bacterial NNT differently. It also explains the evolutionary reason 
for acquisition of the dI-dII linker, as it contributes towards higher efficiency of the mammalian 
enzyme, as the dI-dIII interface can be weaker and allow for faster turnover. dI-dII linker also 
allows NNT to exist in an “auto-inhibited” double face-down conformation, which could be 
important for additional regulation of mammalian NNT. 
 
3.6.4. Potential role of kinetic restriction  
The mechanism and ensuring the directionality could also be helped by a kinetic 
mechanism. Specifically, dIII-NADP+ re-association with dII before hydride transfer takes 
place (step 4, Figure 3.21) could be prevented by the relative rates of H664 deprotonation into 
the N-side (slow) and hydride transfer (fast). Furthermore, dI has had time to exchange the 
nucleotide since hydride transfer of the previous cycle, while deprotonation of dII into the 
matrix can only take place after dIII has dissociated in step 4. Presumably, the kinetic 
parameters of NNT are tuned such that the reaction is driven forward. It will be interesting to 
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investigate the role of kinetics for the catalytic mechanism of NNT, but these parameters cannot 




The structures presented here are the first high-resolution structures of an intact 
transhydrogenase from any species. We describe for the first time in atomic detail the dII-dI 
linker, the face-down conformation of dIII, the structure of dIII without bound nucleotide, the 
dII-dIII domain interface and the structural changes induced in the proton channel and the 
NADP(H) binding site by dIII binding to dII. These observations, together with a wealth of 
published biochemical evidence on NNT, allow us to revise and streamline the catalytic 
mechanism. The revised mechanism elegantly explains the full reversibility of NNT, pH 
dependencies of reverse and cyclic reactions, different effects of NADP+ and NADPH on the 
overall conformation of the NNT as well as complex phenotypes of mutants, promoting 
decoupling or cyclic reactions. Further work on NNT will need to explain how exactly the 
reaction is coupled in the two monomers. Our structures combined with a better understanding 
of the mechanism will facilitate further understanding of the functional role of NNT and could 







4. Complex I 
4.1. Biochemical characterization of ovine complex I 
4.1.1. Effects of detergents on NADH:DQ activity 
As has been described previously, complex I activity depends highly on the type of 
detergent in which the protein is purified and assayed (Sharpley and Hirst, 2006; Letts et al., 
2016). Firstly, because the integrity of complex I depends strongly on the type of detergent, 
and many detergents interfere with the quinone or lipid binding pockets. Secondly, because the 
NADH:DQ assay employs a hydrophobic substrate (DQ, Figure 4.1) and adequate mixing and 
accessibility to the protein is required to achieve maximum activity that is not diffusion-limited. 
The assay conditions have been thoroughly optimized before (Letts et al., 2016), and included 
the addition of CHAPS to the assay buffer, which greatly improves accessibility of quinone. 
Here we mainly compared the different preparations of complex I used for cryo-EM grid 
screening.  
The highest activity (~6 U/mg) was observed in CxI preparations in very mild 
detergents such as FOM or LMNG (Figure 4.1). Surprisingly, activity in nanodiscs (MSP2N2) 
or amphipols, which should theoretically preserve the near-native lipid environment around 
complex I much better than detergents resulted in strong inhibition of activity (~1 U/mg). 
Nevertheless, the remaining activity was fully sensitive to rotenone, suggesting that the 
particles maintained structural integrity and remained well-coupled. The reduced activity was 
thus very likely due to the decreased rate of quinone exchange between the buffer and the 
nanodisc/amphipol particle. Activity in all of the detergents was higher than in Brij-35 which 
was used previously to determine the ovine complex I structure (Fiedorczuk et al., 2016).  
Since the FOM preparation activity was so high, the activity in a buffer containing only 
FOM and no CHAPS was also measured, but this resulted in lower final activity measurements, 
likely because DQ solubility in a FOM buffer is lower (Figure 4.2). To assess the effects of the 
temperature on the activity, the preparations with the highest activities were also assayed at 
4ºC, to determine the rate of complex I reaction at the temperatures at which cryo-EM grids 
are typically prepared (Figure 4.2). Activity at 4ºC was reduced by about 90%. These 
measurements were used for predicting the consumption of substrates in the CxI sampled 





Figure 4.1. Complex I activity depends on the detergent.  
Complex I has the highest activity in mild detergents such as LMNG and FOM but low activity in nanodiscs and 
amphipols.  
 









































b, CxI has the highest activity in mild detergents such as LMNG and FOM but low activity in nanodiscs 






4.1.2. Inhibition by rotenone and imiquimod 
Many inhibitors of complex I are known and continue to be described (Murai and 
Miyoshi, 2016). Rotenone is one of the strongest known inhibitors of complex I (Figure 4.2). 
Ovine complex I preparation was fully sensitive to rotenone as described previously 
(Grivennikova et al., 1997). Rotenone inhibition was also structurally characterized in this 
work for the first time.  
 
Figure 4.3. Inhibitors of complex I.  
a. Imiquimod is an inhibitor of ovine complex I with IC50 of 39 M. b. Imiquimod does not inhibit 
NADH:Ferricyanide activity of complex, indicating that imiquimod binds within the quinone cavity and not at the 
FMN site. c. Neither rotenone nor imiquimod significantly affect ROS generation by complex I. d. Structure of 
rotenone.  
 
In addition to rotenone, imiquimod has recently been identified as a novel complex I 
inhibitor in vivo with potential clinical implications (Groß et al., 2016). Imiquimod indeed 
inhibits the NADH:DQ reaction of the purified ovine complex I, albeit with a relatively high  
IC50 of around 39 mM (Figure 4.3a). Imiquimod does not inhibit NADH:ferricyanide 

















































































































binding pocket (Figure 4.3b). Molecular similarity to quinone and rotenone as well as 
hydrophobicity are consistent with this conclusion. 
Since an increase of ROS production in the presence of imiquimod was observed in 
cells, we tested effects of imiquimod on ROS production by purified complex I. There was no 
difference in the initial rates of ROS production by ovine complex I in the presence of NADH 
and either absence or presence of DQ, rotenone or imiquimod (Figure 4.3c). We measured 
superoxide production, since mammalian complex I produces ROS as ~95% 
superoxide/~5%H2O2 (Esterhazy et al., 2008). Thus, ROS production by ovine enzyme is 
similar across all conditions, as reported previously for complex I from Yarrowia lipolytica 
(Dröse, Galkin and Brandt, 2009). In vivo it is likely that the ROS increase comes from 
inhibition of complex I increasing NADH concentrations significantly and thus leading to 
increased ROS production at the FMN site, which is highly sensitive to NADH/NAD+ ratio.  
 
4.2. Preliminary structure of ovine complex I in nanodiscs 
Initially, reconstitution and structural studying of complex I in nanodiscs was initiated 
as nanodiscs provide a near-native lipid environment. As outlined in chapter 2, a preliminary 
cryo-EM dataset of complex I reconstituted into MSP2N2 nanodiscs and in the presence of DQ 
was collected. It showed that MSP2N2 can wrap around the elongated membrane arm of 
complex I, despite having a predicted nanodisc diameter of about 140 nm.  
We could not observe bound quinone in this structure, either because too low 
concentration was used (20 M) or because of the low resolution achieved (up to 4 Å in the 
peripheral arm and 4.4 Å in membrane arm). Lipid environment of this preparation preserved 
the structural integrity of loosely bound membrane subunit B14.7. Due to the small size of the 
dataset, the focus-reverse-classify procedure could not be implemented. Ultimately, due to the 
much higher activity of complex I purified in LMNG, the latter preparation was used for all 






4.3. High-resolution features of complex I model 
The sample of complex I in LMNG proved to be the best candidate for high resolution 
structural analysis and it allowed us to build the most complete model of mammalian complex 
I so far (96.9% residues modelled, Table 4.1). Resolutions up to 2.3 Å for peripheral arm (PA) 
and up to 2.5 Å for membrane domain (MD) resulted in a better-defined geometry in many 
ambiguous regions (Figure 4.3). This is a significant improvement over the previous resolution 
of 3.3 Å (Agip et al., 2018) and resulted in several novel features described below.  
 
4.3.1. Post-translational modifications of complex I 
Complex I is post-translationally modified at several residues, either during polypeptide 
synthesis and assembly or as part of regulation (Carroll et al., 2005; Carroll, Fearnley and 
Walker, 2006). While many of the regulatory post translational modifications occur in 
intrinsically disordered N- or C-terminal parts of polypeptides, we observed density for several 
post-translational modifications connected with stability and assembly of complex I. These 
included N-terminal acylation of three of the supernumerary subunits, B18, B14.5a and B14.7 
(Figure 4.4e). Almost all of the supernumerary subunits in complex I undergo some sort of N-
terminal modifications upon import into the mitochondria but in many supernumerary subunits 
N-termini were disordered (Carroll et al., 2005). 
Furthermore, mitochondrially-encoded subunits of complex I (ND1-ND6) all have an 
N-formyl methionine, as a bacterial-like remnant of mitochondrial gene expression synthesis 
and the density for N-formyl methionine was clearly observed in three of these subunits (Figure 
4.4e). Symmetric dimethylation of the conserved Arg85 of 49 kDa has been observed before 
and occurs in the vicinity of the N2 cluster (Agip et al., 2018). 
Finally, phosphorylation of the Ser36 of 42 kDa subunit has been described before 
(Schilling et al., 2005) and it was suggested that the phosphorylated Ser36 would clash with 
nucleotide binding by 42 kDa subunit (Agip et al., 2018). 42 kDa is a nucleoside kinase 
homologue but despite possessing all the active site residues, no nucleoside kinase activity 
could be measured in the sample of purified ovine complex I. Phosphorylated S36 indeed 
clashed with ADP (or ATP) binding in the 42 kDa subunit, as suggested for the mouse complex 
I (Agip et al., 2018), but there remained a smaller density in the active site which could be 





Table 4.1. Model overview and comparison with the previous ovine complex I model (5LNK)  
 Subunit 
name 
Chain Range built / 






















51 kDa 1 9-438 / 445 1-8, 439-
445 




24 kDa 2 5-217 / 217 1-4 98.2 98.6 N1a (2Fe)  
75 kDa 3 6-693 / 704 1-5, 694-
704 








30 kDa 5 7-214 / 228 1-6, 215-
228 
91.2 91.2   
PSST 6 24-179 / 179 1-23 87.2 86.6 N2 (4Fe) several conformations 
TYKY 9 1-176 / 176 0 100 100 N6a (4Fe) 
N6b (4Fe) 
 
ND3 A 1-115 / 115 0 100 100  15-50 re-modelled 




ND6 J 1-175 / 175 0 100 73.7   
ND4L K 1-98 / 98 0 100 87.8  N-formyl Met 
ND2 N 1-347 / 347 0 100 100   
ND4 M 1-459 / 459 0 100 100 rotenone N-formyl Met 
























10 kDa a 32-75 / 75 1-31 58.7 54.7   
13 kDa b 1-95 / 96 96 99.0 99.0 Zn2+  
18 kDa c 8-133 / 133 1-7 94.7 92.5   
39 kDa d 1-340 / 345 341-345 98.6 87.0 NADPH previously missing C-
terminus and two internal 
loops 
B8 e 13-98 / 98 1-12 87.8 85.7   
B13 f 3-115 / 115 1-2 98.3 97.4   
B14 g 14-127 / 127 1-13 89.8 89.8   
B14.5a h 1-112 / 112 0 100 84.8  N-acetyl Ala 
B17.2 i 1-145 / 145 0 100 99.3   
SDAP-α j 5-84 / 88 1-4, 85-88 90.9 96.6 Phospho-
pantetheine 
 
42 kDa k 1-320 / 320 0 100 70.9   
15 kDa l 1-105 / 105 0 100 90.5   
B9 m 4-83 / 83 1-3 96.4 96.4   
B12 n 11-89 / 97 1-10, 90-97 81.4 73.2   
B14.5b o 1-120 / 120 0 100 100   
B15 p 1-128 / 128 0 100 62.5   
B16.6 q 5-143 / 143 1-4 97.2 97.9   
B17 r 1-38, 66-126 / 
127 
37-65, 127 76.4 66.1   
B18 s 1-122 / 136 123-136 89.7 78.7  N-myristolyl Gly 
B22 t 1-177  /178 178 99.4 93.3   
AGGG u 5-69 / 72 1-4, 70-72 90.3 91.7   
ASHI v 4-158 / 158 1-3 98.1 27.2   
ESSS w 6-123 / 125 1-5, 124-
125 
94.4 68.8   
KFYI x 1-49 / 49 0 100 98.0   
MNLL y 8-57 / 57 1-7 87.7 93.0   
MWFE z 1-70 / 70 0 100 98.6   
B14.7 V 1-140 / 140 0 100 0  previously polyAla; N-
acetyl Ala 
SGDH W 5-143 / 143 1-4 97.2 97.2   
SDAP-β X 2-88 / 88 1 98.9 100 Phospho-
pantetheine 
 
PGIV Y 1-171 / 171 0 100 100   
PDSW Z 3-173 / 175 1-2, 174-
175 
97.7 97.7   








Figure 4.4. Cryo-EM density examples. 
a. Density in various regions of the MD focus-refined map from the turnover dataset. b. Density in various regions 
of the PA focus-refined map from the turnover dataset. c. Densities for metal ions and iron-sulfur clusters. d. 
Density for lipid molecules. e. Densities for various post-translational modifications. f. Densities for bound 
nucleotides. g. Densities for quinones. 





Figure 4.3. Cryo-EM density examples. 
a. Density in various regions of the MD focus-refined map from the turnover dataset. b. Density in various 
regions of the PA focus-refined map from the turnover dataset. c. Densities for metal ions and iron-sulfur 
clusters. d. Density for lipid molecules. e. Densities for various post-translational modifications. f. 
e sities for bound nucleotides. g. Densities for q inones. 
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4.3.2. Lipid binding sites 
We modelled more and better-defined lipid molecules than previously, including 
cardiolipins and several lipid molecules bound above the quinone entry site, indicating the local 
distortion of the membrane plane around the quinone entry site (Figure 4.5). This puts the 
quinone entry site roughly between the two lipid leaflets and was proposed earlier to facilitate 
quinone flipping and diffusion (Parey et al., 2019). Cardiolipin, known to be essential for 
respiratory enzymes activity, was found in 8 locations, some of them consistent with locations 
in other species (Agip et al., 2018; Blaza, Vinothkumar and Hirst, 2018) along with 5 new ones. 
Supernumerary subunit B14.7 is almost fully separated from the MD by a lipid cushion, hence 
this subunit could have been acquired solely for the interaction with complex III in the 




Figure 4.5. Interactions of complex I with lipids.  
a. Lipids modelled into the complex I structures shown as sticks. Phosphatidylethanolamine (blue), cardiolipin 
(red) and phosphatidylcholine (green). b. Surface electrostatic potential of complex I reveals many lipid binding 
sites, negatively charged quinone entry site and membrane curvature around quinone entry point. c. 
Hydrophobicity plot of complex I with white regions showing hydrophobic and red regions showing hydrophilic 
residues reveals the transmembrane region. Tryptophan and tyrosine residues, which often denote membrane 
edge are shown in green. d. Open2-turnover structure filtered to 8 Å reveals curvature of the detergent belt around 
the quinone entry site.  























Figure 4.5. Interactions of complex I with lipids. a. Lipids modelled into the complex I structures 
shown as sticks. Phosphatidylethanolamine (blue), cardiolipin (red) and phosphatidycholine (green). b. 
Surface electrostatic potential of complex I reveals many lipid binding sites, negatively charged quinone 
entry site and membrane curvature around quinone entry point. c. Hydrophobicity plot of complex I with 
white regions showing hydrophobic and red regions showing hydrophilic residues reveals the 
transmembrane region. Tryphophan and tyrosine residues, which often denote membrane edge are shown 
in green. d. Open2-turnover structure filtered to 8 Å reveals curvature of the detergent belt around the 
quinone entry site (indicated).




4.3.3. Ion and water densities 
Finally, we observed a highly coordinated (four backbone oxygens, a glutamine and 
one water molecule) cation bound about 7 Å away from FeS clusters N4 and N5. We tentatively 
assigned the cation as K+, based on its density (much stronger than water) and distances (~ 2.7 
Å) to coordinating oxygen atoms (Figure 4.6a) (Zheng et al., 2008). Presence of the cation in 
the vicinity of N5, which unusually does not show EPR signal, could be necessary to fine-tune 
its potential or that of the nearby N4 cluster (Bridges, Bill and Hirst, 2012). The cation probably 
also stabilizes a very tight turn of the 75 kDa loop between the N4 and N5 clusters. 
We were also able to model water molecules, with important implications for the proton 
translocation mechanism which will be discussed in detail later. Densities for water molecules 
were especially well interpretable in local resolution filtered oversampled maps of focus-
refined MD and PA of complex I during turnover (Figure 4.6b,c).  
 
Figure 4.6. Further Cryo-EM density examples. 
a. Density and surroundings for the putative K+ ion bound next to the N5 and N4 cluster. b. Examples of water 
densities near ND4/E378 in the open MD class. c. Example of water density around ND4/E378 in closed MD 
structure. 













igure 4.4. Furthe  Cryo-EM density examples. 
a. Density and surroundings for the putative K+ ion bound next to the N5 and N4 cluster. b. Examples of 
water densities near ND4/E378 in the open MD class. c. Example of water density around ND4/E378 in 
closed MD structure.





4.4. Comparison of open and closed complex I 
4.4.1. Overview 
We collected datasets of ovine complex I in LMNG in five different conditions: native, 
with added NADH, with added NADH and DQ, with added rotenone and NADH, and in the 
deactive state. All of the datasets contained a mixture of open and closed conformations of 
complex I arising from the combined side- and frontward tilting of the PA by up to 7º as 
described previously (Vinothkumar, Zhu and Hirst, 2014; Fiedorczuk et al., 2016; Zhu, 
Jiapeng, Vinothkumar and Hirst, 2016; Letts et al., 2019) (Table 4.2, Figure 4.5). The relative 
ratios between open and closed conformations were roughly the same in most of our datasets 
with the exception of the deactive complex I, which completely lacked a closed conformation 
and complex I inhibited with rotenone, which had a smaller proportion of the closed state, 
presumably as a result of the presence of rotenone (or DMSO in which it was dissolved) (Figure 
4.7). In each dataset, several open classes could be classified. The most open classes (largest 
PA-MD angle) of the native, deactive and rotenone datasets showed partial disordering of the 
ND6 TMH4, 49 kDa N-terminus, anchor helix of ND5 and B14.7, which could represent a 
partially disassembled or deactivated enzyme. Open classes from NADH dataset on the whole 
appeared slightly more closed than in the native dataset, possibly due to the localized 
differences of the PA-MD interface as described below.  
Otherwise, the open classes did not differ from each other, particularly at the 
catalytically significant sites. The different degrees of openness in open classes thus likely 
reflect the loose PA-MD interface rather than functionally different states of complex I. The 
transitions between open classes should be viewed as continuous and we therefore treat open 
complex I here as a single, albeit heterogeneous, state of the complex.  
 
Table 4.2. Proportion of open and closed conformations of complex I in the collected LMNG datasets and 
resolutions achieved 
Condition Closed (%) res. (Å) Open (%) 
 
res. (Å) PA res. (Å) MD res. (Å) 
native 12 3.8 88 3.2 2.8 3.2 
NADH 10 3.4 90 2.8 2.5 2.8 
rotenone 5 3.7 95 2.8 2.4 2.8 
turnover 11 3.1 89 2.6 2.3 2.5 






Figure 4.7. Closed and open conformations of complex I.  
a. Ovine complex I exists in open and closed conformations, the ratios of which differ between different conditions 
investigated (Table 4.2). b. Overall comparison of closed (cyan) and open (grey) complex I reveals tilting of the 
entire PA and large changes in ND1 subunit. c. E- channel in open and closed MD differs radically in tilting and 
displacements of several helices and different side chain conformations.  
Adapted from Kampjut & Sazanov, 2020.  
 
The opening of complex I coincides with unfolding of several loops, which can roughly 
be divided into the quinone cavity forming loops and the interface forming loops (Figure 4.6). 
The former consists of the 49 kDa β1-β2 loop (yellow) and the PSST loop (grey) that form the 
deep part of the quinone binding pocket and the ND1 TMH5-6 loop (green) that forms the 
shallow part of the pocket. The 49 kDa loop binds the quinone head group and is connected to 
the MD via the rest of the -sheet. The interface-forming loops consist of the ND3 loop 
(orange) and the TMH3-4 loop of ND6 (blue). Unfolding of these loops on closed-to-open 
transition is associated with a notable rotation of the C-terminal half of TMH3 of ND6 by about 





Figure 4.6. Closed and open conformations of complex I. a. Ovine complex I exists in open and closed 
conformations, th  ra ios f which diff r between d fferent conditi ns investigated. Resolution achieved 
for each state ov rall and for PA- or MD-focused refinements is show . b. Overall comparison of closed 
(cyan) and open (grey) complex I reveals tilting of the entire PA and large changes in ND1 subu it. c. E-
channel in open and closed MD differs radically in tilting and displacements of several helices and 
different side chain conformations. 















Figure 4.8. Conformational dynamics of the quinone binding site loops.  
Loops at the interface between the peripheral and membrane arms, ND3 (orange) and ND6 (blue) adopt different 
states shown schematically. Quinone binding cavity loops include the 49 kDa loop (yellow), PSST loop (grey) and 
ND1 loop (green), which also undergo radical changes, as indicated.  













































Figure 4.7. Conformational dynamics of the quinone binding site loo s. 
Loops at the int rface between the peripheral and membran  arms, ND3 (orange) and ND6 (blue) adopt 
different states shown schematically. Quinone binding cavity loops include the 49 kDa loop (yellow), 
PSST loop (grey) and ND1 loop (green), which also undergo radical changes, as indicated.





Figure 4.9. Densities for the mobile loops in different conformations.  
a. Density for the ND1 loop in the “down” conformation (Turnover closed class, left-hand side) and the “up” 
conformation (NADH open2 class, right-hand side). b. Density for the 49 kDa loop in the retracted (Turnover 
closed class, left-hand side) and in the extended conformation (NADH open2 class, right-hand side). c. Density 
of the ND6 TMH3 in closed state (without 𝛑-bulge) and in open state (with 𝛑-bulge). N.B. the rotation of the 
upper part of the helix. d. Density for the ND3 loop in the fully ordered (turnover closed class, top), partially 
disordered (open2 turnover class, middle) and disordered conformation (NADH open2 class, bottom).  




Figure 4.8. Densities for the mobile loops in different conformations. 
a. Density for the ND1 loop in the “down” conformation (Turnover closed class, left-hand side) and the 
“up” conformation (NADH open2 class, right-hand side). b. Density for the 49 kDa loop in the retracted 
(Turnover closed clas , l ft-hand side) and in the extended conformatio  (NADH open2 class, right-ha d 
side). c. Density of the ND6 TMH3 in closed state (without -bulg ) and in open state (with -bulge). 
N.B. the rotation of the upper part of the helix. d. Density for the ND3 loop in the fully ordered (turnover 
closed class, top), partially disordered (open2 turnover class, middle) and disordered conformation 
(NADH open2 class, bottom). 
Adapted from Kampjut & Sazanov, 2020.
b
49 kDa loop “retracted” 49 kDa loop “extended”
a
ND1 loop “up”ND1 loop “down”





























4.4.2. Opening and reduction result in vast rearrangements of the mobile loops 
In all of the open conformations (from all datasets) we observed disordering of the 
central part of the ND3 loop (residues 38-42 involving also small changes in the adjacent 
termini of TMH2 and TMH3), the ND6 loop and the amphipathic helix (residues 259-272) of 
the supernumerary 39 kDa subunit. While the N-terminal part of the ND3 loop was ordered in 
all datasets (residues 27-37), the C-terminal part of ND3 loop (residues 43-48) was disordered 
in NADH dataset, but ordered in most others. 
Dramatic changes were observed also in the whole of ND1 subunit, with shifts of most 
helices increasing from the IMS towards the matrix side and reaching up to 5 Å displacements 
(Figure 4.10a). These movements in turn lead to the observed tilting of PA and probably also 
help to accommodate the widening of quinone cavity as described below. Furthermore, we 
observed formation of the -bulge in TMH3 of ND6, resulting in a remarkable 120º rotation of 
the C-terminal half of the helix above the -bulge upon closed/open transition (Figure 4.10b).  
In contrast to the interface forming loops, the conformations of the quinone binding site 
loops (49 kDa, PSST and ND1), depended not only on the openness, but also on the ligands 
bound and the reduction state of the whole complex.  
The 49 kDa loop was ordered in the retracted (out of quinone cavity) conformation in 
closed classes and disordered in the open classes of the native, turnover and deactive datasets. 
When rotenone was bound in the deep binding site (Qd) in open complex I, 49 kDa loop was 
also ordered in the retracted conformation. In open classes of NADH-reduced enzyme (but not 
closed classes), however, 49 kDa loop was ordered in the extended-into-the-quinone-cavity 
conformation, shortening the cavity considerably (Figure 4.10d). These results suggest that 
binding of a ligand in the Qd site can order the 49 kDa loop. Since the extended conformation 
was not observed in the rotenone and turnover datasets, which also contained NADH, quinone-






Figure 4.10. Opening and reduction of the complex induce long-range conformational changes. 
a. Reogranization of the ND1 subunit upon opening with a detailed view of the rearrangements of the conserved 
glutamates which are part of the E-channel. On the right open state is gray and closed state is colored by subunit, 
while on the right open state is cyan and closed is green. b. TMH3 of ND6 rotates by almost 180o in the open 
state (cyan), acquires a π-bulge near Y60 and the TMH3-4 loop gets disordered. c. PSST loops and R77 undergo 
large conformational changes between open (cyan) and closed (green) states. d. 49 kDa loop is ordered in the 
closed state (green), gets disordered upon opening (cyan) and reorders in the extended position the reduced open 
state (pink). e. ND1 loop which is in the “down” conformation in the closed state (green), gets disordered upon 
opening and switched to the “up” conformation in the reduced open state (pink). In the “up” position ND1 clashes 
with the ND3 (orange) and 49 kDa (yellow) loops which are also reordered. Reorganization of the ND1 loop 
results in breaking of two salt bridges with PSST/R77 and R81 (grey).  
Adapted from Kampjut & Sazanov, 2020.  
 
 
ND1 loop was similarly ordered in the “down” conformation in the closed classes and 
disordered in the open classes of the native, turnover, rotenone and deactive datasets. In NADH 
open classes (but not closed), however, ND1 loop rearranged into an “up” position, which 
displaced the ND3 loop as well as the other two ND1 matrix side loops (Figure 4.10e). 
Disordering of ND1 loop breaks several salt bridges, among which are highly conserved E214-
PSST/R81 and E202-PSST/R77. Mutagenesis studies showed inhibitory effects of R77 and 
R81 mutations and MD simulations suggested that quinone dynamics in the cavity is correlated 
with the state of the salt bridge PSST/R81-ND1/E214; i.e. quinone can only diffuse within the 





















































Figure 4.9. Opening and reduction of the complex induce long-range conformational changes. 
a. Reogranization of the ND1 subunit upon opening with a detailed view of the rearrangements of the 
conserved glutamates which are part of the E-channel. On the right open state is gray and closed state is 
colored by subunit, while on the right open state is cyan and closed is green. b. TMH3 of ND6 rotates by 
almost 180º in the open state (cyan), acquires a π-bulge near Y60 and the TMH3-4 loop gets disordered. c. 
PSST loops and R77 undergo large conformational changes between open (cyan) and closed (green) 
t t s. d. 49 kDa loop is ordered i  t  closed state (green), gets disord red upon opening (cyan) and 
reorders i  the ext nded position the educed open state (pink). e. ND1 loop which is in the “down” 
conformation in the close  state (green), gets disordered upon opening an  switched to the “up” 
conformation in the reduced open state (pink). In the “up” position ND1 clashes with the ND3 (orange) 
and 49 kDa (yellow) loops which are also reordered. Reorganization of the ND1 loop results in breaking 
of two salt bridges with PSST/R77 and R81 (grey).
Adapted from Kampjut & Sazanov, 2020.
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In the “up” conformation, E214 formed an alternative salt bridge with ND1/R62 and a 
hydrogen bond with PSST/Q106, while E202 was exposed to the quinone cavity lumen (Figure 
4.10e). ND1 loop did not switch into the “up" conformation in rotenone and turnover datasets, 
which also contained NADH, suggesting that binding of the ligand in the quinone cavity 
reverses the NADH-induced changes and could be an important step during the catalytic cycle. 
In contrast to 49 kDa and PSST loops, ND1 loop not only reforms the cavity upon the 
transition into the “up” conformation but it also appears to push ND1 TMH3 and TMH4 about 
5 Å towards MD. Strikingly, as TMH4 bends near Y142 upon such transition, this tyrosine 
swings out in the open state by almost 180º, freeing the space for E192 to move within 
hydrogen bonding distance to E143 (Figure 4.10a). Changes in density appearance and the 
predicted pKa also indicate that at least one of the glutamates (E192, pKa increases from 7.52 
to 9.15 as calculated by ProPKa software (Olsson et al., 2011)) becomes protonated in the open 
state. These extensive conformational changes propagate in the membrane domain from the Q 
cavity all the way towards the ND6/TMH3 -bulge and the E-channel (Figure 4.7), likely 
representing a major part of the coupling mechanism.  
PSST loop itself also changed the conformation in the native, turnover, NADH and 
deactive datasets. In the closed classes it adopted the “raised” conformation, in which residues 
48-51 bulge out into the quinone cavity, while in the open classes they form part of the -sheet. 
Furthermore, residues 75-80 flip in the open classes, resulting in a 180º rotation of R77 (Figure 
4.10c). In the rotenone dataset, however, PSST loop always adopted the raised conformation 
and R77 contributed to rotenone binding as discussed later.  
 
4.4.3. Rearrangements of the quinone binding cavity 
Opening of complex I and change in the conformations of the above loops completely 
reshape the negatively charged quinone binding cavity (Figure 4.11a). Closed cavity is very 
tight, clearly excluding the possibility of quinone protonation by the bulk solvent. In the open 
conformation, quinone cavity is much wider, in a large part due to PSST re-arrangements. It 
becomes possibly even accessible to bulk solvent near the ND3 loop (although that may be 
closed by a disordered loop) and also through extra cavity passing by ND1/R134. This 
widening will facilitate quinone movements in and out of cavity before and after reduction. In 
the NADH open conformation cavity becomes much shorter, mostly due to 49 kDa loop 




Our open NADH structures do in fact show a density near the quinone binding cavity 
entry (Qs site), which could be modelled as a quinone, presumably co-purified with the enzyme 
(Figure 4.11b). The density appeared stronger in the open NADH classes than in the closed 
class. There was also a weaker density found in a similar position in the native complex I 
(Figure 4.11b). We cannot unambiguously assign these densities as they could come from lipid, 
detergent or native quinone (in the case of native complex) or quinol (in the case of NADH-
complex I). Density in a similar position has also been reported in Y. lipolytica and has been 
hypothesized to correspond to a negatively charged lipid head group (Parey et al., 2018) and 
more recently to a native quinone (Parey et al., 2019). Based on the appearance, connectedness 
and strength of these densities we modelled quinol into the NADH-open complex I but not in 
the other classes.  
Finally, our results do not support the quinone shuttling mechanism (Brandt, 2011; 
Wikström and Hummer, 2012; Wikström, Sharma, Ville R I Kaila, et al., 2015; Haapanen and 
Sharma, 2018). UQ10 bound in the Qd site would occlude with its long tail the entire cavity 
along with the shallow binding site (Baradaran et al., 2013; Warnau et al., 2018). 
 
 
Figure 4.11. Changes in the quinone binding cavity.  
a. Cross sections through the quinone binding cavity in closed, open and NADH-open states colored by 
electrostatic potential reveal that opening and reduction result in large changes of the quinone binding cavity 
shape. In closed state UQ-10 is modelled (gray), based on decyl-ubiquinone binding and illustrating tight fit of 
the native substrate. b. Comparison of the densities near the entry into the quinone cavity in closed native complex 
Closed-native Open-native Closed-NADH Open-NADH
Figure 4.10. Changes in the quinone binding cavity. 
a. Cross sections through the quinone binding cavity in closed, open and NADH-open states colored by 
electrostatic potential reveal that opening and reduction result in large changes of the quinone binding 
cavity shape. In closed state UQ-10 is modelled (gray), based on decyl-ubiquinone binding and illustrating 
tight fit of the native substrate. b. Comparison of the densities near the entry into the quinone cavity in 
closed native complex (green) vs. open native complex (magenta) and closed NADH complex (green) vs. 
open NADH complex (blue). NADH open state has the strongest density, which was modelled as quinone.

















(green) vs. open native complex (magenta) and closed NADH complex (green) vs. open NADH complex (blue). 
NADH open state has the strongest density, which was modelled as quinone.  
Adapted from Kampjut & Sazanov, 2020.  
 
4.5.Rearrangements of the NADH binding site 
In all datasets containing NADH (NADH, turnover and rotenone) a clear NADH 
density was resolved in the same position near FMN as in T. thermophilus (Figure 4.12a) 
(Berrisford and Sazanov, 2009). As the NADH binding site is rather shallow and open to the 
solvent, no further changes were observed upon NADH binding. It was reported based on the 
NuoEF subcomplex crystal structures from Aquifex aeolicus that the peptide bond 51kDa/E99-
G100 flips away from FMN when the subcomplex is reduced by NADH, as a mechanism to 
prevent ROS production (Schulte et al., 2019). However, C=O bond is always facing away 
from FMN in ovine enzyme in all the datasets of sufficient resolution, whether the enzyme is 
reduced or oxidized (Figure 4.12b,c). This casts doubts over the proposed mechanism (Schulte 
et al., 2019) and the difference could be because of substitution of serine for glycine at position 
100 in ovine complex I or the effect of working with a subcomplex in A. aeolicus.  
 
 
Figure 4.12. NADH-induced changes in the NADH-binding pocket.  
a. NADH density in the 51 kDa subunit. NADH binds by forming -stacking interactions between the nicotinamide 
ring and the FMN as well as between the adenine and F73 and F206. b-c. The conformation of the backbone 
between residues 98 and 101 remains unchanged in all the models and backbone carboxyl of G99 (indicated) 
faces away from the FMN in all cases. Turnover PA focus-refined map (b) and deactive PA focus-refined map (c) 
are shown for comparison.  




















Figure 4.11. NADH-induced changes in the NADH-binding pocket. a. NADH density in the 51 kDa 
subu it. NADH binds by forming -stacking int r ctions between the ni otinamide ing and the FMN as 
well as b twe n the adenine and F73 and F206. b-c. The conformation of the back ne between residues 
98 and 101 remains unchanged in all the models and backbone carboxyl of G99 (indicated) faces away 
from the FMN in all cases. Turnover PA focus-refined map (b) and deactive PA focus-refined map (c) are 
shown for comparison.






4.6. Rotenone binding sites differ between open and closed complex I 
and include a unique site in the antiporter subunit. 
Structurally, inhibition of complex I is not well described and the traditional three 
classes of complex I inhibitors, A (competitive), B (non-competitive), and C (amilorides, 
biguanides, capsaicin), were predicted to have distinct binding sites (Degli Esposti, 1998; 
Murai and Miyoshi, 2016). In the Y. lipolytica complex I structure, a class A inhibitor DQA 
density was reported in the vicinity of the 49kDa/H59 homologue. Rotenone, one of the 
strongest known specific inhibitors of mammalian complex I (IC50 ~ 1nM) and an atypical class 
B inhibitor, was predicted to bind next to the ND1 loops by photoaffinity labelling studies 
(Earley and Ragan, 1984; Earley et al., 1987). Because rotenone is much bulkier than typical 
Q-like inhibitors (such as piericidin A), it was hypothesized that it cannot penetrate into the Q 
cavity of complex I and might instead block the cavity by binding outside (Haapanen and 
Sharma, 2018). Rotenone was also reported to have different Ki values for the active (1 nM) 
and deactive (80 nM) complex I and its tight binding to the active form partially prevents and 
reverses enzyme deactivation (Kotlyar and Vinogradov, 1990; Grivennikova et al., 1997).  
We observed rotenone density in the Qd site in all the conformational classes of the 
ovine complex I, coordinated by the key Y108 and H59, mimicking DQ and piericidin A 
binding in T. thermophilus (ROT1, Figure 4.13a,c) (Baradaran et al., 2013). Additionally, in 
the open classes rotenone was also found in the Qs site close to ND1/R25, exactly where a 
stable quinone binding site #4 has been proposed based on MD simulations (Haapanen, 
Djurabekova and Sharma, 2019) (ROT2, Figure 4.13a,d). Finally, in the open2 and 3 classes 
(84% of all particles) rotenone density was unexpectedly observed far away from the quinone 
cavity in the ND4 subunit. This binding site is created by tilting out of the TMH6 and is deep 
between TMH5-7, directly contacting the key K206 in the proton channel (ROT3, Figure 
4.13a,e,f).  
We cannot unambiguously assign the Ki values to the three binding sites. The ND4 
binding site could correspond to the lower affinity (80 nM) binding site reported for the 
deactive conformation (Grivennikova et al., 1997), which would also be consistent with 
changes observed in the deactive conformation that expose this rotenone binding pocket 
(Figure 4.13f). Binding in the ND4 site could also explain why rotenone has been observed to 
inhibit Na/H+ antiporter activity of deactive complex I (Roberts and Hirst, 2012). ND4-bound 
rotenone, curiously, did not influence the conformations of the proton pumping residues of the 
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ND4 subunit, despite being bound directly by the connecting lysine ND4/K206. It would be 
interesting to see if any other inhibitors bind in this region, particularly biguanides which have 
been shown to bind more strongly to the deactive form of complex I (Matsuzaki and 
Humphries, 2015). Existence of inhibitors specific for the antiporter-like subunits of complex 
I could also be a useful tool for the detailed studies of proton pumping. 
 
 
Figure 4.13. Rotenone inhibition of complex I.  
a. The most open classes of rotenone-inhibited and deactive complex I exhibit disorder in the ND5 horizontal and 
anchor helix as well as in the B14.7 subunit (colored). TMH4 of ND6, which undergoes rearrangements in 
deactive state is labelled in pink. The three rotenone binding sites are indicated as well; ROT2 binds to open 
classes only and ROT3 binds to open2 and open3 classes. b. PSST and 49 kDa loops do not change between open 
(cyan) and closed (green) rotenone states. Native open conformation is shown in grey. c. The deep rotenone 
binding site: rotenone is within hydrogen binding distance to H59 and Y108 and mimics the conformation of 
bound quinone during reduction from the N2 cluster. d. The shallow rotenone binding site: rotenone is stabilized 
by polar interactions with conserved arginines and stacking interactions with F224. e. ND4 rotenone binding site: 
rotenone is stabilized by positively charged residues, including proton-pumping K206, R142 and by stacking 
interactions with W216. f. To open the ND4 subunit binding site, the outer TMH6 needs to undergo a slight tilting 
and rearrangement observed in rotenone open2 and open3 classes (cyan), but also in the most open class of the 
deactive dataset (orange). Native structure is overlaid in green.  
Adapted from Kampjut & Sazanov, 2020.  
 
Rotenone binding did not change the diameter of the quinone cavity entry or induce 
massive rearrangements of the quinone cavity as proposed earlier (Haapanen and Sharma, 
2018). Bulky rotenone can thus fit, perhaps with local re-arrangements, through the narrow 
quinone cavity entry site. This casts doubt on the existence of an alternative access pathway to 




the largest one, investigated in these studies were significantly larger than rotenone and should 
therefore be able to fit through the quinone cavity opening (Uno et al., 2019, 2020). As noted 
above, in the open complex I binding of two rotenone molecules in the quinone cavity ordered 
the 49 kDa and PSST loops (Figure 4.13b) but not ND1 or ND3 loops, which suggests that 
ligand binding to the open complex I directly affects the conformations of the PSST and 49 
kDa loops, while the ordering of the ND3 and ND1 loops can only happen upon reduction or 
closing of the complex. Overall, rotenone appears to be unique among complex I inhibitors by 
having multiple binding sites, which may explain its extremely high affinity for the enzyme.  
 
4.7. Deactivation leads to tilting of the ND6 TMH4 helix, arresting the complex  
To better understand the structural rearrangements leading to complex I deactivation, 
we prepared deactive ovine complex I by incubation without substrates at an increased 
temperature as described previously (Figure 4.14) (Kotlyar and Vinogradov, 1990) and 
collected a cryo-EM dataset. The deactive ovine complex I sample did not contain any closed 
conformation but we could classify four different open classes, which were overall more open 
than the native open classes. They also had a large portion of the B14.7 subunit disordered and 
classes 3 and 4 also showed some disorder around the horizontal helix HL and its TM anchor, 
the N-terminus of the 49 kDa subunit and the TMH5 of ND4 (Figure 4.14a).  
The most striking feature of all our deactive classes, however, was the almost complete 
relocation (by tilting) of the ND6 TMH4 helix, accompanied by the insertion of the TMH3-4 
loop between the matrix and membrane arms, as well as unfolding of the 112-118 ND6 -sheet 
(Figure 4.14a). TMH3-4 loop gets disordered in the open state and TMH3 acquires a -bulge, 
which is likely the “waiting” state of the catalytic cycle when quinone cavity loops get partially 
and transiently disordered. During prolonged absence of turnover, unfolding proceeds to 
encompass wider regions of the complex further away from the quinone cavity and results in 
TMH4 tilt and a stable insertion of ND6 loop between the two arms, preventing any transition 
into closed conformation and thus deactivating the enzyme. Reversal of this process is 
consequently slow and requires multiple turnovers. The stable decoupling of matrix and 
membrane arms of complex I and perhaps also the rearrangements within the ND4 subunit are 
consistent with the observation that deactive bovine complex I is a sodium proton antiporter 
(Roberts and Hirst, 2012). 
Opening of complex I during deactivation was confirmed using the NEM assay, which 
is the standard biochemical assay for the deactive complex I and depends on testing the liability 
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of the ND3/C39 to alkylation (Galkin et al., 2008). However, while ND3 accessibility is a good 
proxy for the opening of complex I as it assays disorder of the ND3 loop, this assay cannot 
assess the conformational states of the other loops and we use it here strictly to assay 
“openness” of complex I. On the other hand, the other known signature A/D feature, the delay 
in reaching maximal activity upon NADH addition to pre-equilibrated lipid-protein-quinone 
mixture is indeed a clear indicator of the A/D state of the enzyme. While the deactivated 
enzyme has consistently shown a significant lag, our standard preparations did not show any 
delay (Figure 4.14b), confirming that in all our datasets (apart from deactive) the protein 
represents the active enzyme.  
According to the NEM assay the ND3 loop was disordered in virtually all the deactive 
particles and in ~80% of the native particles, consistent with the structural data (Figure 4.14c). 
Interestingly, activating isolated complex I with 5 M NADH (and 200 M DQ) did not result 
in a higher proportion of ND3 loop being ordered, also consistent with our structural data from 
the turnover sample. Since the reaction was allowed to proceed for 20 s before freezing the 
turnover sample, if activation or catalytic activity were involved in “closing” of the complex, 
significant difference from the native/NADH closed proportion would be observed. This again 
confirms that openness of complex I is not correlated with the deactive state, but is an intrinsic 
property of the sample, with open/closed ratio reflecting the thermodynamically more 
favorable open state co-existing with the less favorable, but accessible, closed state.  
Interestingly, when activating submitochondrial particles, we achieved 40% closed 
complex I upon activation. This indicates that the lipid membrane is probably necessary for 
closing of complex I (ordering of the 39 kDa amphipathic helix, lateral tension of the lipid 
bilayer on the ND1 subunit). If the proton pumping into the IMS happens in the closed step as 
predicted by our mechanism, closed state should be more populated after the establishment of 
a high proton motive force. 
Our observation of a very distinct deactive state structure is a definite proof that open 
state of complex I is a part of catalytic cycle and not a deactive form of the enzyme as proposed 






Figure 4.14. Deactivation of complex I.  
a. In deactive complex I ND6-TMH4 gets tilted towards the matrix-membrane arm interface and the TMH3-4 loop 
inserts between the two arms, stabilizing them in the open conformation. b. Deactive complex I shows a lag in 
reaching maximum activity. Reaction was started by the addition of NADH to complex I preincubated in lipid and 
DQ containing buffer. c. Complex I within SMPs is ~20% closed, which increases to ~40% closed upon activation 
with 5 μM NADH and 200 μM DQ (ASMP), while deactivation of SMPs (DSMP) decreases it to ~0%. d. Activation 
of purified complex I (ACxI) does not change closed/open ratio. 30 min incubation with 5 mM NADH as in the 
NADH dataset does not inhibit complex I (CxI+NADH).  
Adapted from Kampjut & Sazanov, 2020.  
 
4.8. Under turnover conditions quinone binds both in the deep and 
shallow sites 
Finally, we collected a dataset of complex I incubated with NADH and decylubiquinone 
and flash-frozen before the substrates were exhausted. Under such active turnover conditions, 
one may expect to identify quinone binding modes and perhaps any conformational changes 
associated with the catalytic cycle, including those in the proton channels, provided that any 
relevant conformations can be separated by classification and that the enzyme explores the 
entire conformational space in the absence of membrane and proton-motive force (pmf). Such 






















































































































































Figure 4.13. Deactivation of complex I. a. In deactive complex I ND6-TMH4 gets tilted towards the 
matrix-membrane arm interface and the TMH3-4 loop inserts between the two arms, stabilizing them in 
the open conformation. b. Deactive complex I shows a lag in reaching maximum activity. Reaction was 
started by the addition of NADH to complex I preincubated in lipid and DQ containing buffer. c. Complex 
I within SMPs is ~20% closed, which increases to ~40% closed upon activation with 5 µM NADH and 
200 µM DQ (ASMP), while deactivation of SMPs (DSMP) decreases it to ~0%. d. Activation of purified 
complex I (ACxI) does not cha ge closed/open ratio. 30 min incubation with 5 mM NADH as in the 
ADH dataset does not inh bit complex I (CxI+NADH).
dapted from Kampjut & S zanov, 20.
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structure, albeit at a medium resolution (4.5 Å) which prevented mechanistic insights (Parey et 
al., 2018).  
This approach depends on the assumption that substrate availability during blotting 
remains the same and that the sample is well mixed and that there is no partitioning of 
substrates. To circumvent these problems, we included relatively high concentrations of 
surfactants and substrates, such that not more than 10% of them would be consumed in the time 
between setting up the reaction and grid freezing. Furthermore, it assumes that there is no 
preferential binding of some intermediates to carbon or air-water interface and that it is possible 
to precisely classify rare conformations from the dataset. The fact that rare conformations can 
be classified has been demonstrated before and in the datasets presented here.  
The ratios between closed and open classes remained unchanged in the turnover dataset. 
Both open and closed classes of this dataset contained a clear density for bound NADH, 
showing that this is the most populated state of the NADH-binding site during turnover, even 
though Fe-S clusters and FMN are likely to be mostly reduced since quinol release is a limiting 
step during complex I turnover (Vinogradov and Grivennikova, 2001; Wikström, Sharma, Ville 
R I Kaila, et al., 2015).  
Closed complex I contained two bound quinones. Quinone in the deep binding pocket 
(Qd) was bound between H59 and Y108, exactly where rotenone was observed to bind (Figure 
4.15a). We also observed a strong density near the entry to the quinone binding cavity, 
overlapping with the second rotenone binding site and site #4 predicted by MD, which we 
modelled as another molecule of decylubiquinone (Figure 4.15a,c). Residues 49 kDa/D160 and 
H59, which coordinate quinone in the Qd site had a continuous density between them, 
indicating the existence of a salt bridge, probably as a result of proton donation to quinone 
(Figure 4.16a). This density was not present in any of the other conditions (Figure 4.16b,c) and 
D160 density was weak as is usual for unbound carboxylates in cryo-EM (Wang, 2017). 
Therefore, it is likely that H59 first donates a proton to reduce quinone and then accepts a 
proton from D160, so that negative charge resides on D160 and the salt bridge is formed. This 
is the first experimental demonstration that H59/D160 pair act as a proton donor for the 
quinone. It also indicates that the species bound in the Qd site in the turnover dataset is quinol 






Figure 4.15. Quinone density is observed at different binding sites in open and closed complex I during 
turnover.  
a. In closed complex I, one quinone molecule is bound in the deep pocket between Y108 and H59 and another in 
the shallow pocket close to ND1/R25. b. In open complex I, a single quinone is bound at the entry to the quinone 
binding cavity close to F224. c. Comparison of binding positions of quinone and rotenone in different classes.  
Adapted from Kampjut & Sazanov, 2020.  
 
In the open turnover classes a quinone density was present only in the shallow pocket 
(Qs) but it was located further outwards compared to the closed class and was overlapping with 
the site #5 predicted by MD (Figure 4.15b,c). The mobile loops of the quinone binding cavity 
were disordered to approximately the same extent as in the native open classes and we did not 
see any density that could correspond to quinone in the deep binding pocket. This suggests that 
opening of the complex I affects quinone binding and dynamics in the cavity and could 
facilitate quinol ejection or quinone uptake by the complex. Presence of two molecules of 
quinone in the closed class is probably an artefact of using a soluble decylubiquinone analogue 
of ubiquinone with a short carbon tail. If native ubiquinone-10 were bound in Qd, its isoprenoid 
tail would clearly prevent quinone binding in Qs (Figure 4.11). Nevertheless, it gives the 









































igure 4.14. Qui one density is obs rved at differe t binding sites i  open an  losed complex I 
during turnover. 
a. In closed complex I, one quinone molecule is bound in the deep pocket between Y108 and H59 and 
another in the shallow pocket close to ND1/R25. b. In open complex I, a single quinone is bound at the 
entry to the quinone binding cavity close to F224. c. Comparison of binding positions of quinone and 
rotenone in different classes.
Adapted from Kampjut & Sazanov, 2020.
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closed classes (Figure 4.15c). None of the classes contained a quinone bound in the position 
#2 as observed in Y. lipolytica, or in position #3, as predicted by MD, presumably because 
these states are much more shortly lived than the others or are species-specific (Parey et al., 
2018; Haapanen, Djurabekova and Sharma, 2019).  
 
 
Figure 4.16. Protons for quinone protonation are donated from the H59-D160 pair. 
a. Detailed view on the binding of quinone next to the N2 cluster and the density showing the salt bridge between 
H59 and E160. b-c. D160 displays weak density and no connection to H59 in all of the classes apart from closed 
turnover class. NADH closed class (b) and rotenone open2 class (c) densities are shown for comparison. d. 
Several water molecules are bound near the deep quinone binding site in the open state.  
Adapted from Kampjut & Sazanov, 2020.  
 
 
4.9. The role of water molecules in electron transfer and quinone 
protonation 
Abundant water molecules that we observed in the cryoEM density of the peripheral 
arm of complex I were mostly consistent across the different conditions; hence they are likely 
to represent tightly bound stationary molecules (Figure 4.17a). Several of them are close to the 
iron-sulfur clusters, but none lie directly between them, hence it is not likely that they 
participate in electron tunneling as proposed before from simulations (Hayashi and 


















Figure 4.15. Protons for quinone protonation are donated from the H59-D160 pair. 
a. Detailed view on the binding of quinone next to the N2 cluster and the density showing the salt bridge 
between H59 and E160. b-c. D160 displays weak density and no connection to H59 in all of the classes 
apart from closed turnover class. NADH closed class (b) and rotenone open2 class (c) densities are shown 
for comparison. d. Several water molecules are bound near the deep quinone binding site in the open state.








hydrogen bonding distance, which may help to elevate its redox potential (Figure 4.17b). We 
also observed several water molecules near the deep quinone binding site and the Y108-H59-
D160 triad in the rotenone open structure, which suggests that in the open state waters can enter 
this area (Figure 4.16d).  
 
Figure 4.17. Water molecules in the peripheral arm.  
a. Peripheral arm, with water molecules within 10 Å of FeS clusters shown as red sphere with corresponding 
density, with other identified waters in the background. Two water molecules within hydrogen bonding distance 
to N2 and two molecules between N3 and N4 clusters (i.e. not in a direct N3-N1b-N4 path) are indicated with 
arrows. b. Detailed view of waters bound next to N2 cluster.  
Adapted from Kampjut & Sazanov, 2020. 
 
 
4.10. The role of water molecules in proton pumping 
The membrane domain overall was less hydrated than the peripheral arm, with a clear 
pattern of hydrated matrix and IMS surfaces and abundantly hydrated central hydrophilic axis 
with relatively dry regions in between (Figure 4.18a). The structures and hydration patterns of 
the membrane arm of complex I allowed us to experimentally define the proton transfer 
pathways within complex I for the first time (Figure 4.18a).  The total number of identified 












Figure 4.16. a. Peripheral arm, with water molecules within 10 Å of FeS clusters shown as red sphere 
with corresponding density, with other identified waters in the background. Two water molecules within 
hydrogen bonding distance to N2 and two molecules between N3 and N4 clusters (i.e. not in a direct N3-
N1b-N4 path) are indicated with arrows. b. Detailed view of waters bound next to N2 cluster.
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of distribution of waters did not change in the closed state with one notable exception. All the 
key protonatable residues along the entire hydrophilic axis from the ND5 tip to the Q cavity 
are clearly interconnected via many water molecules, with the exception of a long break in the 
E channel between ND4L/E34 and ND3/D66 in the open state (Figure 4.18a, green arrow). 
This is caused by the ND6 TMH3 -bulge with bulky hydrophobic residues such as F68 and 
M64 blocking the path. Strikingly, when TMH3 rotates and the -bulge disappears in the closed 
state, these residues are rotated away and are replaced by the conserved glycines 62-63, creating 
a water-filled cavity between ND3/D66 and ND4L/E34. This allows for water chain to extend 
from ND1 all the way to ND2 only in the closed state (Figure 4.18b,c). TMH3 of ND6 is the 
most conserved TM helix in complex I membrane domain, and even conservative mutations in 
the -bulge area are highly detrimental to activity (Efremov and Sazanov, 2011), indicating 
that identified here breaking and reforming of the water wire is probably essential for the 
mechanism. Furthermore, three critical glutamates of the E channel, ND1/E143, ND4L/E34 
and E70 change their conformations and become charged in the closed complex I as suggested 
by their density appearance and pattern of hydrogen bond interactions (Figure 4.20). In 
particular, ND4L/E34 rotates away from ND4L/E70 as they became charged and surrounded 
by waters. Apart from these most critical changes, many more side-chain and backbone re-
arrangements occur in this area upon transition from open to closed state, as shifts of ND1 






Figure 4.18. Water molecules delineate proton pathways in the membrane arm of complex I. 
a. Central hydrophilic axis connects the three antiporters in the open state of complex I. Both N- and C- terminal 
Lys/Glu are abundantly hydrated. Water wires towards IMS and matrix side are visible only in ND5. E-channel 
has a dry region between D66 and E34 and no connection to IMS or matrix side. It is connected to the quinone 
binding cavity only in the closed state (green arrow), allowing for protons from E34 and E70 to be delivered to 
Q-site (red arrow). b. Top view of the E-channel in open state of complex I shows that the E-channel dry region 
is caused by the ND6 π-bulge formation and E34 rotation. c. Continuous water wire in the E-channel of the closed 
state of complex I.  
Adapted from Kampjut & Sazanov, 2020.  
 
 
In contrast to the E-channel, antiporters did not change significantly the conformation 
between closed and open states or between open structures of the rotenone, NADH, turnover 
and deactive datasets. Analysis of the proton transfer pathways connecting all the protonatable 
residues (Lys, Glu, His, Asp, Tyr, Ser, Thr) and waters within hydrogen bonding distances 
(proton hopping via Grotthuss mechanism, with bond slack up to ~4 Å) suggested that E-
channel and ND2 and ND4 antiporters lack any connection to the IMS site (Figure 4.18). These 
parts of the structure are particularly dry and hydrophobic and it is hard to imagine 
conformational changes which might bring about connections there (some water molecules 
visible in these areas in Figure 4.18 are actually far away from the key residues). Any clear 
connections are also lacking on the matrix site, but in principle relatively minor conformational 
changes there may bring in extra waters allowing connections from this side (dashed H+ input 





Figure 4.19. Comparison of antiporters in open and closed complex I during turnover.  
a. Central hydrophilic axis in the open MD class. b. Central hydrophilic axis in the closed MD class. Due to lower 
resolution fewer waters could be modelled but the overall hydration pattern remains the same.  
Adapted from Kampjut & Sazanov, 2020.  
 
Notably, the distal antiporter ND5 is radically different – K392 from the C-terminal 
half-channel is clearly connected to the IMS via the conserved D393 and many waters around.  
Connection to the matrix side via TM8 H248 also appears to exist with only small barriers, 
which may be important to prevent back-leak of protons. The only other clear link to the matrix 
side is via a water wire leading to the quinone cavity in the closed state, suggesting that protons 
could flow directly from ND1 and the quinone cavity (Figure 4.18). Since this path from 
ND4L/E34 and E70 towards Q-cavity is isolated from the bulk solvent, it is likely that these 
residues are de-protonated in the closed state because they donate two protons for the re-
protonation of Q-coordinating residues Y108/H59/D160. That way “charge action” of redox 
reaction is brought in from the Q-site all the way to the first antiporter ND2, revealing a key 
missing piece in the mechanistic puzzle.  
 
4.11. The role of charge interactions in proton pumping 
Even though we did not observe significant conformational changes in the antiporters, 
a clear pattern of changes in charge distribution of key residues was revealed by the analysis 
of the cryoEM density. As noted before, charged carboxylates lose side-chain density (except 
when involved in salt bridges) and additionally, strong hydrogen bonds formed by lysines or 




































Figure 4.18. Comparison of antiporters in open and closed complex I during tunrover. 
a. Central hydrophilic axis in the open MD class. b. Central hydrophilic axis in the closed MD class. Due 
to lower resolution fewer waters could be modelled but the overall hydration pattern remains the same.




and closed state MD maps revealed the clearest change in the ND4 antiporter – E123-K206 
pair from the N-terminal half-channel has both residues neutral in the open state and both 
charged in the closed state (Figure 4.20c), while E378 from the C-terminal half-channel 
changes from charged in open to neutral in closed (Figure 4.20b). For some of the key residues, 
especially connecting lysines, it was difficult to assign a particular state, however, it was clear 
that N-terminal Glu-Lys pairs change in anti-phase (ND4 vs ND2/ND5) and the overall likely 
distribution is as depicted in Figure 4.21.  
 
 
Figure 4.20. Comparison of density and hydrogen bonding patters of key proton-pumping residues between 
open and closed complex I during turnover.  
Breaking of several hydrogen bonds and salt bridges (circled) and changes in glutamate carboxyl densities 
between open and closed MD. This indicates charge differences between these residues. a. N-terminal lysine of 
ND5. b. C-terminal glutamate of ND4. c. N-terminal lysine of ND4. d. Glutamates of ND4L.  
Adapted from Kampjut & Sazanov, 2020.  
 
The dramatic difference in hydration between ND5 and other antiporters prompted us 
to re-evaluate a traditional view on proton pumping in complex I, as proposed by us originally 
(Efremov and Sazanov, 2011; Baradaran et al., 2013), where each antiporter is thought to pump 
one proton each. Very high proton transfer connectivity along the entire central axis all the way 
to the exit from ND5 towards IMS, coupled with the absence of IMS connectivity in other 
antiporters, suggests an alternative possibility. It is feasible that all four pumped protons are 
ejected via ND5, transported there along the central axis (ND5-all model). Consistently, apart 
from the key half-channel residues, each antiporter contains additional conserved histidines 
between the connecting and terminal key residue – H186 in ND2, H293 and H319 in ND4, and 
H328, H332 and H248 (or K336) in ND5. These increasing amounts of histidines may serve 
as temporary storage of protons before they can be ejected from ND5 or transferred towards 
ND5. That way accumulating increasing additional positive change in the C-terminal half-
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channel (+2 in ND2, +3 in ND4) may drive ND5 in a mode akin to electrostatic wave model 
(Verkhovskaya and Bloch, 2013). Mutations of these histidines usually do not lead to dramatic 
results (Efremov and Sazanov, 2011), however, this is not unexpected as the only effect may 
be a drop in proton pumping efficiency. Such mutations need to be investigated in more detail 
in the future and may help to distinguish between ND5-all or one antiporter-one proton models, 
both of which appear feasible now.      
Overall, the fact that under turnover conditions we do not see conformational changes 
in the antiporters but see instead a change in charge distribution in key residues would argue 
in support of a electrostatic wave type of the mechanism rather than conformational coupling 
(Baradaran et al., 2013). However, the mechanism which we propose on the basis of our 
findings is radically different from the previous electrostatic wave model (Verkhovskaya and 
Bloch, 2013) because the electric “pulse” in our model originates from proton transfer from the 
E channel towards quinone as described above. Additionally, conformational coupling clearly 
plays a key role in the E-channel re-arrangements leading to this proton transfer, so our new 
model is of mixed type – conformational coupling in the E channel and electrostatic in the 
antiporters. We do not fully exclude yet a role for conformational coupling in antiporters, as it 
is possible that full conformational change can be achieved only in the lipid bilayer or in the 
presence of the proton motive force. Furthermore, conformational changes within antiporters 
could be temporary and high-energy and correspond to a transition state accessible only when 
the ND6 -bulge is being formed (Zhang and Li, 2019).  
 
Table 4.3. Charge distribution in membrane arm of closed and open complex I during turnover. 
Densities of the key residues, as well as their hydrogen bonds, salt bridges and the number of coordinated waters 
were compared between the two states. Legend of symbols: Lys: + protonated, 0 neutral. Glu: 0 neutral, - 
deprotonated. SB: salt bridge density. HB: hydrogen bond density. SC: side chain. Bb: backbone. Empty cell – no 
clear information. 
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4.12.1. Deactivation mechanism 
Here we described high-resolution structures of complex I in a wide variety of 
conformations which we used to propose a detailed coupling mechanism for complex I. We 
showed that the open complex I is a quinone-binding, i.e. “waiting”, intermediate, which 
clarifies why ovine preparation, which exists mostly in the open conformation had high activity 
and showed no lag in reaching it, indicating that it was in the active state (Figure 4.14) (Letts 
et al., 2016). Open complex I is thermodynamically more stable hence preparations of complex 
I which take longer to isolate, involve elevated temperature or employ specific detergents 
contain more open complex I (Fiedorczuk et al., 2016; Letts, Fiedorczuk and Sazanov, 2016; 
Agip et al., 2018; Blaza, Vinothkumar and Hirst, 2018). In the absence of substrates, the open 
waiting state can revert into the fully deactive form by ND6-TMH4 tilting and ND6 loop 
insertion into the PA-MD interface (Figure 4.14). The high kinetic barrier of active-to-deactive 
transition in mammals is thus explained by the large-scale reorganization of ND6. This is 
consistent with previous mouse and bovine “deactive” conformations which showed an 
extremely weak ND6 TMH4 density, indicating that they were partly, but not fully deactivated 
(or the fully deactive state class was not separated in 3D classification). They are also consistent 
with Y. lipolytica structures in which ND6 TMH4 is much less likely to shift due to its close 
association with ND5 and NUJM (homologue of B14.7) subunits. Hence, Y. lipolytica complex 
I quasi-deactive state is actually a waiting open state, in which the ND3 loop is disordered and 
so is susceptible to alkylation, but the enzyme reverts into the processive state without lag. 
When NADH or quinone is present, ND6 reorganization in mammals is prevented by 
reordering of ND1 and 49 kDa loops, which interfere with inserted ND6 loop.  
 
4.12.2. Quinone reduction mechanism 
We showed that coordinated conformational changes in the ND1, ND3, ND6, PSST 
and 49 kDa loops, which are initiated by opening/closing and substrate binding are critical for 
catalysis. PSST and 49 kDa loops need to be ordered in the retracted state to enable quinone 
reduction as observed in the turnover closed class. Our rotenone structures showed that binding 
of a ligand in the deep site is enough to reorder 49 kDa and PSST loops into this retracted 
conformation even when overall complex I is “open”. When quinone is bound, closing could 
complete fully and involve ND1 and ND3 loops as well (this is supported by the turnover 
closed class structure, although the enzyme is reduced in this case). The ND1 loop appears to 
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be a critical coupling element as NADH induces large conformational changes in the ND1 loop, 
but only when complex I is in the open state. This is consistent with maintaining the correct 
stoichiometry of the reaction and with the various decoupling mutations (V208L, G214K and 
Y215H) observed in the ND1 loop (Kirby et al., 2004; Wray et al., 2013). Finally, these 
changes combined influence the ND3 loop conformation because unfolding or reorganization 
of the ND1/49 kDa loops clashes with the ordered and inserted ND3 loop (NADH open 
classes). ND1 and ND3 loops play a structural role in the MD-PA interface and they likely 
influence the open/closed transition of the complex along with the large tilts of TM helices in 
ND1, coupling the changes within the quinone cavity to the rest of the enzyme and to the 
membrane arm. Changes during opening would concomitantly drive quinol ejection as the 
quinone binding cavity expands at first (any open state in our structures) and then shrinks as 
the distal part is closed off (NADH open state). 
 
4.12.3. Proton pumping mechanism 
Rearrangements in ND1 and ND3 and opening of the whole complex likely lead to the 
disordering of the ND6 loop and importantly, the formation of the -bulge in the ND6 TMH3. 
-bulge acts as a gatekeeper in the E channel: in the closed state it allows a water wire to extend 
all the way from Q site to ND2, while in the open state this connection is broken. Its formation 
also allows deprotonation of critical glutamates in the E channel, ND4L/E34 and E70, as well 
as ND1/E192. They likely serve as proton donors to quinone (or rather to its coordinating 
residues). This would give a direct electrostatic pulse from quinone to antiporters, since 
quinone would take its protons from ND4L, in the vicinity of ND2. Such a “relocation” of 
charge immediately explains how redox reaction initiates proton translocation.  
Analysis of water networks and electron densities in our high-resolution structures 
allowed us to suggest a novel model for proton translocation in complex I depicted in Figure 
4.21. The switch in the orientation/openness of the proton channels is likely associated with 
the global change in the structure, i.e. between open and closed states. Since the open state is 
clearly energetically more favorable, it is likely that in this relaxed state the channels are open 
to the matrix side, so that protein can re-protonate the central axis from the matrix. It is also 
likely that the energized closed state is associated with proton expulsion into the IMS through 
the dry MD side and against the proton motive force (Sazanov, 2015). Since there are no 
obvious links to the matrix side in antiporters other than ND5, it is not clear if all of the possible 




since the protein needs a large area to gather a few available protons at the high pH of the 
matrix. The links to IMS, apart from ND5, are much less clear which leads to our suggestion 
that all four protons may be pumped out via ND5 (thus IMS outputs from other antiporters are 
dashed).  
 
Figure 4.21. The proposed proton pumping mechanism.  
Charge distribution of the proton pumping residues differs between the open and the closed states. Coloured 
circles correspond to glutamate/aspartate (red), lysine (blue) or histidine (cyan) and are shown in the same 
orientation as in Figure 1c. Full circles represent charged residues and empty circles are neutral (state of 
histidines is not clear). Arrows show proton movements to achieve the charge distribution as depicted in each 
state. 
Adapted from Kampjut & Sazanov, 2020  
 
Analysis of the putative charges of key residues based on cryoEM density of open and 
closed turnover states (Table 4.3) suggests an asymmetric distribution of charges between the 
antiporters, with ND4 being out of sync with ND2 and ND5 (Figure 4.21). In the open state in 
ND4 the N-terminal Glu-Lys pair is neutral, while in ND2 and ND5 this pair is charged. In the 
closed state the situation is completely reversed. Consistently, the C-terminal Lys residues in 
ND2 and ND5 appear not to be protonated in the open state, while the C-terminal Glu in ND4 
is protonated. Again, the situation is reverse in the closed state. The state of connecting lysines 
171 
 
is not clear from the density but in the open state they are likely to be protonated from the 
matrix as noted above. Therefore, it is likely that they donate their protons to protonate the C-
terminal Lys/Glu residue in the closed state. One exception is out-of-phase ND4, as it would 
have to be protonated in the closed state, accordingly with the state of other key residues. It is 
likely that the exchange of TM12 lysine for glutamate is a primary driver allowing for such an 
out-of-phase operation. In the case if all antiporters worked in sync, an undesirable excessive 
accumulation of charges and electrostatic imbalance around the central axis might have 
occurred, which is prevented by this adaptation. The charge is not clear for all of the key 
residues from the density itself, however, the distribution in Figure 4.21 is the most consistent 
with the available observations while ensuring that the overall charge within each subunit and 
the overall nature of interactions is conserved as described below. 
In detail, the pumping cycle starts in the closed state with conformational changes in 
the ND1 area initiated by quinone binding and reduction. This leads to ND6 TMH3 rotation, 
freeing up a water-filled cavity linking the Q cavity to ND4L/E34 and E70. These residues 
donate two protons for re-protonation of D160/H59/Y108, coordinating the quinol. This creates 
a strong negative charge in ND4L, which is compensated by the nearby ND2/E34 taking up 
the proton from its partner K105 (Figure 4.18). These N-terminal Glu-Lys pairs do not form a 
salt bridge in any antiporter in any of the conditions that we observed (as they are slightly too 
far away from each other), but instead acquire more waters around them when charged. The 
absence of positive charge on K105 removes the electrostatic barrier and allows the nearby 
connecting K135 to lose its proton to the C-terminal K263. This positive charge is compensated 
by the nearby ND4/E123 donating its proton to its partner K206. Connecting ND4/K237 is 
protonated from the matrix, but the positive charge on K206 prevents the movement of its 
proton further on to the C-terminal E378. This glutamate loses its proton to the IMS due to 
electrostatic interactions with charged K237 and K206. ND4/E378 is involved in a charged 
network with the nearby ND5/R176-D179 and E145-K223 pairs. It is not clear whether R176-
D179 pair change their charge state, but negative charge on ND4/E378 would be compensated 
by ND5/E145 taking up the proton from its partner K223, similarly to the situation on 
ND4L/ND2 interface. As in ND2, the absence of positive charge on K223 removes the 
electrostatic barrier and allows the nearby connecting H248 (or K336) to lose a proton to the 
C-terminal K392, completing a transition from open to closed state charge distribution. 
As complex I opens after quinol is ejected into the lipid bilayer, protons residing on the 
C-terminal residues must be ejected into the IMS (except for ND4). In our scenario the N-




from the connecting to the C-terminal residue. As the enzyme reverts to the open state, 
ND4L/E34 and E70 will be re-protonated, most likely via ND2 as the water wire to the Q site 
will be broken. At this stage one proton is likely to be ejected from the E channel into IMS, 
although the exact pathway is not yet clear. Arrival of protons to E34/E70 will cause the nearby 
ND2/E34 to donate its proton to ND2/K105. As the connecting K135 is protonated from the 
matrix in the open state, the resulting positive charge will help to drive the proton from the C-
terminal lysine ND2/K263 out. However, K263 is not re-protonated again by K135 due to the 
electrostatic barrier from K105. As the positive charge on K263 is lost, its neighbor ND4/E123 
acquires the proton back from K206. Loss of charge on ND4/K206 allows the connecting K237 
to lose its proton to E378. As ND4/ E378 acquires a proton, the nearby ND5/E145 will lose its 
proton to ND5/K223 due to electrostatic interactions. As the connecting ND5/ H248 (or K336) 
is protonated from the matrix, double positive charge on K223 and H248 (or K336) will drive 
K392 proton out, re-setting the system to the open state in Figure 4.21. It should be noted that 
in this scenario simple electrostatic interactions are sufficient to drive proton translocation in a 
consistent manner across each antiporter, a feature which is allowed by the out-of-sync 
operation of ND4. 
As noted above, the exact output pathways into the IMS are not yet clear. Either all four 
protons hop over to ND5 via the abundant central axis links using connecting histidines (cyan 
in Figure 4.21) as a temporary storage (ND5-all path) or they are ejected one by one by each 
antiporter individually. In the ND5-all option, an accumulating positive charge on histidines 
(from +1 in E-channel, +2 in ND2 with one His and +3 on ND4 with two His) might in principle 
provide the necessary driving force to eject four protons from ND5 in one go. However, such 
accumulation might cause significant electrostatic imbalance in MD, so the other possibility 
would be for ND5 to eject protons one by one in quick succession as they arrive, with histidines 
serving as a back-up in case of bottlenecks. Strongly in favor of the ND5-all option is an 
extreme difference in the IMS-side hydration between ND5 and other antiporters, revealed in 
this work. An additional argument is that the ND5 subunit, despite being distal, is clearly the 
most conserved of antiporters. On the other hand, one proton per antiporter option is easier to 
envisage considering the internal symmetry of antiporters and the electrostatic considerations 
such as above. Nevertheless, our mechanism outlined above is applicable in both modes of 
pumping, as the only difference in the case of the ND5-all model would be a re-distribution of 
protons towards the ND5 subunit (instead of directly into IMS) via many waters and charged 
residues, including histidines, which link the antiporters in the central axis.      
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The absence of any conformational changes in the antiporters in turnover conditions 
argues against a major role of conformational changes in proton transport, the model which we 
(and others) advocated previously (Baradaran et al., 2013). Although we cannot exclude that 
such changes might be revealed by studies in liposomes under pmf, the described change in 
charge distribution allowed us to propose a model which is supported by our new data, is 
consistent with available mutagenesis data and is fully sufficient to explain the previously 
enigmatic mechanism of proton pumping.  
Ultimately, all of these changes are initiated by the reduction of quinone in Qd site, as 
experimentally shown here for the first time, which results in temporary negative charge on 
D160/H59/Y108 and is transmitted via charged residues into the ND1 loop and the E-channel 
(Figure 4.15-4.16). The release of redox energy by quinone movements between Qd and Qs 
sites can be quantified in the framework of the low-potential site Qd and high-potential Qs site 
as proposed earlier (Wikström, Sharma, Ville R I Kaila, et al., 2015). 
 
4.12.4. Entire catalytic cycle 
On the basis of the above model of proton pumping and the various, many of them 
novel, conformations of complex I observed here, we propose a first detailed model of the 
entire catalytic cycle (Figure 4.22). Since the electron transfer rates are fast and the overall 
reaction is limited by quinone binding/quinol release (Vinogradov and Grivennikova, 2001), 
we assume that in most steps the enzyme will be kept reduced. The enzyme cycles between the 
open and the closed conformations, with most steps in the open state, consistent with its 
prevalence in the data. The catalytic cycle of complex I begins with quinone binding into the 
cavity of the open enzyme (state 1, represented in our study by open native classes). Quinone 
binding will promote the transition into the closed conformation in which the ND1 and 49 kDa 
loops reorder into the “down” and “retracted” conformations and quinone moves into the deep 
site, where it will get reduced (state 2, closed turnover class). This can only take place when 
the complex is in the closed conformation and the 49 kDa loop is retracted. Quinone reduction 
and protonation leads to the accumulation of negative charges on the proton donors, Y108 and 
D160/H59 pair. The overall result of these redox reactions is a conformational and electrostatic 
signal towards the E-channel and further on to the antiporters, leading to the ejection of protons 
into the intermembrane space as described above. This signal is mediated, at least in part, by 
the ND6 TMH3 rotation and the release of the -bulge and constitutes the arrival of double 




Subsequent diffusion of quinol out of the deep site towards the shallow site causes disordering 
of the 49 kDa, ND1 and ND3 loops as well as re-formation of the -bulge in the ND6 subunit 
and the opening of the entire complex (state 3, open turnover classes). At this stage complex I 
gets fully reduced again and the 49 kDa loop gets extended and the ND1 loop flips upwards as 
observed in the NADH structures (State 4, open NADH classes). This helps to eject the quinol 
from the shallow binding site. The re-protonation of the key central axis residues from the 
matrix side can possibly be happening at States 3, 4 or 1, but we depicted it at State 4 as it is 
probably the most long-lived state (enzyme waiting for quinone availability). Complex I is thus 
reset into the “open waiting state” in which it can bind quinone again and restart the catalytic 
cycle (state 1, native open state). If there is no quinone or NADH present, however, this state 
will slowly convert into the deactive state in which the ND6 TMH4 tilt and loop insertion 
between the PA and MD stabilizes the open conformation (state 5, deactive open classes).  
This model explains the directionality and tight coupling of the reaction, as (1) NADH-
induced changes in the quinone cavity can only happen in the open conformation of the 
complex, (2) reduction of quinone happens only in the closed state and (3) proton pumping is 
induced during the transition between the two states. The key novel features of our mechanism 
are: firstly, the delivery of negative charge from the redox reaction site towards antiporters via 
concerted conformational changes propagating from the Q site towards the E channel; 
secondly, the description of how this negative charge drives the proton pumping in the 
antiporters via electrostatic wave propagation; and, thirdly, the optional, but probable, 
alternative pathway of proton ejection into IMS only via the ND5 subunit. Thus, our 
model, based on a wide range of experiments, represents a novel and rather unexpected 
combination of some features from previously discussed conformational coupling and 
electrostatic wave-type mechanisms. A consistent mechanistic picture emerges also from our 
X-ray, cryo-EM and MD studies on the bacterial enzyme (manuscript submitted). What 
remains to be done in future studies is the elucidation of the fine details of proton translocation 
processes, potentially by trapping complex I in a transition state, time-resolved studies or 






Figure 4.22. Full catalytic cycle of complex I.  
Schematic representation of the main catalytic steps in complex I shows how reduction of quinone and its diffusion 
in and out of the cavity are coupled to loop movements, opening of the complex and pumping of protons. 
Deactivation pathway branches off from the main catalytic cycle at the quinone binding step when complex I is 
incubated in the absence of substrates for an extended period of time.  









5.1.1. Theoretical considerations 
Transhydrogenase is a proton-pumping enzyme that operates by an entirely unique 
mechanism. This is unsurprising because it needs to solve a fundamental biophysical problem 
associated with its reaction: the midpoint electric potentials of the substrate and product redox 
pair is the same. The transhydrogenation reaction is fully reversible and depends only on the 
chemical potentials of substrates and products. Under the usual physiological conditions 
transhydrogenase produces NADPH and NAD+ and consumes the pmf. However, bacterial 
cytosol or mitochondrial matrix usually contain much lower concentrations of 
transhydrogenase substrates (NADH and NADP+) than its products (NAD+ and NADPH). To 
ensure fast kinetics, Kd for the substrates (NADH and NADP+) therefore needs to be much 
lower than for the products (NAD+ and NADPH).  
This presents a paradox as it seemingly violates the Sabatier principle. This states that 
the binding of substrates and products to the catalyst needs to be neither too strong nor too 
weak. If it is too weak, the substrates fail to associate with the enzyme, while if it is too strong, 
the products fail to dissociate. For biological enzymes it has been shown that binding is in fact 
the strongest to the transition state, which explains why enzymes speed up reactions (Dill and 
Bromberg, 2010).  
In transhydrogenase, substrate binding must be fairly strong to scavenge the few 
molecules of NADP+ from the mitochondrial matrix. This is indeed the case for NNT, as Kd 
for NADP(H) of isolated dIII is in the nanomolar range (Prasad et al., 1999). It is therefore 
envisaged that the relative binding affinities for nucleotides change during catalysis and are 
driven by proton motive force-induced conformational changes (“binding-change” 
mechanism) (Jackson, 2012). NADP+ binds mainly via its adenine, phosphate and ribose 
moieties, the nicotinamide remains free for reaction during the hydride transfer step. This is 
obvious from the structures of dI2dIII, which show that surface-exposed nicotinamides from 
dI and dIII are brought close together during the hydride transfer step. Substrate binding 
therefore does not need to massively destabilized to ensure sufficient population of the 
transition state. However, during the nucleotide exchange process, NADPH binding must be 
strongly destabilised to ensure exchange for NADP+. The destabilisation is achieved by Kd 
lowering by “opening” of the dIII domain by its interaction with dII.  
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To ensure that the products do not dissociate before the proton transfer step is complete, 
the nucleotide exchange process is coupled to proton transfer. dIII can only dissociate after 
nucleotide has been exchanged and after H664 became protonated. This ensures that there is 
no “slipping”, as decoupling of these two processing would lead either to a futile cycle between 
NADH and NADPH or disruption of the proton motive force. 
The mechanism for transhydrogenase proposed in this thesis is consistent with and 
stems from these theoretical considerations and the structures presented explain the functioning 
of these principles in practice. Pmf (by affecting the protonation state of H664) indeed 
destabilises products after the hydride and proton transfer steps are complete. Product 
dissociation before the proton transfer step is complete is prevented by the occlusion of dIII 
when in the dissociated form and opening of the NADP(H) binding pocket after dIII binds to 
dII and proton translocation is complete.  
Out-of-phase functioning and hydride transfer have been described in earlier work and 
are fully consistent with the data presented here, even though the hydride transfer step 
conformation and out-of-step functioning of the two monomers were not observed in our 
structures. 
 
5.1.2. Work arising 
It would be important to trap the mammalian transhydrogenase in more conformations. 
Trapping mammalian NNT in a pure asymmetric state seems hard to achieve in the light of the 
mechanism proposed here. Face-up conformation is transient in solution which is a feature of 
the mechanism. Different mixtures of nucleotides or NADP(H) analogues could stabilize the 
face-up conformation, but ultimately it is difficult to predict which precise conformation a 
particular substrate or analogue mixture would stabilize. 
A purely asymmetric structure can probably be obtained only in the case of NNT during 
active turnover, when the two monomers are catalysing reaction out-of-phase. Even then, due 
to the transience of dI-dIII, the asymmetric conformation might be very short-lived. Perhaps 
the most likely conditions for the asymmetric state would be turnover with low NADH and 
high NAD+ concentration, such that NADH binding to dI becomes the limiting step in the 
entire turnover, and the enzyme waits in the asymmetric state for NADH to bind. In the 
complete absence of nucleotides, NNT will revert to an auto-inhibited apo structure.  
The structures of NNT during active turnover and at high resolution could allow 




It could also give rise to understanding of the ratios of different species during active turnover 
and identification of rate-determining steps, perhaps under different conditions.  
Perhaps most interestingly such a study could help us understand the exact out-of-phase 
mechanism of NNT and the role of the dimer. To what extent the two monomers are 
coordinated is the major unsolved question in the NNT mechanism. Structures during active 
turnover could help to establish this. 
Finally, because of the critical differences between the bacterial and mammalian 
transhydrogenases, the structure of bacterial NNT needs to be determined as well. This will 
allow the comparison with the mammalian mechanism and determine whether any differences 
exist. Bacterial NNT can also be mutated and the structures of the mutants solved or further 
biochemically characterised. In particular, the mutants of the dII-dIII, dI-dIII interfaces, such 
as R544, N154 or Q175 would be interesting. Secondly, mutants of the proton translocation 
pathway could help to determine or confirm the roles of some of the less obvious residues in 
the vicinity of H664, such as S799, T495 or S492. Finally, the structural ramifications of E-
loop mutants such as Y1006 would be particularly interesting as they give rise to decoupled 
NNT without the occluded dIII conformation. Finally, the constructing a covalently linked 
NNT dimer would allow one to mutate only one of the monomers and the biochemical 
properties and structures of such mutants could be useful for probing the role of the dimer for 
the catalysis of NNT reaction.  
 
5.2.Complex I  
5.2.1. Principles of coupling in complex I 
Similarly to NNT, complex I is also a reversible enzyme, and it can oxidise quinol and 
reduce NAD+ if the driving proton-motive force is large enough. The reaction can also occur 
in vivo but is undesirable as it results in large amount of ROS production at the FMN site and 
the existence of the deactive state has been argued to be a mechanism to prevent this (Galkin 
et al., 2008; Babot et al., 2014). Also, S-nitrosylation at the C39 of the ND3 loop has been 
described to be connected with lowering the ROS production and backflow of electrons 
(Chouchani et al., 2016).  
 The mechanism of coupling proposed here is easily reversible which is consistent with 
the previous observations. High pmf would promote the reverse reaction by promoting 
alternative antiporter conformations. Translocation of protons would create a negative 
electrostatic potential (probably localised on the Y108/H59/D160 triad), which would promote 
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quinol binding and oxidation. Negatively charged Y108/H59/D160 triad would also lower the 
N2 redox potential enabling reverse electron transfer from N2 to FMN and NAD+. 
 As in the NNT mechanism, both electrostatic and conformational changes contribute to 
the coupling. Slipping is preventing by coupling proton pumping to disordering and ordering 
of the quinone binding cycle, thus preventing more than one quinone to bind per proton 
translocation cycle. Furthermore, only one quinone can fit into the cavity at any one time.  
 
5.2.2. Work arising 
Further structural work will be required to firmly establish all the intricacies of the 
model proposed here. In particular it will be important to differentiate between the two proton 
pumping models proposed in Chapter 4: four protons translocated by ND5 or one proton 
translocated per antiporter. The main reason for ambiguity at the moment is the different 
hydration pattern between the antiporter subunits with only ND5 showing clear water wires 
connecting the matrix and IMS sides of the membrane. It would be interesting to prepare 
complex I samples at different pH values or in energised proteoliposomes to potentially observe 
different conformations or hydration patters in the antiporter-like subunits. Additionally, higher 
resolution structures with only quinone (or quinol) bound could help resolve the question 
whether quinone/quinol on its own can promote alternative conformations.  
Structures of complex I from other organisms at similar resolutions will be interesting 
to compare and contrast the mechanisms outlined here. Firstly, structures of Y. lipolytica and 
other related complex I proteins with similar ND6 architecture will help to understand the ND6-
drive deactivation mechanism proposed here. As the coupling mechanism is probably 
conserved in bacteria as well as the wider complex I-like protein family, deeper structural 
understanding of these systems will be important to understand the most conserved features of 
the complex I structure and mechanism. Additionally, site-directed mutagenesis could provide 
evidence for many facets of the mechanism presented here. Despite several residues having 
already been mutated in complex, in particular the N- and C-terminal lysines and several 
residues of the quinone binding loops, more work is needed, in particular in the light of the 
specific predictions made by the mechanism here.  
Ultimately, some direct observation of proton pumping will be necessary in the future 
to fully establish the mechanism proposed here. There is potential for time-resolved cryo-EM 
in this area, but numerous technical difficulties will need to be solved to make this a useful 
technique. Another branch of investigations in the future are also studies of complex I in situ, 




5.3.Grotthuss model of proton pumping 
As described in the introduction, proton pumping can be direct or indirect. Direct proton 
pumping happens when the proton carrier itself is sequentially oxidised and reduced. Indirect 
proton pumping on the other hand is mediated by proton carriers which do not get themselves 
oxidised or reduced. 
Protons can also follow two paths across the membrane, either they are carried by a 
membrane-soluble mobile carrier such as quinone or they follow pathways within proteins 
specialised for proton translocation. As the latter is the situation encountered in complex I and 
NNT, it warrants a more thorough discussion. 
It has been proposed already in 1806 that protons could diffuse along a string of water 
molecules by hopping from one molecule to another (Figure 5.1). This way, formation of a 
covalent bond of a proton with the next water molecule and cleavage of a covalent bond with 
the previous water molecule results in productive translocation of a proton (Cukierman, 2006). 
This mode of proton translocation is believed to be the dominant mode in proteins and has been 
described in photosynthetic reaction centres, bacteriorhodopsin, cytochrome c oxidases. It 
probably occurs also in proton channels (Li et al., 2015). This mode of proton translocation 
allows a tight control over translocation of single protons, which are otherwise highly mobile 
in solution (protons have the highest electrical mobility of all biologically important ions and 
are 10-fold more mobile than cations of alkali metals for example).  
 
Figure 5.1. Grotthuss mechanism of proton transfer. 




The water wire in the figure above presents a proton-permeable pathway but it is passive 
and cannot be controlled. In proteins instead of a long string of waters permeating the 
membrane, some positions are usually exchanged for protonatable side chains, such as lysine, 
histidine, aspartate and glutamate or hydroxyl group-containing side chains such as tyrosine, 
serine and threonine (Figure 5.2). This does not change the underlying mechanism of proton 
translocation but allows more control over the process and allows the proton pumps to couple 
proton pumping to other enzymatic processes by adjusting pKa values of the intervening 
residues. Aspartate and glutamate have pKa 4.0 and 4.5 respectively and are negatively charged 
at neutral pH, while lysine has pKa 10.4 and is positively charged at neutral pH (Fersht, 1985). 
Histidine has pKa around 6.0 and can be either neutral or positively charged at neutral pH. The 
pKa values depend strongly on the electrostatic environments around the residues and can vary 
widely (Nakamura, 1996). In Figure 5.2 increasing the pKa value of glutamate, such that it is 
neutral in step 1 closes the proton translocation channel. Similarly, increasing the pKa of lysine 
such that it is protonated in ground state would stop the proton translocation at the step 3. 
Fluctuations in protein conformation, electrostatic influences of substrate binding or redox 
reactions can modulate transfer of protons by changing the pKa of side chains which are parts 
of the water wires. This was confirmed both by NNT and complex I structures, which had at 
least two protonatable “gate-keeping” residues in each proton chain.  
 
 





pKa values of hydroxyl-group containing residues are too high for them to exist in stable 
negatively or positively charged states, hence they can only serve as water-chain mediators but 
probably not as gate-keepers providing appreciable control over the proton translocating 
pathways.  
The remaining questions in proton pumping mechanism are to what extent the diffusion 
of hydronium ions and water is allowed along the path, which probably depends on the exact 
protein environment surrounding them. Deep within the dry regions of NNT proton path and 
complex I antiporter channels there is probably little diffusion due to steric occlusion. On the 
other hand, complex I contains quite large water-filled pockets between the antiporters and the 
E-channel/quinone cavity which can accommodate several water molecules that should in 
principle be laterally mobile. Whether proton transfer to reduced quinone happens by H3O+ 
diffusion or by proton hopping along a chain of water molecules will need to be established in 
future studies.  
Another crucial open question with regards to water wires is how transient they are. If 
there are intervening protonatable protein residues the pKa of which is controlled, then water 
wires could in principle exist all the time without disrupting the pmf. Indeed, a complete water 
wire was observed in ND5 subunit of complex I. On the other hand, the formation of the water 
wire could happen in an otherwise dry region of the protein only at a decisive point during the 
reaction which would add another layer of control over proton translocation. Molecular 
dynamics simulations suggests that water wire formation is transient in transhydrogenase dII 
(Padayatti et al., 2017). Understanding to what extent the water wires are transient will be 
necessary to distinguish between the two models of proton translocation proposed for complex 
I: the ND5-all and one-antiporter-one-proton models. Currently it is not possible to say whether 
the differences in the hydration of antiporters in complex I mean that only ND5 translocates 
protons or that water wire formation in ND4 and ND2 is transient and was not observed 
experimentally. 
 
5.4.Redox-coupled proton pumping 
5.4.1. Role of electrostatic interactions 
Electrostatic interactions are the core of the proton pumping mechanisms in both NNT 
and complex I. They have also been proposed for photosystem II and cytochrome c oxidase 
(complex IV) (Ugur, Rutherford and Kaila, 2016; Saura et al., 2019). Because proton gating as 
described above necessarily requires changes of pKa of critical residues, electrostatic control is 
probably a universal principle for redox-coupled proton pumping.  
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Electrostatic interactions are strong long-range interactions, because the Coulombic 
interactions between charged objects diminishes with distance only as r-1. Charge separation is 
therefore rare at the macroscopic scale because it is too high-energy, however, at the 
microscopic scale it can drive processes. Electrostatic potential energy, U(r) of a single point 
charge in the presence of another charge can be expressed as U(r) = C q1 q2 / D r, where C is 
the Coulomb’s constant, q1 and q2 are the charges, D is a dielectric constant and r is the distance 
between the charges. Alternatively, at the molecular scale it is useful to think about the above 
relationship as the Bjerrum length, lB, which is the charge separation at which the Coulombic 
electrostatic potential between the charges just equals the thermal energy. lB = C q1 q2 / D kB 
T. 
In water, which is a polar solvent, electrostatic ions are well shielded, which is reflected 
by a high dielectric constant of water D = 80 (at room temperature). Dielectric constant reflects 
1) the polarizability of atoms and molecules of the solvent themselves, 2) their permanent 
dipole moment, and 3) the polarizability from a shift in the network of hydrogen bond. 
Additionally, when salts are dissolved in water, they will also shield electrostatic objects.  
In protein cores, the dielectric constant is much smaller, because there is no network of 
hydrogen bonds, and only polarizability and dipole moments make contributions, and even the 
dipole moments in protein cores are usually aligned such as in alpha helices, to cancel each 
other out and assume the most stable lowest energy conformation. D within proteins has been 
estimated to be around 4.  
This difference in dielectric constants means that the Bjerrum length for two charges 
within the protein at 37ºC is 134 Å, while in water it is only 7 Å. Within a typical protein, 
nearly all the charges will “feel” each other and will be carefully balanced. Any perturbation 
to the network will cause long-range changes, which if appropriately tuned and harnessed can 
be used to drive processes. In NNT, 13 Å separation between the nicotinamide and histidine-
664 of opposing or equal charges therefore results in electrostatic potential 10-fold larger than 
the thermal energy and can drive dIII dissociation. Equally, in complex I, most charged residues 
along the central axis are within 10 Å and influence each other electrostatically as suggested 
by the mechanism. The mechanisms suggested in this thesis are thermodynamically feasible. 
Electrostatic mechanisms probably occur to some extent in all proton pumping, as they provide 
a large driving force and are easy to generate by adjusting pKa of protein residues or redox 






5.4.2. Role of cooperativity 
Cooperativity is often employed in biology to make transitions between states sharper. 
The role of cooperativity in complex I and NNT mechanisms is still speculative. Nevertheless, 
in NNT, the two monomers appear to be negatively cooperatively linked which ensures anti-
phase action. The best evidence for this comes from measurements of Kd, which show that 
binding of a substrate on one monomer increases the Kd for the same substrate on the other 
monomer (Venning et al., 2000). The structures presented here suggest many possible ways of 
communications between the monomers that could explain this cooperativity, such as dIII-dIII 
interaction or regulating dI-dIII formation. In complex I the role of cooperativity is even more 
speculative, but it is not hard to envisage that the row of three antiporters in complex I 
membrane domain does display some cooperativity. As the mechanism suggests, once one 
antiporter switches the conformation, it is more energetically favourable for the other 
antiporters to switch into the same conformation as well.  
In proton pumps in general, the role of cooperativity could perhaps help to ensure the 
correct stoichiometry between the redox reactions and proton translocation and thus prevent 
slipping. In NNT, action as a dimer likely adds another layer of control: hydride transfer step 
in one monomer is coupled to proton transfer in the other and the reaction cannot proceed until 
both are complete. Thus, the two monomers keep each other in check. Similarly, in complex I, 
antiporters seem to undergo transitions between the alternative states cooperatively. Apart from 
slipping this could also ensure the correct stoichiometry of proton pumping in complex I as the 
reaction can proceed to the next step only after all the antiporters have switched and 
translocated a proton. This could be especially important for pumps with more than one 
translocation pathway.  
 
5.4.3. Role of conformational changes 
Conformational changes do not necessarily have to have a role in proton pumping, as 
the Grotthuss mechanism can readily operate on a purely electrostatic basis. However, 
conformational changes can open and close substrate binding sites and proton translocating 
pathways. In both complex I and NNT conformational changes play a crucial role. The reason 
could be that conformational changes can easily provide directionality to the reaction and thus 
make the system more robust and less prone to errors such a slipping. Additionally, a 
conformational change mechanism might be easier to evolve and be less sensitive to mutations 




It seems that a conformational change mechanism is employed to control the substrate 
exchange in both complex I and transhydrogenase. In complex I quinone binding cavity 
changes shape dramatically and controls quinone binding in the deep and the shallow sites. 
Controlled binding to the two sites is connected to proton pumping and thus the coupling 
between the redox reaction and proton pumping is controlled. If conformational changes were 
not involved and quinone binding and reduction in the deep site could happen at any time, it is 
easy to imagine the uncoupling of the redox reaction from proton pumping.  
In transhydrogenase, E loop closes over the nucleotide and prevents its dissociation 
until dIII binds dII and opens the proton channel. Again, substrate exchange is coupled to 
proton pumping and, in many ways, the two mechanisms are analogous. Should NADP(H) be 
allowed to exchange freely with the solution, transhydrogenation reaction would easily become 
decoupled from the proton pumping.  
Whether slipping could be prevented by purely electrostatic means is difficult to 
ascertain. Since complex I and transhydrogenase are completely reversible enzymes, 
conformational change is perhaps necessary to drive the reaction in a single direction. In 
irreversible enzymes, however, formation of the product could drive the reaction forward and 
maintain the correct sequence of events and stoichiometry without the need for large 
conformational changes. 
 
5.5.Comparison to other redox-coupled proton pumps 
Many other redox-coupled proton pumps exist, some distant relatives of the enzymes 
described here and some completely unrelated. Complex I is part of the large family of proteins, 
including Mbh, Mrp and Ndh, with shared broad structural features and evolutionary history. 
Nevertheless, the structures of these related proteins are only now starting to be described. It 
will be important to see to what extent the mechanism is conserved between these enzymes. 
Interestingly, they can contain between one and four antiporter-like subunits and thus adjust 
the stoichiometry of proton pumping. Furthermore, proton pumping modules do not necessarily 
have to be coupled to quinone reduction but can also be connected to sodium translocation with 
seemingly minor structural changes in Mrp and it will be interesting to understand how the 
modular architecture of complex I is compatible with the mechanism.  
Transhydrogenase does not have any known homologous proteins, and in particular no 
known homologues of the proton-translocating dII domain. However, comparison between the 





Among unrelated proton pumps, Complex III is the only mitochondrial proton pump 
that employs a redox loop mechanism to pump protons across the membrane. Hence, it does 
not operate by a Grotthuss mechanism, but conformational changes and electrostatics 
nevertheless play an important role. Firstly, electrostatic potentials of redox groups are 
carefully tuned to allow electron bifurcation after each oxidation of quinol. Conformational 
changes, on the other hand, are involved in electron transfer between haems b and c as the 
swivelling of the Rieske protein shuttles the electrons between the two haemes.  
Finally, complex IV is the only "purely electrostatic” proton pump which employs a direct 
proton pumping mechanism. From the discussion in the preceding chapter it appears that this 
is only possible because it is also the only enzyme which catalyses an irreversible reaction. 
Delivery of each electron to the haem a-CuB site results in pumping of a proton. Finally, after 
the delivery of the fourth electron, oxygen double bond is split and reduced, which is an 
essentially irreversible step of the reaction. This resets the enzyme and kinetically restricts its 
return to the previous step.  
The crucial difference to the mechanisms of transhydrogenase and complex I is that if 
complex IV fails to couple proton pumping to redox reaction in one cycle, the enzyme is reset 
before the beginning of the next step and cannot run in the opposite direction. Consumption of 
pmf to produce oxygen and reduced cytochrome c is not possible. In transhydrogenase or 
complex I, on the other hand, failure to couple redox and proton pumping reactions, can 
however result in a futile cycle of substrates or uncoupling of pmf across the inner 
mitochondrial membrane. Decoupled transhydrogenase would catalyse a reaction between 
NADH and NADPH until the electric potentials of the two nucleotide pools equilibrated. Even 
worse, reverse operation of complex I would result in disruption of the proton motive force and 
ROS production. 
This notion could perhaps explain why complex I and transhydrogenase employ both 
electrostatic and conformational mechanisms for redox reaction coupling to proton pumping. 
Additionally, cooperativity between the two monomers of transhydrogenase and between the 
three antiporter-like subunits of complex I could exert further control on the transitions between 
the conformational states of these enzymes. We are beginning to understand how different 
unrelated enzymes have evolved similar or different mechanisms to solve the same underlying 
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Data collection and 
processing 
   
Magnification    130000x 130000x 130000x 
Voltage (kV) 300 300 300 
Electron exposure (e–/Å2) 72 72 90 
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Appendix 2 – Model and data collection statistics for native complex I 
dataset 
 




















Data collection and 
processing 
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Data collection and 
processing 
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